

























The Dissertation Committee for Alexander Asterios Plionis  
 
              certifies that this is the approved version  
 





Automated Multi-Radionuclide Separation and Analysis with  
 




     Committee: 
 
     Sheldon Landsberger, Supervisor 
 
     Kendra Biegalski 
 
     Steven R. Biegalski 
 
     Erich A. Schneider 
 
     Dominic Peterson 
 
Automated Multi-Radionuclide Separation and Analysis with 









Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 
Doctor of Philosophy 
 
 









I would like to dedicate this dissertation to my wife, Krista Scott Plionis.  Her love and 









I would like to thank Dr. Sheldon Landsberger for guiding me to this research 
project and for all the advice and encouragement he has provided me during the course of 
its research and writing.  From him I have learned not only the academics of Nuclear 
Engineering, but also the traits of a professional scientist. 
I would also like to thank Dr. Dominic Peterson for his supervision of my 
research during my time at the Los Alamos National Laboratory.  From him I have 
learned how to function as a scientist within the national lab complex. 
In addition, I would like to express my deepest gratitude to Edward Gonzales for 
mentoring and supporting me throughout my tenure at Los Alamos.  His recent mentor of 
the year award is a well-deserved honor. 
I am very grateful to my entire family and especially my wife for all of their love 
and support in getting me though all of life’s difficulties. 
Special appreciation is given the entire faculty and staff of the Nuclear 
Engineering Program for their time, advice, and patience during my studies at the 
University of Texas at Austin.  This appreciation is also extended to the entire Chemical 
Sciences and Engineering group at the Los Alamos National Laboratory for their 
generous financial, technical, and moral support throughout this project. 
 vi
Automated Multi-Radionuclide Separation and Analysis with 





Alexander Asterios Plionis, PhD 
The University of Texas at Austin, 2007 
 
Supervisor:  Sheldon Landsberger 
 
The radiological dispersal device (RDD) is a weapon of great concern to those 
agencies responsible for protecting the public from the modern age of terrorism.  In order 
to effectively respond to an RDD event, these agencies need to possess the capability to 
rapidly identify the radiological agents involved in the incident and assess the uptake of 
each individual victim.  Since medical treatment for internal radiation poisoning is 
radionuclide-specific, it is critical to identify and quantify the radiological uptake of each 
individual victim.  This dissertation describes the development of automated analytical 
components that could be used to determine and quantify multiple radionuclides in 
human urine bioassays.  This is accomplished through the use of extraction 
chromatography that is plumbed in-line with one of a variety of detection instruments.  
Flow scintillation analysis is used for 90Sr and 210Po determination, flow gamma analysis 
is used assess 60Co and 137Cs, and inductively coupled plasma mass spectrometry is used 
to determine actinides.  Detection limits for these analytes were determined for the 
appropriate technique and related to their implications for health physics. 
 vii
Table of Contents 
List of Tables ......................................................................................................... ix 
List of Figures ...................................................................................................... xiv 
List of Figures ...................................................................................................... xiv 




Chapter 2:  Relevant Theory ..................................................................................21 
High pressure extraction chromatography (hpec), principles and practices .21 
Extractive resins............................................................................................25 
Flow scintillation/gamma counts, principles and applications .....................39 
Mass Spectrometry, principles and applications...........................................45 
Chapter 3:  Flow Scintillation Analysis of 90Sr .....................................................51 
Introduction...................................................................................................51 
experimental..................................................................................................54 
Results and discussion ..................................................................................57 
Conclusions...................................................................................................68 
Chapter 4:  Flow Scintillation Analysis of 210Po ...................................................69 
Introduction...................................................................................................69 
Experimental .................................................................................................72 
Results and discussion ..................................................................................75 
Conclusions...................................................................................................89 
Chapter 5:  Flow Gamma Analysis of 60Co and 137Cs ...........................................90 
Introduction...................................................................................................91 
experimental..................................................................................................94 
Results and discussion ..................................................................................99 
 viii
Conclusions.................................................................................................106 
Chapter 6:  Optimization of Actinide Analysis By HPEC and ICP-MS .............108 
Introduction.................................................................................................108 
experimental................................................................................................111 
Results and discussion ................................................................................113 
conclusions..................................................................................................127 
Chapter 7:  Actinide Separation and Electrodeposition Using HPEC .................128 
Introduction.................................................................................................128 
experimental................................................................................................132 
Results and discussion ................................................................................136 
Conclusion ..................................................................................................142 
Chapter 8:  Health Physics Implications..............................................................143 
Internal dosimetry practices........................................................................144 
90Sr risk assesment ......................................................................................148 
210po risk assesment ....................................................................................150 
Short-lived Gamma  emitter risk assesment ...............................................151 
Actinide risk assesment...............................................................................155 
Conclusions.................................................................................................156 
Chapter 9:  Conclusions and Recommendations .................................................160 
Conclusions of research efforts...................................................................161 
applicability of developed methods to health physics ................................164 
Recommendations for interpretation and application of this research........166 
Recommendations for future research ........................................................167 
Outline of work done by the author ............................................................170 






List of Tables 
Table 1.1: Isotopes of Concern for Use in an RDD. ............................................2 
Table 2.1: Converting Dw to k’ (eichrom.com/products/extraction.cfm) ..........27 
Table 3.1: Gradient used in this study................................................................55 
Table 3.2: Simulated urine bioassay result.  All recoveries activities are within one 
standard deviation of the activities administered..............................66 
Table 4.1: Gradient used in this study................................................................73 
Table 4.2: Percent of each isotope recovered in the column effluent.  Lead is not 
retained on the column and is found entirely within the effluent of the 
HCl load solution.  Bismuth is found entirely within the first 50 mLs of 
the nitic strip.  Polonium is eluted with subsequent additions of nitric 
acid, with diminishing returns after 150 mLs of nitric acid..............76 
Table 4.3: Dilute urine bioassay results.  The bias corrected activities of the 
samples are shown with their determined recoveries.  Both sample 
recoveries are within one standard deviation of expected values.  For the 
10x dilution with 417 DPM, calibration curve C was used to correct for 
the bias.  For the 5x dilution with 500 DPM, calibration curve B was 
used. ..................................................................................................88 
Table 5.1: Background activity for 60Co and 137Cs. .........................................102 
Table 5.2: Critical, detection, and quantification limits for a 30 minute count of a 
60Co or 137Cs source, using the NaI(Tl) detector.............................102 
Table 5.3: Detection limits for transient-flow counting of a 60Co or 137Cs samples, 
versus different flow cell volumes for the NaI(Tl) detector. ..........103 
Table 6.2: Elution gradients used in this work.................................................114 
 x
Table 7.1: Commonly encountered alpha-emitting actinides. .........................130 
Table 7.2: Gradient used in this study..............................................................133 
Table 7.3: Fraction collection windows and associated actinide isotopes. ......138 
Table 7.4: The total recovered actinide fraction in each collection window. ..140 
Table 8.1: Summary of urine health physics data.  The table shows the activity of 
each isotope that would be expected in urine from patients with a lethal 
dose and from those with a 1 in 1M chance of mortality for inhalation 
and ingestion. ..................................................................................157 
Table A.1: 90Sr inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FSA (green).....................................................................................175 
Table A.2: 90Sr ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FSA (green).....................................................................................176 
Table A.3: 210Po inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FSA (green), alpha spectrometry (yellow)......................................177 
Table A.4: 210Po ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FSA (green), alpha spectrometry (yellow)......................................178 
Table A.5: 60Co inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FGA (orange), FSA (green). ...........................................................179 
 xi
Table A.6: 60Co ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FGA (orange), FSA (green). ...........................................................180 
Table A.7: 137Cs inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FGA (orange), FSA (green). ...........................................................181 
Table A.8: 137Cs ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
FGA (orange). .................................................................................182 
Table A.9: 233U inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow).  For this isotopes the limits for ICP-MS 
and alpha spectrometry are very similar, so only the limit for ICP-MS is 
shown. .............................................................................................183 
Table A.10: 233U ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................184 
Table A.11: 235U inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. ICP-MS (blue), alpha 
spectrometry (yellow). ....................................................................185 
Table A.12: 235U ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. ICP-MS (blue), alpha 
spectrometry (yellow). ....................................................................186 
 xii
Table A.13: 238U inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. ICP-MS (blue), alpha 
spectrometry (yellow). ....................................................................187 
Table A.14: 238U ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. ICP-MS (blue), alpha 
spectrometry (yellow). ....................................................................188 
Table A.15: 237Np inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................189 
Table A.16: 237Np ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................190 
Table A.17: 238Pu inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), alpha 
spectrometry (yellow). ....................................................................191 
Table A.18: 238Pu ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), alpha 
spectrometry (yellow). ....................................................................192 
Table A.19: 239Pu inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................193 
Table A.20: 239Pu ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................194 
 xiii
Table A.21: 242Pu inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................195 
Table A.22: 242Pu ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................196 
Table A.23: 241Am inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), alpha 
spectrometry (yellow). ....................................................................197 
Table A.24: 241Am ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), alpha 
spectrometry (yellow). ....................................................................198 
Table A.25: 243Am inhalation risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................199 
Table A.26: 243Am ingestion risk assessment.  Colored lines indicated quantification 
limits for various analytical techniques. TIMS (pink), ICP-MS (blue), 
alpha spectrometry (yellow). ..........................................................200 
 xiv
List of Figures 
Figure 1.1: The flow scintillation/gamma system. 1) The computer system. 2) The 
gradient pump. 3) The reagent bottles. 4) The analytical injector (syringe 
port). 5) The 2000 μL sample loop. 6) The extraction chromatography 
column. 7) The β-RAM model 4B flow scintillation unit. 8) The tandem 
flow gamma detector.........................................................................14 
Figure 1.2: Inside the tandem flow gamma detector.  The well-type NaI detector is 
housed within a formed lead casing.  The high voltage source and pre-
amplifier are housed within unit casing.  Not pictured is the DSpec Pro 
MCA and positive NaI interface module. .........................................15 
Figure 1.3: The mass spectrometry system. 1) The computer system. 2) The ion 
chromatography unit. 3) The reagent bottles. 4) The autosampler. 5) The 
nebulizer. 6) The mass spectrometer. Not pictured is the chromatography 
column...............................................................................................16 
Figure 1.4: The fraction collector.  Plumbed into the column exit, this system 
distributes the effluent into one of several containers according to a pre-
programmed protocol........................................................................17 
Figure 1.5: The electrodeposition system. 1) The constant current power supply. 2) 
The cell holder. 3) An electrodeposition cell....................................18 
Figure 1.6: An electrodeposition cell.  The cell is comprised of a platinum wire 
anode that is connected to the power supply, an attachable cathode cap 
that fits onto the bottom of the cell, and the plastic holding cell, itself.  
Not pictured is a 5/8” diameter stainless steel planchette, onto which the 
actinides are deposited. .....................................................................19 
 xv
Figure 1.7: The alpha spectrometry system.  This system features 44 individual 
alpha spectrometers that are managed by one of four input MCB 
Ethernims.  Not pictured is the vacuum pump and manifold that allows 
all of the counting chambers to be pumped down to the desired pressure.  
Also not pictured is the computer system which collects and analyzes the 
spectra. ..............................................................................................20 
Figure 2.1: A generic chromatogram.  This chromatogram shows six eluent peaks 
over the course of the run time and their normalized detector response 
(adapted from c2v.nl)........................................................................23 
Figure 2.2: The extractive crown ether molecule that gives Sr Spec resin its 
properties (eichrom.com)..................................................................28 
Figure 2.3: Acid dependency of Sr on Sr Spec resin.  Sr is well retained from high 
concentrations of nitric acid and is not well retained for low 
concentrations (Eichrom.com)..........................................................29 
Figure 2.4: Acid dependency of Po on Sr Spec resin.  Po is well retained from ~1M 
nitric acid.  Po is not well retained for high or low concentrations of 
HNO3 (Eichrom.com)........................................................................30 
Figure 2.5: HCl dependency of Po and Sr resin (Vajda 1997). ...........................31 
Figure 2.6: Effects of nitrate salt concentration on Sr retention on the Sr resin 
(Eichrom.com). .................................................................................32 
Figure 2.7: Elution behavior of common elements and fission products on the Sr 
resin.  Dilute oxalic acid can be added to the load solution to prevent the 
adsorption of actinides (Eichrom.com).............................................33 
Figure 2.8: The extractive CPMO molecule that gives TRU resin its properties 
(Eichrom.com). .................................................................................34 
 xvi
Figure 2.9: Acid dependency factors for actinides on TRU resin (Eichrom.com).35 
Figure 2.10: Acid dependency factors for uranium on TRU resin with varying 
concentrations of oxalic acid (Eichrom.com). ..................................36 
Figure 2.11: Effects of matrix interferences with Am retention on TRU resin.  Fe(III) 
is the principle interference (Eichrom.com). ....................................37 
Figure 2.12: Elution behavior of common elements and fission products on the TRU 
resin (Eichrom.com). ........................................................................38 
Figure 2.13: A Typical Homogenous Flow Cell. ..................................................40 
Figure 2.14: Proper Placement of the Flow Cell within an FSA (modified from 
L’Annunziata 2003) ..........................................................................40 
Figure 2.15: Schematic Diagram of an the Internal Structure of an ICP-MS 
(L’Annunziata 2003).........................................................................46 
Figure 2.16: Sample Spectrum from a Mass Spectrometer.  Each actinide is 
represented by a different color.  The time is in seconds after   the start 
of an elution scheme.  Pulse intensity is in counts per second. ........48 
Figure 2.17: The relationship between isotope half-life and mass equivalence for a 1 
Bq sample.  The dashed line represents the detection limits for 239Pu 
with the indicated mass spectrometer (McAninch 1999). ................49 
Figure 3.1: A Block Diagram of the Flow Analysis System...............................56 
Figure 3.2: The spectral appearance of 90Sr/Y within the β-RAM. Most of the signal 
occurs within channels 0-600............................................................57 
 xvii
Figure 3.3: Sample chromatograms showing the 90Y and 90Sr peak locations over the 
course of 4 analysis cycles for a 3cm column.  The 90Y peak is more or 
less consistent, while the 90Sr peak drifts.  The column finally fails on 
the 4th cycle, when 90Sr is not retained and co-elutes with 90Y in one 
large peak. .........................................................................................59 
Figure 3.4: Sample chromatograms showing the 90Y and 90Sr peak locations over the 
course of 16 analysis cycles for a 15cm column.  The 90Y peak is more 
or less consistent, while the 90Sr peak drifts slightly.  The column finally, 
failed on the 17th cycle (not shown)..................................................60 
Figure 3.5: Peak heights versus various activities of 90Sr for 3cm and 15cm 
columns. ............................................................................................61 
Figure 3.6: A calibration curve of detector response to various levels of 90Sr activity 
as determined by transient-flow counting.  The fact that the value for R2 
is close to unity and that the intercept is near zero indicates that there is a 
highly linear detector response for this analyte.  Error bars represent 3σ.
...........................................................................................................63 
Figure 3.7: Detector traces for various activities of 90Sr as determined by transient-
flow counting and a 3cm column.  Traces as low as 264 dpm are visually 
apparent.  Computer-aided peak finders are helpful for detecting lower 
activities of 90Sr.................................................................................64 
Figure 3.8: Maximum 90Sr peak height for various urine concentrations.  Peak 
height declines with increasing urine concentration as a result of peak 
broadening.........................................................................................67 
Figure 4.1: A Block Diagram of the Flow Analysis System...............................74 
 xviii
Figure 4.2: The spectral appearance of 210Po within the β-RAM. Most of the signal 
occurs within channels 100-350........................................................77 
Figure 4.3: Sample chromatogram showing the 210Po peak location.  Note, that two 
distinct peaks occur.  A minor peak at ~9 min. and the major peak at ~12 
min. ...................................................................................................78 
Figure 4.4: Figures of merit resulting from the 210Po peak resulting from various 
eluents.  The 6M HNO3 strip solution is clearly the best reagent to 
remove polonium from the Sr-Spec resin. ........................................81 
Figure 4.5: Plots of the figures of merit for the peaks resulting from various load 
solutions. ...........................................................................................82 
Figure 4.6: Plots of effective efficiency and figure of merit at peak maximum for 
various cocktail/eluent ratios.  The optimum ratio is between 1.75 and 2.
...........................................................................................................83 
Figure 4.7: A trace of 210Po as determined by transient-flow counting and by 
stopped-flow counting. .....................................................................84 
Figure 4.8: Various activities of 210Po determined by stopped-flow counting.  While 
not shown for clarity, a trace of 104 DPM registered an average CPM of 
4.2......................................................................................................86 
Figure 4.9: A calibration curve of detector response to various levels of 210Po 
activity as determined by stopped-flow counting.  Non-linear detector 
responses seem to persist for activities of < 400 DPM.  Three possible 
trendlines are shown. A) Includes all points, y = 1.0398x -104.24, R2 = 
0.93. B) Includes activities >400 DPM, y = 1.4781x -407.2, R2 = 0.9702. 
C) Includes activities <400 DPM, y = 0.5002x +16.1, R2. ...............87 
Figure 5.1: Block diagram of the FSA and FGA units........................................96 
 xix
Figure 5.2: NaI(Tl) efficiency curve. ..................................................................97 
Figure 5.3: 200 μL gamma flow cell.  The sample flows in one end and out the 
other.  The metal spacer ensure that the flow cell is positioned within the 
well of the NaI(Tl) counter.  Larger cells may also be accommodated.
...........................................................................................................98 
Figure 5.4: Detector traces of 60Co and 137Cs observed by FSA.  2170 dpm of 137Cs 
and 1662 dpm of 60Co both elute approximately 3.5 minutes after 
injection.  60Co peaks were generally somewhat broader than 137Cs 
peaks. ..............................................................................................100 
Figure 5.5: The γ-ray energy spectrum of a mixed 137Cs/60Co source.  Regions of 
interest (ROIs) are bounded by red lines. .......................................101 
Figure 5.6: 60Co calibration curve.  y= 0.723x -260, R2 = 0.9926.  Error bars are 3σ.
.........................................................................................................105 
Figure 5.7: 137Cs calibration curve.  y= 0.762x -414, R2 = 0.9954.  Error bars are 3σ.
.........................................................................................................105 
Figure 6.1: Separation of actinide analytes on 30 cm long TRU resin (50-100 µm) 
packed at pressures between 1000 psi and 3000 psi.  Separation using 
Gradient 2 in Table 6.2. ..................................................................115 
Figure 6.2: Separation of Pu, Am, and Np on columns of 30 cm, 10 cm, and 3 cm.  
Columns were packed with TRU resin (50-100 µm) at a pressure of 
3000 psi.  Separation using Gradient 2 in Table 2..........................117 
Figure 6.3: Separation of actinide analytes on columns of 3 cm, 10 cm, and 30 cm.  
Columns were packed with TRU resin (50-100 µm) at a pressure of 
3000 psi.  Separation using Gradient 2 in Table 6.2.......................119 
 xx
Figure 6.4: Separation of actinide analytes on columns packed with different sizes of 
TRU resin (100-150 µm, 50-100 µm, 20-50 µm).  All columns were 3 
cm long and were packed with a packing pressure of 3000 psi.  
Separation using Gradient 2 in Table 6.2........................................121 
Figure 6.5: Flow rate versus pressure.  Note the good linearity up to very high flow 
rates. ................................................................................................122 
Figure 6.6: Retention of Americium on a 3 cm long TRU column (50-100 µm, 3000 
psi packing pressure) at flow rates between 1 ml/min up to 8 ml/min.123 
Figure 6.7: :  Separation of actinides on a 3 cm long TRU column (50-100 µm, 3000 
psi packing pressure).  Flow rates were 2 ml/min, 3 ml/min, 4 ml/min 
and 8 ml/min. ..................................................................................124 
Figure 6.8: :  Separation of actinides using Gradient 3 in Table 2.  Column used was 3 
cm long TRU column (50-100 µm, 3000 psi packing pressure). ...126 
Figure 7.1: A diagram showing the actinide separation and fraction collection 
system. ............................................................................................135 
Figure 7.2: A chromatogram of the normalized mass spectrometer detector response 
to the actinides studied.  Note that small portions of the neptunium peak 
are seen in the region of Pu and Th elution.  This figure also shows 
fraction collection time windows for the collection of the actinide peaks 
into four separate samples for electrodeposition. ...........................137 
Figure 7.3: The results of a typical Th solution run.  Each spectrum shows counts 
versus energy (keV).  Windows 1, 2, and 4 show only the tracer, 230Th, 




Chapter 1:  Introduction 
The radiological dispersal device (RDD) is a weapon of concern to those agencies 
responsible for protecting the public from the modern age of terrorism.  The Centers for 
Disease Control and Prevention (CDC) is charged with promoting health and quality of 
public life by preventing and controlling disease, injury, and disability.  It would be the 
frontline institution for administering to the health and well being of victims of an RDD 
attack.  In order to effectively respond to an RDD event, an agency like the CDC needs to 
possess the capability to rapidly identify the radiological agents involved in the incident 
and assess the uptake of each potential victim.  This task is made more daunting by two 
factors: one, the prospect that a densely populated area will be targeted and two, the fact 
that an RDD can be comprised of one or any number of the thousands of radionuclides 
that exist.  Since medical treatment for internal radiation poisoning is radionuclide-
specific, it is critical to identify and quantify the radiological uptake of each individual 
victim as quickly as possible. 
While over 3,100 radionuclides are known to exist, most have too short a half-life 
to be produced in macro quantities, thus they are not suitable for use in any type of 
weapon (KAPL 2002).  Several dozen radionuclides do exist in significant quantities and 
many of these are accessible in consumer products, industrial sites, and research 
institutions.  In assessing the threat posed by these accessible radionuclides, CDC has 
come up with a short list of radionuclides of greatest concern, shown in Table 1.1.  The 
purpose of this research is to develop analytical components that could be utilized in a 
proto-type system that will analyze and quantify radionuclides from urine samples of 
RDD victims in a rapid and automated manor.  This will be accomplished by the 
chemical separation of analytes using extraction chromatography and multiple counting 
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techniques including: flow scintillation analysis, flow gamma analysis, mass 
spectrometer, and optional off-line alpha spectrometry.       
Table 1.1: Isotopes of Concern for Use in an RDD. 
ISOTOPE DECAYS BY HALF-LIFE 
51Cr β/γ 27.702 d 
57Co β/γ 271.8 d 
60Co β/γ 5.271 y 
90Sr β 28.78 y 
131I β/γ 8.020 d 
137Cs β/γ 30.07 y 
192/192mIr β/γ 240 y 
210Po α 138.38 d 
226Ra α 1599 y 
233U α 1.59E5 y 
235U α 7.04E8 y 
237Np α 2.14E6 y 
238Pu α 87.7 y 
239Pu α 2.41E4 y 
242Pu α 3.75E5 y 
241Am α 432.7 y 




The creation of a system capable of multiple radionuclide separation and analysis 
is extremely complex due to the number of individual components that need to be 
developed and optimized.  Multiple detection methods are required for different types of 
radiations and to accommodate the vast differences in half-lives and emission type of the 
associated nuclides shown in Table 1.  This research attempts to identify, create and 
optimize the necessary components of such a system. 
The detection of 90Sr is difficult because it is a pure beta emitter and has a 
sufficiently high specific activity to preclude detection via inductively coupled mass 
spectrometry (ICP-MS) at biologically important activities.  Liquid scintillation is the 
preferred method of detection for 90Sr, but the technique is problematic in that it requires 
the quantitative separation of 90Sr from virtually all other beta emitters to prevent 
interferences.  To perform this separation, a high pressure gradient pump and an 
extractive chromatographic resin is employed in a technique called high pressure 
extraction chromatography (HPEC).  And while traditional liquid scintillation counting is 
done off-line with a dedicated instrument, this research shows that on-line detection of 
90Sr can be accomplished using flow scintillation analysis (FSA), whereby the HPEC 
effluent is mixed on the fly with scintillating cocktail and counted with a detector that is 
plumbed on-line. 
210Po is an isotope that presents many challenges to its separation chemistry and 
detection.  It is a virtually pure alpha emitter with a very high specific activity.  
Identification and detection are traditionally accomplished by a chemical separation 
followed by deposition onto a planchette for alpha spectrometry.  The same HPEC 
technique employed for 90Sr can be utilized for 210Po by varying the loading and stripping 
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conditions.  This research will show that 210Po may also be detected using FSA—a 
completely novel approach for counting this isotope. 
Among the isotopes in Table 1 are a number of relatively short-lived β/γ emitters 
(51Cr, 57Co, 60Co, 131I, 137Cs, and 192/192mIr).  These isotopes are most easily quantified by 
their high intensity characteristic γ-ray energies.  The isotopes 60Co and 137Cs, are 
representative of this group.  It is, therefore, prudent to use these isotopes to demonstrate 
proof of principle in developing novel counting methods for identification and 
quantization of the short-lived β/γ isotope group.  Traditionally, these isotopes are 
quantified off-line by high purity germanium detectors.  However, automation for these 
off-line systems usually consists of one-of-a-kind custom sample changers that do not 
interface with automated chemistry techniques.  In order to further automate the 
separation and detection of the short-lived β/γ emitter group, they must be incorporated 
into a flowing system.  These isotopes are typically not well retained by HPEC, which 
results in their being separated en mass from the many isotopes that are well retained by 
HPEC.  Detection is accomplished using flow gamma analysis (FGA), whereby a well-
type sodium iodide (NaI) detector is used to provide rudimentary spectral analysis of the 
isotopes in the flowing system.  This research shows that this novel technique is a 
suitable method for quantifying 60Co, 137Cs, and other similar isotopes. 
Another significant isotope group in Table 1 is the long-lived actinide group 
(233U, 235U, 237Np, 238Pu, 239Pu, 242Pu, 241Am, 243Am).  These isotopes are most easily 
quantified using alpha spectrometry and their characteristic alpha radiation energies.  
Alpha spectrometry requires extensive source preparation methods that can only be 
accomplished by off-line radiochemistry (ASTM 2005a; 2005b).  Automated analysis of 
this group is more easily accomplished by mass counting with an ICP-MS.  Since all of 
these isotopes have low specific activities, fast ion counting is usually more efficient than 
 5
radiometric counting techniques.  In addition, mass spectrometry easily accommodates 
automated separation methods, such as HPEC.   
It is conceivable that one might want the flexibility to utilize the automated 
separation techniques to facilitate off-line detection methods.  For this reason, HPEC was 
examined as source preparation tool for traditional alpha spectrometry.  This is 
accomplished by plumbing a fraction collector on-line with the HPEC system to collect 
the column effluent into different beakers.  In this manor, alpha emitters with spectral 
interferences, e.g. 234U and 237Np, can be collected into different beakers and 
electrodeposited separately.  This novel application of HPEC can reduce the typical alpha 
source preparation time by several hours. 
When assessing the detection limits of the techniques that have been evaluated, it 
is important to not lose sight of the health physics implications, as they apply to internal 
dosimetry.  By knowing the effective dose coefficients of the isotopes studied and the 
established detection limits, we can determine the effectiveness of each technique as a 
screening method for determining the level of radiological uptake for the victims that 
produced the sample.  We can therefore determine the committed dose of a given victim, 
and relate this dose to a prognosis in terms of chances of a fatalality .  Such knowledge 
may provide medical professionals with the information they need to determine what, if 
any, treatment is needed for a given patient. 
As outlined above, the research objectives of this work can be concisely stated to 
be to develop and optimize the individual components of an automated radionuclide 
separation and detection system.  These components include 90Sr analysis by FSA, 210Po 
analysis by FSA, 60Co and 137Cs analysis by FGA, actinide analysis by mass 
spectrometry, optional on-line actinide separation for off-line alpha spectrometry, and the 
determination of the health physics implications of the individual component capabilities. 
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LITERATURE REVIEW 
Due to the multifaceted nature of the proposed system, a complete review of the 
literature pertaining to the topics covered in this project would be quite extensive, easily 
comprising thousands of publications.  Among the many components of the proposal are: 
actinide chemistry, synthetic extractive ligands, chromatography, liquid scintillation 
counting, gamma spectroscopy, mass spectrometry, automation techniques, and the 
health physics of bioassays.  In order for this literature review to be concise and relevant, 
it will focus on the intersection of two or more of these topics—extractive resins for 
chromatography, flow scintillation analysis (FSA), flow gamma analysis (FGA), 
polonium chemistry and detection, mass spectrometry for the detection of radionuclide, 
and automated actinide separations for electrodeposition.  The reader is encouraged to 
investigate the works cited herein for a more detailed accounting of specific topics when 
the desired understanding is beyond the scope of that presented within this review. 
Extractive Resins for Chromatography 
Extractive chromatography for the purpose of radiochemistry came into existence 
in the early 1990s through the efforts of a research team comprised of Horwitz et al. at 
Argonne National Laboratory. Building on the previous success (Horwitz 1984; 1985) of 
a liquid-liquid extraction process using the key ingredient octyl(phenyl)-N, N-
diisobutylcarbamoylmethylphosphine oxide (CMPO), the team began investigating more 
convenient uses for the compound as it pertained to actinide separations.  The result was 
a publication describing a method of extracting actinides from an aqueous solution onto a 
column that had been packed with inert polymer beads coated with CMPO and then 
eluting the actinides as a group (Horwitz 1990).  The same methodology was explored in 
subsequent publications using other extractive compounds (Horwitz 1991; 1992a; 1992b; 
Chiarizia 1993; Horwitz 1993a; 1993b; 1997).  Realizing the commercial potential of 
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pre-packed extraction columns, Horwitz launched Eichrom Inc. in 1990 and now supplies 
a variety of selective columns for radioanalytical chemistry.  Extractive chromatography 
soon surpassed ion exchange resins as the medium of choice for radinuclide extraction, 
preconcentration, and separation. 
One of the most successful of these extractive resins was Sr-Spec, a crown ether 
molecule (bis-4,4’(5’)-[tert.-butylcyclohexano]-18-crown-6) that is selective for Sr, Pb, 
Po, Tc, Pu, and to a lesser extent, Th, U, Np, and Am (Horwitz 1992b).  This resin is used 
extensively in this research for its ability to selectively retain and elute 90Sr and 210Po.  
Another successful resin is the TRU-Spec resin, which is COMPO dissolved in TBP 
(Horwitz 1990).  This resin is selective for Th, U, Np, Pu, Am, Bi, Fe, and to a lesser 
extent, Tc.  This resin is used in this research for its ability to retain a mixture of actinides 
and to selectively elute them under specific conditions.   
Flow Scintillation Analysis 
Despite a history dating back to the 1970s of flow scintillation analysis (FSA) in 
the biosciences (Parvez 1988), a report as late as 1989 notes the fact that, “the application 
of FIA [FSA] for the automation of radioanalytical methods has not been reported”(Kuca 
1989).  Two years later the first radioanalytical application of FSA was attempted to 
detect radioactive silver displaced from a preloaded column (Grudpan 1991).  Other 
publications were seen that touted the potential benefits of FSA, but no separations were 
performed to evaluate such systems (Tolgyessy 1993; U 1994a; 1994b; 1994c; 1995).  
The first radionuclide separations with on-line scintillation detection were conducted on 
reactor coolant water for a variety of radionuclides and in nuclear waste for 90Sr, both 
involving very high sample activity (Fjeld 1995; Grate 1996).  The first use of FSA for 
bioassay purposes was for 90Sr where a MDA in the rage of nCi/L was achieved 
(Desmartin 1997).  The next year there were a series of publications by Egorov and 
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Grate, who were working with a Radiomatic FSA at Pacific Northwest National 
Laboratory, including: the first coupling of an FSA and Eichrom’s TRU extractive 
chromatographic column (Egorov 1998a), determination of 99Tc from nuclear waste 
using a TEVA column (Egorov 1998b), and optimization of FSA analysis for 238Pu and 
241Am from a TRU column (Grate 1998).  Subsequent publications investigated the 
detection and optimization of other radionuclides (Egorov 1999a; 1999b; Grate 1999a; 
1999b; 2005).  Another team—DeVol et al., based out of Clemson University—
conducted similar work, with an emphasis on environmental monitoring, using a β-RAM 
FSA by IN/US Systems (Fjeld 1995; Coates 2001; Roane 2002; Hughes 2003; Roane 
2003; Fjeld 2005; Hughes 2006a; 2006b) 
The combination of automated chemical separations with on-line detection 
capability make FSA an ideal technique for determining the pure beta emitter, 90Sr, and 
the high specific activity alpha emitter, 210Po.  The ability to enhance FSA detection 
limits using a stopped flow detection technique has also been described and is used in this 
research (Grate 1996; Egorov 1998b; Grate 1999b). 
Flow Gamma Analysis 
The body of publications pertaining to flow gamma analysis (FGA) is small when 
compared to that which exists for FSA.  The study on reactor coolant water, cited in the 
above paragraph, does evaluate the chromatographic separation and detection of several 
gamma emitters (55Fe, 60Co, 137Cs), though it does not mention whether the detection was 
accomplished by an on-line detector (Fjeld 1995).  The paucity of publications relating to 
FGA is most likely the result of the fact that off-line gamma counting is easy and yields 
better results (with an HPGe vs. an on-line NaI).  Many off-line gamma counters are also 
partnered with an automated sample changer that facilitates high sample throughput.  
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Thus, there would be no need to develop an on-line gamma counting capability for 
routine gamma analysis.  The exceptions to this statement would be:  
1) If one were committed to an on-line detection system for the sake of having a 
more automated system while producing less waste  
2) If one wanted to use chromatographic separations in order to sequentially 
analyze mixed gamma-emitters in order to lower background counts  
3) If one wanted to analyze a mixture of gamma and non-gamma emitters in a 
single system   
There seems to be room for research on all three of the above scenarios, 
indicating a direction for further development of the proposed system.  Despite the lack 
of interest in the journals, there is extensive coverage of FGA instrumentation, gamma 
flow cells, and techniques in the Flow Scintillation Analysis chapter of the Handbook of 
Radioactivity Analysis (L'Annunziata 2003).   
Polonium Chemistry and Detection 
The element polonium (specifically the isotope 210Po) was the first new element 
discovered in pitchblende by Marie Curie and was later named for her home country of 
Poland.  Since its discovery, polonium has been widely studied and was utilized in the 
early days of the Manhattan Project as a neutron generator (Pearlman 1944).  In 1945 the 
first comprehensive paper on polonium volatility, production, purification, 
electrodeposition, migration, and health concerns was produced (Dodson 1945).  At the 
time, the tolerance for hand contamination was 1000 cpm and semiweekly urine 
bioassays were screened for a maximum permissible level of 3000 cpm per 24 hour 
voiding.  Since the 1940s, the health hazards of 210Po were further studied, and bioassay 
methods were further refined (Fink 1950; Anonymous 1951; Robbins 1955; Stannard 
1964).  After the 1960s, polonium bioassay studies shifted from studying the effects of 
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large work-related exposures of inorganic polonium in favor of assays of organic 
polonium from natural sources and tobacco products.  An excellent review of 210Po 
determination in environmental materials was recently published (Matthews 2007).  The 
consensus among the literature is that 210Po is considered to be one of the most toxic 
naturally occurring radionuclides (Al-Masri 2004).    
The three principle methods of separating 210Po from radioactive interferences and 
matrix ions are solvent extraction, ion-exchange chromatography, and extraction 
chromatography (Matthews 2007).  The increasing popularity of extraction 
chromatography is due to the commercially available and proprietary Sr-Spec extractant 
by Eichrom Technologies.  This is known to retain 210Po from acid solutions with 
recoveries of approximately 70% (Vajda 1997).  Several publications utilize a method 
whereby 210Po is loaded onto the column with a hydrochloric acid solution and stripped 
with nitric acid (Vajda 1997; Biggin 2002; Obara 2003; Vreček 2003).  This method and 
variations on it were employed in this research.  The method of detection used in the all 
of the above references was traditional alpha spectroscopy.  There is only one modern 
reference in the literature of using liquid scintillation to determine 210Po activity (Brown 
2005).  In the paper, Brown was using a standard Tri-Carb liquid scintillation unit in 
combination with ICP atomic emission mass spectrometer to analyze hydrometallurgical 
samples that were known to be concentrated in 210Pb, 210Bi, and 210Po relative to other 
uranium daughters.  This research is the first to use flow scintillation analysis to detect 
210Po. 
Mass Spectrometry for Radionuclide Detection 
The routine use of mass spectrometery in the nuclear sciences is still less frequent 
than the use of radiometric methods.  The improvement in sensitivity, coupled with the 
reduction of background noise and interferences, has accentuated the fact that mass 
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spectrometry is a complementary companion to radiometric techniques for radionuclide 
detection (Lariviere 2006).  The first attempt to measure long-lived anthropogenic 
radionuclides in environmental samples by ICP-MS an analysis of 99Tc seaweed and 129I 
in rainwater at the ng level, collected after the Chernobyl accident (Brown 1988).  The 
first use of an extractive chromatography to preconcentrate actinides to enhance mass 
spectrometry analysis came several years later (Hollenbach 1994).  Very high 
concentrations of fission products and actinides from spent nuclear fuel were also 
determined by preconcentration of a sample stream with a high pressure liquid 
chromatography (HPLC) system feeding a mass spectrometer (Alonso 1995).  A method 
for determining the ultra-trace concentrations of long-lived U, Np, and Pu isotopes found 
in urine bioassays was later determined using a similar HPLC and TRU column system 
and an ICP-MS (Wyse 1998).  Further development and improvement of column loading 
and elution schemes optimized ICP-MS detection by lowering detection limits and 
improving actinide separations (Boulyga 2001; Egorov 2001).  Work done in the 
Chemistry Division at the Los Alamos National Laboratory (LANL) used a single TRU 
column to demonstrate the detection of 238U, 232Th, 237Np, 239Pu, and 241Am in urine 
bioassays (Hang 2004; 2005).   
However, the great limitation of mass spectrometry for radionuclide 
determination is that the technique is not effective for high specific activity isotopes, 
where there is simply not enough mass present to be detected at the desired activity 
levels.  A theoretical evaluation of the limitations of mass spectrometry to detect high 
specific activity isotopes, and of radiometric methods for detecting very low specific 
activity isotopes was also done in the Chemical Sciences and Engineering group at 
LANL (Gonzales 2005). 
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Automated Actinide Separation for Electrodeposition 
The past 10 years have witnessed a number of publications on the automated 
analysis of actinides.  The driving factor behind these publications is that the source 
preparation for alpha spectrometry is lengthy and labor-intensive.  One of the most 
challenging factors is the separation of the actinides from their matrices and from each 
other, where they may interfere spectrometrically (this process can take a full day’s 
work).  Many of these research efforts employ high pressure chromatography driven 
mass spectrometry (Thompson 1986; Alonso 1995; Aldstadt 1996; Egorov 2001; 
Unsworth 2001; Hang 2004; 2005; Lariviere 2006).  However, mass spectrometric 
techniques are limited in their ability to detect relatively high specific activity actinides.  
The second most prevalent technique is flow scintillation analysis that is driven by flow 
injection (Aldstadt 1996; Egorov 1998a), sequential injection (Grate 1996; Egorov 
1998b; 1999a; Grate 1999a; 1999b; Egorov 2001), and high pressure chromatography 
(Fjeld 1995; Smith 1995; Desmartin 1997; Reboul 2002; Roane 2002; Fjeld 2005; Grate 
2005).  One publication employs a high pressure chromatography system to 
preconcentrate and determine 235U and 241Am by gamma spectroscopy (Stricklin 2002).   
Source preparation by electrodeposition, and isotopic determination by alpha 
spectroscopy remain the method of choice for several relatively short-lived alpha emitters 
such as: 228Th, 232U, 238Pu, 241Am, and various curium and californium isotopes.  For this 
reason, a system that permits the automated separation of actinides, while facilitating off-
line electrodeposition and alpha spectrometry, could be useful for field-deployable 
emergency response activities, routine bioassays, or routine radioanalytical work.   
The bridge between automated chromatographic separations and off-line 
electrodeposition is fraction collection (which also has many other uses).  With fraction 
collection, a device called a fraction collector receives the column effluent and distributes 
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portions of it into different containers.  The fraction distribution may be accomplished by 
pre-set time windows, or some method of detecting when an analyte is present in the 
effluent stream, such as the signal from a UV-Vis spectrometer.  Fraction collectors have 
been employed in a few publications regarding automated actinide analysis (Egorov 
1998a; Grate 1999b; Grate 2001).  One publication employed manual effluent collection 
after flow scintillation analysis for alpha spectrometry, but the method of alpha source 
preparation was a neodymium fluoride precipitation (Grate 1999a).  The precipitation 
was necessary because the sample was mixed with scintillation cocktail, precluding the 
chemical workup needed for electrodepositon.  However, the technique of using a 
fraction collector to collect HPEC effluents for the explicit purpose of electrodeposition 
is novel and described in this research.   
INSTRUMENTATION 
Here, a brief overview of the instrumentation used in this work is provided.  
Pictured are: the flow scintillation/gamma system (Figure 1.1); inside the tandem flow 
gamma detector (Figure 1.2); the mass spectrometry system (Figure 1.3); the fraction 
collector (Figure 1.4); the electrodeposition system (Figure 1.5); an electrodeposition cell 
(Figure 1.6); and the alpha spectrometry system (Figure 1.7).  
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Figure 1.1: The flow scintillation/gamma system. 1) The computer system. 2) The 
gradient pump. 3) The reagent bottles. 4) The analytical injector (syringe 
port). 5) The 2000 μL sample loop. 6) The extraction chromatography 
column. 7) The β-RAM model 4B flow scintillation unit. 8) The tandem 
flow gamma detector. 
The flow scintillation system, featured in chapters 3 and 4, is comprised of 













Figure 1.2: Inside the tandem flow gamma detector.  The well-type NaI detector is 
housed within a formed lead casing.  The high voltage source and pre-
amplifier are housed within unit casing.  Not pictured is the DSpec Pro 
MCA and positive NaI interface module. 
As sold, the tandem flow gamma unit was intended to be a “black box” gross 
gamma counter for generating radio-HPLC chromatograms.  The unit was not designed 
to provide energy discrimination of the detected γ-rays.  Since the project goals of 
radionuclide identification necessitated the need for energy discrimination, the unit 
output signal was split and configured with a MCA.  This allowed for the unit to provide 
both chromatographic and spectral information of the radionuclides detected. 
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Figure 1.3: The mass spectrometry system. 1) The computer system. 2) The ion 
chromatography unit. 3) The reagent bottles. 4) The autosampler. 5) The 
nebulizer. 6) The mass spectrometer. Not pictured is the chromatography 
column. 
The mass spectrometry system used in the work featured in chapters 6 and 7.  The 
ion chromatography unit used with this system is like the gradient pump in Figure 1.1, 
except that it is controlled by the Chromeleon IC management system, which coordinates 
this unit with the autosampler, the mass spectrometer, and the computer.  The 
autosampler allows for the automated injection of multiple samples into the IC system.  
The nebulizer pictured in Figure 1.3 is not the concentric cyclonic spray chamber used in 
this work.  It is a specialized nebulizer that allows for improved sensitivity by condensing 








Figure 1.4: The fraction collector.  Plumbed into the column exit, this system distributes 
the effluent into one of several containers according to a pre-programmed 
protocol. 
The fraction collector pictured in Figure 1.4 was used in chapter 7 of this work.  
The system is used in combination with components 1-6 of Figure 1.1, where it is 
plumbed in-line with the column exit.  The purpose of the system is to distribute the 
column effluent into various collection vessels according to a pre-programmed collection 
protocol.  Here the vessels are 30 mL Pyrex beakers.  The dripper of the fraction collector 
is free to move in the x and y-direction to access the beakers.  As pictured, the fraction 
collector is draining to waste. 
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Figure 1.5: The electrodeposition system. 1) The constant current power supply. 2) The 
cell holder. 3) An electrodeposition cell. 
The electrodeposition system seen in the above figure was used in create counting 
sources for the experiments of chapter 7.  The power supply is capable of delivering 0.6 
Amps of constant current to each of 16 cells during the course of the deposition time.  
The cell holder allows for uniform deposition parameters for each of the 16 cell positions.  






Figure 1.6: An electrodeposition cell.  The cell is comprised of a platinum wire anode 
that is connected to the power supply, an attachable cathode cap that fits 
onto the bottom of the cell, and the plastic holding cell, itself.  Not pictured 
is a 5/8” diameter stainless steel planchette, onto which the actinides are 
deposited. 
Each cell is assembled with a 5/8” diameter stainless steel planchette that fits into 
a cathode cap that screws onto the bottom of plastic cell.  The electrolyte solution 
(containing the actinides) is then poured into the cell.  The cell is then inserted into the 
holder, which positions the planchette with respect to the platinum wire anode.  The 
anode is connected to the constant current power supply.  When activated, the actinides in 
solution are driven to the cathode where they are deposited in a thin uniform layer. 
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Figure 1.7: The alpha spectrometry system.  This system features 44 individual alpha 
spectrometers that are managed by one of four input MCB Ethernims.  Not 
pictured is the vacuum pump and manifold that allows all of the counting 
chambers to be pumped down to the desired pressure.  Also not pictured is 
the computer system which collects and analyzes the spectra. 
Once the counting sources have been prepared by electrodeposition, they can be 
counted with the alpha spectrometry system.  This system was used to count the samples 
produced in chapter 7 of this work.  Within each counting chamber is a 450 mm detector 
face, and a sample pedestal that allows the sample to be positioned relative to the 
detector.  Signals from each detector are acquired and analyzed using commercially 
available software. 
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Chapter 2:  Relevant Theory 
This section provides the theoretical foundation for the various topics featured 
within this research.  A common feature of all projects described herein is high pressure 
extraction chromatography (HPEC).  HPEC system components, extractive resins, and 
column packing techniques will be discussed in detail.  Flow analysis is another 
important topic that will be discussed, including: system components, flow scintillation 
analysis, and flow gamma analysis.  The use of mass spectrometry as a radioanalytical 
tool will also feature prominently, with topics to include: elementary principles, system 
components, and analytical procedures.  Finally, a brief discussion of the process and 
instrumentation of fraction collection will be given. 
HIGH PRESSURE EXTRACTION CHROMATOGRAPHY (HPEC), PRINCIPLES AND 
PRACTICES 
HPEC is a variation classical chromatographic methods that have been used by 
chemists since the beginning of the 20th century.  The driving principle behind all 
chromatographic techniques is that different substance move through a medium at 
different rates depending on their chemical affinity for the molecules that comprise the 
medium.  Thus, a mixture of substances may be separated by passing the mixture through 
the chromatographic medium and noting the rate at which each individual substance 
emerges from the medium.   
An analogy that has often been used to describe chromatography is to imagine a 
swarm of bees and wasps that are carried by the wind over a flower bed.  As the swarm 
encounters the flowers, the bees, which are attracted to the nectar, slow to browse among 
the flowers.  The wasps, which are uninterested in nectar, pass over the flower bed 
without slowing down.  To a casual observer down wind of the flower bed it would seem 
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that two distinct swarms exist; the first, consisting of only wasps and the second, only 
bees.  This analogy illustrates the four principle components of most chromatography 
systems, the analytes (bees and wasps), the mobile phase (the wind), the stationary phase 
(the flowers), and a method of detection (the observer).  Two key principles are also 
demonstrated. The first is that the relative differences in affinity of the analytes for the 
stationary phase result in a separation of the analytes.  The second is that if one has prior 
knowledge of the analytes and their retention factors on a medium, one does not need a 
detector capable of itself discriminating among the analytes, since the analytes have 
become separate and recognizable before encountering the detector.   Thus, the product 
of chromatographic detection is typically a plot of gross signal peaks as a factor of time, 
called a chromatogram.  A generic chromatogram is shown in Figure 2.1.  Ideally, peaks 
are sharp and well resolved, such as the first 3 peaks.  However, in practice, peaks often 
overlap (as the analytes co-eluet) or are broadened due to multiple factors, such as resin 
mesh size, flow rate, and resin retention characteristics.  It is also possible to have a 
single analyte elute into two or more different peaks due to the existence of multiple 




Figure 2.1: A generic chromatogram.  This chromatogram shows six eluent peaks over 
the course of the run time and their normalized detector response (adapted 
from c2v.nl). 
Retention of analytes in a chromatographic system may be based on charge (ion-
ion interactions or ion-dipole interactions), van der Waal’s forces, relative solubility, or 
adsorption.  Two major theories exist to describe the resulting analyte behavior.  The first 
theory employs retention factors, Rf.  Retention factor is a measure of the speed at which 
an analyte moves through the chromatographic system and may be described by: 




DR =                                                       (2.1) 
where DA is the distance moved by the analyte and Ds is the distance moved by the 
solvent.  Retention factors can vary considerably for a given analyte due to variations in 
the elute composition, changes within the stationary phase, temperature, sample matrix, 
and system setup.  Therefore, retention factors can only be compared under absolutely 
identical run conditions.   
The other theory of describing analyte behavior is plate theory which supposes 
that the chromatographic column contains a large number of separate layers, called 
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theoretical plates. Separate equilibrations of the sample between the stationary and 
mobile phase occur in these "plates" and the analyte moves down the column by transfer 
of equilibrated mobile phase from one plate to the next.  These plates do not actually 
exist, but provide a means of conceptualizing how sample zones can equilibrate with the 
medium as they travel through the column.  The number of theoretical plates that a real 
column possesses can be found by examining a chromatographic peak after elution and 




tN R=                                                 (2.2) 
where the number of theoretical plates, N, is proportional to the square of the retention 
time, tR, and inversely proportional to the square of the full-width-half-max, FWHM, of 
the peak.  The retention time, tR, is further defined as the time between sample injection 
and the analyte peak reaching the detector.  The larger the number of theoretical peaks 
the better the efficiency of the column.  This method of evaluating column performance 
is more easily comparable from method to method.  However, this work will use an acid 
dependency factor, k’, to describe analyte behavior within the column.  Details of method 
will follow in the next section of this chapter. 
The most common chromatography system configuration contains the stationary 
phase within a column.  The pure form of the stationary phase molecules is often not 
permeable enough to accommodate the passage of the mobile phase, so stationary phase 
molecules are often bound to a substrate, which is packed into the column.  One popular 
substrate is a micro bead made of an inert polymer, which sieved to uniform in size to 
within a specified tolerance.  These beads can then be coated with the stationary phase 
molecule so that the entire surface area of the bead becomes the stationary phase site.  A 
slurry of these beads (called a resin) can then be loaded into a column and packed under 
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pressure.  This way all of the internal space of the column is filled with the stationary 
phase, leaving very little void space within the column.   
Early column chromatography experiments fixed the column in a vertical position 
and utilized a reagent reservoir and the force of gravity to force the mobile phase through 
the column.  While this type of setup is still used today, pressurized systems for 
administering the mobile phase are now common.  A pressurized system allows for 
quicker processing of a sample and sharper eluent peaks because diffusion of the analyte 
plug is minimized.  The broad application of this technique has become known as high 
performance/pressure liquid chromatography (HPLC).   
Chromatography systems are also categorized by their specific separation 
mechanism.  One very popular mechanism is ion exchange, in which the stationary phase 
contains molecules with a functional group that is opposite in charge of the analyte.  
Thus, exchange resins are typically either of the anion or cation variety.  Anion exchange 
resin is most often used for radionuclide determination because metal ions will form 
negatively charged complexes under certain acid concentrations. 
EXTRACTIVE RESINS 
Extraction chromatography is a technique that is ideally suited to the separation of 
radionuclides from a wide range of sample types. This technique, which was developed 
by Horwitz in the late 1980s and early 1990s, combines the selectivity of liquid-liquid 
extraction with the ease of operation of column chromatography.  During this time a 
number of resins with selectivities for various radionuclides were developed and 
commercialized by the company Horwitz founded, Eichrom Industries.  Most of 
Eichrom’s resins have been used extensively over the last 20 years for research in 
radioanalytical chemistry, in publications too numerous to detail.  As such, there is much 
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data on the behavior of radionuclides with these resins that are available in publications 
or on Eichroms’s website, (eichrom.com). 
The key statistic that details the affinity of an analyte for a particular resin is the 
acid dependency factor, k’.  As its name suggests, the factor relates the analyte-resin 
affinity to the type and molarity of acid used in the mobile phase of a chromatography 
experiment.  More simply, k’, is the number of free column volumes (FCVs) of an acid 
solution one must pass through the column onto which an element is sorbed to obtain the 





Dk ='                                                    (2.3) 
D, is the distribution ratio of the analyte, vs, is the volume of the stationary phase, and vm, 
is the volume of the mobile phase.  Values for k’ and D are not directly measured in 
extraction chromatography.  Rather, the weight distribution ratio, Dw, is determined by 
conducting an experiment that measures the amount of a given metal ion taken up by a 
















0                                                        (2.4) 
In these experiments a known activity and volume of a radioactive isotope, A0 , is 
added to a known mass of resin and shaken until equilibrium is established.  The activity 
of the isotope remaining in solution, As, is then measured.  The activity of the isotope 
adsorbed onto the known mass of resin is A0-As.  Eichrom then provides conversion 
factors for converting values of Dw to k’ (shown in Table 2.1) by a process that is detailed 




Table 2.1: Converting Dw to k’ (eichrom.com/products/extraction.cfm) 
RESIN VS/VM TO CONVERT DW TO K' DIVIDE BY 
TEVA 0.23 1.9 
UTEVA 0.25 1.7 
TRU 0.22 1.8 
Actinide 0.20 1.9 
Sr 0.22 2.0 
 
By conducting numerous batch distribution experiments with a particular analyte/resin 
combination and various acid solutions, one can plot how k’ changes with respect to acid 
concentration.  This data is invaluable to the creation of methods for radionuclide 
separation.  Two of the resins listed in Table 2.1 were used in the experimental section of 
this work: Sr Spec resin (chapeters 3-5) and TRU Spec resin (Chapters 6 and 7).  
Therefore, we will examine the data relating to the acid dependency factors for these 
resins in the following sections. 
Sr-Spec Resin  
Sr Spec resin consists of the compound, 4,4’(5’)-bis(tert-butylcyclohexano)-18-
crown-6, dissolved in octanol and impregnated on polymer support beads.  It serves as 
the stationary phase in columns used in this work to concentrate 90Sr (chapter 3) and 
210Po (chapter 4) from their sample matrices and potential interferences.  Figure 2.2 
shows a drawing of this molecule.  These analytes were subsequently eluted into the 
mobile phase as pure sample zone, which could then be detected by FSA.  This resin was 
also used in chapter 5, where 60Co, 137Cs, and 192/192mIr were detected by FGA, though 
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that research was used to demonstrate that these analytes are not retained by the Sr resin 
and therefore could be separated from solutions that contained Sr and Po.   
 
                                        
Figure 2.2: The extractive crown ether molecule that gives Sr Spec resin its properties 
(eichrom.com).   
90Sr is increasingly well retained by Sr resin for mobile phases with nitric acid 
concentrations of 2-8M, as seen in Figure 2.3.  In 8M nitric acid, k’ for Sr is ~100; that is, 
it takes about 100 FCVs of 8M nitric acid for the Sr peak to elute.  However, potential 
interferences, like Ca, which has a k’ of ~0.3, will elute within the first FCV of 8M nitric.  
Once adsorped, Sr can be eluted from the column by changing the mobile phase to weak 
nitric acid; since k’ is 0.2 for Sr at a nitric acid concentration of 0.02M.  Water can also 
be used as an eluent for Sr in an HPEC system, since it will mix with the residual nitric 
acid in the system to form a mobile phase which is dilute in nitric acid (Grate 1996; Grate 
1999b).  Therefore, an elution scheme, such as the one developed in chapter 3, can be 
created where a solution containing Sr is loaded on the column with several FCVs of 8M 
nitric acid.  This load solution will retain Sr but will wash out other metals such as K, Ca, 
Na, and Cs.  A Striping solution of several FCVs of water can then be applied to remove 
the Sr.  In this manor 90Sr can be concentrated on the column and eluted as a sample zone 
which can be detected. 
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Figure 2.3: Acid dependency of Sr on Sr Spec resin.  Sr is well retained from high 
concentrations of nitric acid and is not well retained for low concentrations 
(Eichrom.com). 
Figure 2.4 shows that several other elements are also well retained by Sr resin.  
Among those is polonium, which well retained from ~1M nitric acid solutions.  Po is not 
well retained for either high or low concentrations of nitric acid, which may be used to 
strip Po once it is adsorped.  We can also note that Pu (IV) and Pb(II) are also very well 
retained by the Sr resin from high molarity nitric acid.  If present in the sample at a high 
activity, these analytes may co-elute with 90Sr and cause interferences in FSA.  
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Fortunately, we do not expect these nuclides to be found in bioassay samples at activity 
levels that are high enough to interfere with 90Sr.   
 
Figure 2.4: Acid dependency of Po on Sr Spec resin.  Po is well retained from ~1M 
nitric acid.  Po is not well retained for high or low concentrations of HNO3 
(Eichrom.com). 
Data for the retention of Po on Sr resin from HCl solutions also exists, Figure 2.5.  
This data shows that Po is increasingly well retained on the resin with increasing 
molarities of HCl.  The distribution ratio for Po in 2M HCl is ~ 100 FCVs, which is 
adequate to perform a separation.  Therefore, a alternative load solution for samples 
containing Po would be 1-8M HCl. 
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Figure 2.5: HCl dependency of Po and Sr resin (Vajda 1997). 
Principle interferences for 90Sr and 210Po that we can expect to encounter in urine 
bioassay samples are not other radionuclides, but stable matrix ions.  Of particular 
concern are potassium (which competes with Sr for binding sites within the resin) and 
nitrate salts, both of which are found at significant concentrations in urine.  Figure 2.6 
shows how the retention of Sr is affected by the presence of various nitrate salts.  As can 
be seen, increasing concentrations of these salts has a deleterious effect on Sr retention.  
Samples with a range of urine concentrations can be studied to determine how urine 
matrix components affect analyte retention.  In cases where retention is seriously 
inhibited, it may be necessary to dilute urine samples for processing or to perform some 
type of sample pretreatment to remove these species. 
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Figure 2.6: Effects of nitrate salt concentration on Sr retention on the Sr resin 
(Eichrom.com). 
Finally, it is helpful to examine retention data for other elements that may be 
encountered, but for which more specific acid dependency data is not available.  Figure 
2.7 tabulates this data.  Many of the short-lived gamma emitters of concern are not 
retained by the Sr resin. 
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Figure 2.7: Elution behavior of common elements and fission products on the Sr resin.  
Dilute oxalic acid can be added to the load solution to prevent the adsorption 
of actinides (Eichrom.com). 
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TRU-Spec Resin  
TRU-Spec resin consists of the compound, octylphenyl-N,N-di-isobutyl 
carbamoylphosphine oxide (CMPO), dissolved in tri-n-butyl phosphate and impregnated 
on polymer support beads, and serves as the stationary phase in columns used in this 
work to concentrate actinides from their sample matrices and potential interferences 
(chapters 6 and 7).  Figure 2.8 shows a drawing of this molecule.  The actinides were 
subsequently eluted into the mobile phase as pure sample zones, which could then be 
detected by mass spectrometry or collected for electrodeposition and alpha spectrometry.   
 
Figure 2.8: The extractive CPMO molecule that gives TRU resin its properties 
(Eichrom.com). 
The acid dependency factors for the actinides on this resin vary considerably from 
actinide to actinide and even for different oxidation states of the same actinide as shown 
in Figure 2.9. Pu(IV), Np(IV), Th(IV) and U(VI) are very well retained for a range nitric 
acid concentrations.  Am (III) is retained from 3M nitric acid, and eluted by lower 
molarities of HNO3.  Np(V) is not well retained from any concentration of nitric acid.  
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Retention of Pu(IV), Np(IV), Th(IV) and U(VI) is also very high from 10M HCl 
solutions but drops off rapidly with lower molarities of HCl.   
 
Figure 2.9: Acid dependency factors for actinides on TRU resin (Eichrom.com). 
Using this data we can conceive of a scheme by which a solution of mixed 
actinides may be separated using a TRU column.  By loading the mixture with 3M nitric 
acid, Th, U, Pu, and Am can be retained on the column, while Np (V) is not retained and 
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passed through the column in a few FCVs.  By changing the mobile phase over to dilute 
HCl, Am will quickly elute.  In time, Th (IV) will also elute, followed by Pu (IV).  
Uranium is still somewhat retained from even dilute HCl.  The timely elution of uranium 
can be facilitated by the addition of oxalic acid, as seen in Figure 2.10.  A variation of 
this basic elution scheme can sequentially elute Th, U, Np, Pu, and Am in a quick and 
effective manor for instantaneous detection by mass spectrometry (chapter 6) or for alpha 
spectrometry (chapter 7). 
             
Figure 2.10: Acid dependency factors for uranium on TRU resin with varying 
concentrations of oxalic acid (Eichrom.com). 
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Applications of such an elution scheme to urine bioassays are subject to potential 
interferences from the urine matrix components.  The most significant of these 
interferences is Fe(III), as seen in Figure 2.11.  Fe(III) is expected to be found in 
significant quantities in urine.  Fortunately, the simple solution to the problem is sample 
pretreatment with a few drops of ascorbic acid.  This agent reduces Fe(III) to Fe(II), 
which does not interfere with the retention of Am. 
 
Figure 2.11: Effects of matrix interferences with Am retention on TRU resin.  Fe(III) is 
the principle interference (Eichrom.com). 
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Finally, it is useful to examine retention data for other elements that may be 
encountered, but for which more specific acid dependency data is not available.  Figure 
2.12 tabulates this data.  Most of the elements tabulated in Figure 2.12 are expected to be 
present in significant quantities in urine bioassays.  Those that would be present (e.g. Na, 
Mg, Al, K, Ca, Cr, Co, Sr) would not interfere with actinide detection either by mass 
spectrometry or by alpha spectrometry. 
 
Figure 2.12: Elution behavior of common elements and fission products on the TRU 
resin (Eichrom.com). 
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FLOW SCINTILLATION/GAMMA COUNTS, PRINCIPLES AND APPLICATIONS 
Flow scintillation analysis has been an established technique for detecting high 
activity radiolabeled compounds in bioscience research for many decades.  However, the 
use of this technique for radionalytical chemistry has been brief.  The application of flow 
gamma analysis is even less well-known; therefore an understanding of the capabilities 
and limitations of these systems is needed to evaluate their suitability for this project.   
Flow Scintillation Analysis 
Flow scintillation analysis is the application of scintillation detection methods for 
the quantitative analysis of radioactivity in a flowing system.  There are two basic types 
of FSAs, homogeneous and heterogeneous, which involve somewhat different types of 
instrumentation, as will be discussed below.  All FSAs rely on the pump of an HPLC to 
propel column effluent through the instrument.  Common to both types of FSAs is an 
interchangeable flow cell that serves as the sampling point for interaction of the sample 
and the detector.  Also common is the detector itself, which typically includes two 
shielded PMTs, coincidence counting electronics, a pulse height analyzer, a multi-
channel analyzer, a computer, and analysis software.  Detection during flow scintillation 
analysis is typically accomplished in a transient mode, where there is continuous flow of 
sample through the cell.  However, a stopped-flow detection mode is also possible to 
enhance the detection of samples that have activity close to background.   
A homogeneous FSA consists of all the features described above, but also 
possesses a cocktail pump and mixing tee so that the column effluent is uniformly mixed 
with scintillation cocktail before entering the flow cell.  The flow cell for this instrument 




Figure 2.13: A Typical Homogenous Flow Cell. 
Prior to operation, the selected flow cell is slid into place between the PMTs of the 
detector as seen in Figure 2.14: 
 
 
Figure 2.14: Proper Placement of the Flow Cell within an FSA (modified from 
L’Annunziata 2003) 
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The major advantage of the homogeneous flow cell is that it provides the highest 
counting efficiencies (20-60%) for low-energy beta-emitters such as 3H (L'Annunziata 
2003).  There are two major disadvantages to using a homogeneous system: one, the wide 
range of chemicals used as eluates and the changing characteristics of the effluent will 
cause variable quench (though this is less significant for higher energy betas and alphas) 
and two, by mixing the HPLC effluents with cocktail, they are rendered useless for 
further chemical separations or analysis.  The primary goal of the proposed system is to 
detect 90Sr and 210Po, both of which should be detected with high efficiency by any 
scintillator. 
Heterogeneous FSAs are different from homogeneous models in that they do not 
use a cocktail pump, but instead employ a flow cell packed with a solid scintillating 
material.  Such heterogeneous flow cells are manufactured with fine beads of an insoluble 
solid scintillator packed within the Teflon tubing of the flow cell.  The HPLC effluent 
stream makes intimate contact with the solid scintillator beads as it moves through the 
flow cell.  The PMTs measure the scintillation photons generated as the radioactive 
fraction of the effluent stream enters the flow cell.  There are several types of solid 
scintillators used in flow cells including yttrium glass, europium-activated calcium 
fluoride, and lithium glass.  The counting efficiencies of these scintillators varies, but are 
generally low (1.5-5%) for 3H but high for 90Sr and actinides (L'Annunziata 2003).  The 
major advantages to heterogeneous FSA are that the sample integrity is preserved 
because no cocktail is used and that there is no chemical quench effect.  A disadvantage 
to this method is that there is the potential for analytes to irreversibly bind to the solid 
scintillating material over time, causing elevated backgrounds.  Early experiments with 
heterogeneous flow cells did show significant problems with carryover from one run to 
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the next for 90Sr (data not shown).  Therefore, a homogeneous flow cell was used for all 
FSA experiments in this work. 
Radionuclide detection in an FSA is accomplished by peaks in the radioactivity of 
the column effluent as it passes through the flow cell.  Confidence in the knowledge of 
what analyte is eluting from the column at a particular time is crucial, since isotopic 
identification by emission energy is usually difficult with beta emitters.  In transient flow 
counting, the sample count time is a function of the flow rate and flow cell volume.  The 
radioactive sample is only “seen” by the detector for the time the sample resides in the 
flow cell.  This residence time can be determined as followed: 
 
F
VTR =                                                                (2.5) 
 
where, V, is the volume of the cell in ml and F is the flow rate in ml/min.  Further, the 




CountsCPM =                                                         (2.6) 
However, background counts resulting from cosmic radiation and electronic noise must 
also be accounted for by running a blank sample through the FSA.  Net CPM can be 
determined as follows: 
RT
backgroundgrossCPMNet −=)(                                      (2.7) 
Determination of the counting efficiency for a particular isotope is needed to convert the 
observed CPM into DPM.  This is accomplished by passing a solution containing an 





CPME =                                                 (2.8) 
Peaks that are sharp, well above the baseline, and separated from each other by 
significant time are easier to detect than those that are broad, near background, and 
display tailing behavior.  These factors contribute to the minimum detectable activity 






=                                                 (2.9) 
Where B is the background count rate and W is the width of the peak in minutes and E is 
the %E/100.  As a general rule, the best flow cell volume for a given HPLC application 
would be a cell with a volume of ½ to ¼ the volume of the smallest peak of interest 
(L'Annunziata 2003).  One can easily conclude that slowing the flow rate and increasing 
the residence time of a sample in the flow cell will result in more counts and a lower 
MDA.  If the sample activity is near background, short sample residence times may 
preclude detection.  In this case, the practice of stopped-flow detection, described by Gate 
and Egorov (Grate 1996; Egorov 1998b; Grate 1999b), may be helpful.  If the flow is 
stopped at the peak maximum and the background is subtracted, the radionuclide activity 
may be determined as followes: 
))()()(( DPMrecdmCPM AEEDC =                                    (2.10) 
where Ed is the detection efficiency, Erec is the recovery efficiency from the HPLC and 







D =                                               (2.11) 
where Cmax is the number of counts at the peak maximum, Ti is the pulse summation 
update time, and Cn is the net peak area counts.  The disadvantage of very slow or 
stopped-flow counting or using a larger flow cell is that peaks from the HPLC are 
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broadened and peak resolution is lowered, precluding the separation of close peaks.  
However, peaks resulting from the proposed separations are expected to be broad and 
well separated (by general HPLC standards), therefore stopped-flow counting will be the 
anticipated method of counting and flow cell sizes will be as large as possible to enhance 
the detection of near-background peaks.   
Flow Gamma Analysis 
Much of the information pertaining to FSA is also applicable to FGA.  
Traditionally, a heterogeneous-type flow analyzer is used with a special gamma counting 
cell.  The FGA is plumbed similarly to a heterogeneous FSA and counting and 
radionuclide identification methods are the same.  The flow cell configuration and 
detector system are the only differences between FGA and heterogeneous FSA.   
Gamma flow cells are available in three main types: high-eneregy gamma cells, 
low-energy gamma cells, and positron cells.  Positron cells are designed to produce 
annihilation gamma rays when positrons interact with the flow cell.   The primary interest 
in FGA for this project is for certain high-energy gamma emitters with intensities of 
around 100%.  Existing high-energy gamma cells consist of Teflon tubing coiled flat 
between two 6 mm thick bismuth germanate (BGO) solid scintillator windows.  The 
BGO has a high density (7.13 g/cc) and is made of high Z material resulting in high 
stopping power for high-energy gamma radiation.  BGO also has a high degree of light 
output per interaction and a short scintillation decay time.  Detection is usually 
accomplished by the same PMT system as the FSA.   
However, there are now commercially available flow gamma detectors that have 
built in NaI detectors for more effective gamma spectroscopy.  This component, shown in 
Figure 1.2, will no doubt provide better gamma analysis capabilities than the traditional 
method of FGA.  As the FGA unit is sold, its detection capabilities are restricted to gross 
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gamma counting only since the system lacks a multichannel analyzer.  This unit is 
designed to interface with existing FSA software to create a chromatogram of gross 
gamma peaks.  While this information is useful in that it allows the user to observe the 
timing and shape of the analyte peaks as they travel through the system, isotopic 
identification of the peak must be accomplished by advanced knowledge of the analyte 
elution characteristics.  In the event that a mixture of gamma emitters may co-elute (such 
as is expected for most of the short-lived gamma emitters of concern with the Sr and 
TRU resins), there is no way to resolve the peak into the contributions of individual 
analytes.   
We have modified the commercial unit by splitting the output signal of the 
detector and routing one of the signals to a DSpec Pro multi-channel analyzer.  This 
allows us to utilize the gross gamma chromatography to observe analyte peaks, but also 
allows use to acquire an energy spectrum of the analyte gammas for positive isotopic 
identification.  This set up provides us with a much more detailed analysis of the sample 
than simple chromatography techniques.   
The system is described in greater detail in chapter 5, along with experimental 
data the shows the effectiveness of this technique for determining 60Co, 137Cs, and 
192/192mIr in simulated urine bioassay samples.  We believe that this system is unique and 
that the novel experimental techniques are applicable to a number of analytical scenarios.  
While there are many gamma spectrometry systems that utilize automated sample 
changers, we believe that this system is the first to incorporate online separation and 
detection to facilitate batch sample processing.   
MASS SPECTROMETRY, PRINCIPLES AND APPLICATIONS 
There are many different types of mass spectrometers that provide detection 
capability for niche analysis needs.  These include: thermal ionization mass spectrometry 
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(TIMS), glow discharge mass spectrometry (GDMS), secondary ion mass spectrometry 
(SIMS), resonance ion mass spectrometry (RIMS), accelerator mass spectrometry 
(AMS), and inductively-coupled mass spectrometry (ICP-MS).  TIMS, AMS, and ICP-
MS are the most utilized types of mass spectrometry for radionuclide determination.  
While TIMS and AMS provide unparalleled sensitivity, the cost of acquiring and 
operating these instruments puts them out of reach of all but the best financed 
institutions.  The best sensitivity for the money is the ICP-MS; consequently, this is the 
instrument most utilized for routine radionuclide analysis.   
The basic ICP-MS system consists of a sample introduction system (often the 
HPLC), a nebulizer to turn the liquid sample into a fine aerosol by mixing it with argon 
gas, a plasma torch to atomize and ionize the sample, a skimmer to create a collimated 
beam on ions, ion optics and a magnetic quadrupole to direct the ion beam and separate 
the beam by mass, and a detector that turns the incident ions into a signal.  A schematic 
diagram of an ICP-MS is shown in Figure 2.15. 
 
Figure 2.15: Schematic Diagram of an the Internal Structure of an ICP-MS 
(L’Annunziata 2003) 
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There are many parameters affecting the performance of the mass spectrometer.  
The first among these is the sample matrix, which should be in a completely dissolved, 
aqueous state with no suspended particles.  There are several types of nebulizers that 
specialize in aerosolizing specific types of sample matrices, but suffice it to say that they 
all accomplish the same stated task.  The argon gas flow to the system can be adjusted to 
provide maximum or minimal sample suspension and to provide maximum or minimal 
contact with the plasma.  The plasma must be hot enough to ionize all elements 
(elemental ionization potentials can vary greatly) but not hot enough that a significant 
fraction of atoms are doubly ionized.  The skimmer, which collimates the beam, must be 
kept clean and free of deposited material so that the beam can traverse to the optics.  The 
ion optics have an applied voltage that can be adjusted to guide the ion beam through the 
device.  The quadrupole mass analyzer is tuned so that it can apply a varying magnetic 
field that will direct ions to the detector based on their mass to charge ratio (m/z).  For 
singly ionized ions (z=1), the m/z is equal to the ion mass in amu.  The mass analyzer is 
programmed by the operator to rapidly scan the range of m/z from 1 to 260 (or any other 
desired upper limit), dwelling on each increment for a set period of time.  In this manor 
the entire m/z range can be analyzed in less than a second for given count time.  The 
intensity of the signal is given in counts per second for each m/z.  A sample spectrum is 
shown in Figure 2.16. 
The detection limit of mass spectrometry as it applies to radionuclides is 
dependent on the half-life of the isotope.  Since radionuclide hazards are often dictated by 
the level of radioactivity in a sample, rather than the total mass or concentration of the 
radionuclide, high specific activity isotopes are disproportionately hazardous.  In this 
way, a 50ppt solution of 232Th would have an activity of 0.003 dpm/mL, while a 50ppt 
solution of 244Cm would have an activity of 8800 dpm/mL.  Thus, mass spectrometry is 
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an excellent technique for determining trace and ultratrace levels of long-lived 
radionuclides, making it far superior to radiometric techniques, such as alpha or gamma 
spectrometry.  However, mass spectrometry fails to determine the same trace and 
ultratrace activities of shorter-lived radionuclides because there is simply not enough 
mass present to be detected. 
 
 
Figure 2.16: Sample Spectrum from a Mass Spectrometer.  Each actinide is represented 
by a different color.  The time is in seconds after   the start of an elution 
scheme.  Pulse intensity is in counts per second. 
Research has shown that under ideal conditions ICP-MS is superior to radiometric 
techniques for isotopes with half-live longer than 70 years (Gonzales 2005).  However, 
under most practical conditions ICP-MS is only useful for determining trace and 
ultratrace activities of radionuclides with half-lives of greater than 500 years.  Figure 2.17 
shows the relationship between radionuclide half-life and mass equivalence for a 1 Bq 
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sample of the isotope.  The dashed line represents the 239Pu detection limits for the 
various mass spectrometers. 
 
Figure 2.17: The relationship between isotope half-life and mass equivalence for a 1 Bq 
sample.  The dashed line represents the detection limits for 239Pu with the 
indicated mass spectrometer (McAninch 1999). 
The ability to detect trace levels of actinides in biological samples has long been a 
concern and analytical techniques that can determine the isotopic composition of 
internally deposited actinides are critically important because isotopic information is 
most useful in determining dose calculations and where and when the uptake occurred.  
Isotopic determination of actinides is also valuable for a number of other purposes, such 
as nuclear forensics and nonproliferation monitoring.  
Inductively coupled plasma mass spectrometry (ICP-MS) is a lower cost, 
commonly available technique that is extremely useful and widely used for actinide 
analysis.  This technique has the advantage of requiring very little sample preparation (for 
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aqueous samples) and producing fast multi-isotopic analysis, with detection limits 
reported into the low ppq levels for several actinides, including: 232Th, 238U, 237Np, 239Pu, 
and 241Am.  However, the capabilities of ICP-MS are often limited by the presence of 
isobars (which produce unresolvable interferences) and polyatomic interferences (some 
of which are shown in Table 2.2).   
Table 2.2: Commonly encountered actinide polyatomic interferences. 
 
ISOBARS POLYATOMIC IONS 
236U and 236Np 230ThH and 231Pa 
238U and 238Pu 236UH and 237Np 
241Pu and 241Am 237NpH and 238U 
242Pu and 242Am 238UH and 239Pu 
 240PuH and 241Am 
  242PuH and 243Am 
While the best sensitivities are realized only in “neat” solutions, samples with 
complex matrices such as environmental (soil, seawater) or biological (urine) samples 
reduce sensitivities.  This is because an increase in the number of matrix molecules in the 
sample stream leads to increasing interferences.  Therefore, it is necessary to remove as 
many matrix components as possible prior to analysis, and to use techniques which 
separate isobars and potential polyatomic interferences.  This necessitates the separation 
of the actinide elements in the sample stream to as large a degree as possible prior to 
detection.    
Chapter 6 shows the optimization of one separation scheme for actinides.  This 
scheme is based on the actinide retention properties of TRU resin, which was detailed 
earlier in this chapter.  While this technique has not yet been optimized for urine 
bioassays, it does allow us to achieve the detection limits we desire for the actinides of 
concern set forth in this work. 
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Chapter 3:  Flow Scintillation Analysis of 90Sr 
An automated procedure for the determination of 90Sr was adapted from existing 
methods of flow scintillation analysis (FSA) for use on aqueous samples with low levels 
of activity (<1000 dpm per sample).  This technique employs high performance 
extraction chromatography (HPEC) and an on-line liquid scintillation counter to provide 
automated separation and simultaneous detection of 90Sr.  Using Sr-Spec resin, 90Sr was 
concentrated on the column from the matrix and potential radiological interferences with 
8M HNO3 and selectively eluted with water and instantly quantified by FSA.    The 
lowest limit of quantification achieved by this technique was 156 dpm, or 2.6 Bq per 
sample.  The total analysis time is 30 min per sample.  A counting technique called 
stopped-flow detection was used to improve detection limits.  Dilute urine samples, 
spiked with 90Sr, were also processed by this method to test the application of this 
technique for bioassay monitoring.  The advantages of FSA are faster analysis, greater 
precision, reduced labor commitment, and improved safety due to the fact that chemical 
and radiological hazards are mostly contained and automated.   
INTRODUCTION 
Significant quantities of 90Sr are produced by the fission of 235U and 239Pu in 
nuclear reactors, and is therefore found at high levels in spent nuclear fuel, reprocessing 
plants, and DOE weapons complexes.  90Sr has been used extensively as a radioactive 
tracer in medical and agricultural studies and is also used in a variety of industrial 
applications. The heat generated by the decay of 90Sr can be converted to electricity for 
long-lived, portable power supplies, which are often used in remote locations, such as in 
navigational beacons, weather stations, and space vehicles.  90Sr is also used in electron 
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tubes, as a radiation source in industrial thickness gauges, and for the treatment of eye 
diseases. Controlled amounts of 90Sr have also been used as a treatment for bone cancer. 
90Sr is a pure β-emitter (546 keV max, 100% intensity) with a half-life of 28.79 
years and a specific activity of 138 Ci/g, which decays to the isotope 90Y, which is also a 
pure β-emitter (2280 keV max, 100% intensity) with a half-life of 64.0 hours. (KAPL 
2002).  The decay product of 90Y is the stable isotope, 90Zr.  Because the half-life of the 
yttrium daughter, 90Sr and 90Y are found in a state of secular equilibrium in aged samples.  
90Sr poses a high health hazard as it has the same valance shell electron configuration as 
calcium and is, therefore, easily metabolized by the body, where it is incorporated into 
the skeletal system.  For this reason, there is a great interest in procedures that can rapidly 
detect 90Sr in urine bioassay samples for emergency preparedness scenarios.   
The nature of β-emitter detection necessitates that need to remove 90Sr from all 
accompanying radionuclides prior to analysis.  Established standard methods consist of a 
series of precipitation steps (Piltingsrud 1972).  While a detection limit of 1mBq/kg is 
possible, 2-3 weeks of analysis time are needed (Alfaro 1995).  After the Chernobyl 
accident, there were no analytical techniques for the determination of 90Sr that were 
sufficiently fast and reliable to estimate the spread and extent of 90Sr contamination 
(Alfaro 1995).  The separation of strontium by personnel unaccustomed to the technique 
was especially problematic, where, even in the presence of additional equipment, sample 
throughput could not be increased to meet the short-term need (Workshop 1986).   
Flow scintillation analysis (FSA) with high performance extraction 
chromatography (HPEC) is a technique that has evolved from its progenitors, sequential 
injection (Ruzicka 1990; Ivaska 1993; Christian 1994) and flow injection (Ruzicka 1988; 
1994).  This technique employs a gradient pump and a column packed with an extractive 
resin, coupled with an on-line liquid scintillation counter.  In this manor, the wet 
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chemistry of the separation is combined with the detection instrumentation.  The process 
allows for the analyte to be concentrated on the stationary phase, which is housed in a 
chromatography column, and eluted in a sample zone that is carried by the mobile phase 
to the detector flow cell.  Variations on this technique for the analysis of several 
radionuclides are numerous: 90Sr (Grate 1996; Grate 1999b; Paulenova 2001; Roane 
2003; Fjeld 2005), 99Tc (Egorov 1998; Grate 2005), actinides (Reboul 2002; Roane 2002; 
Hughes 2003; Fjeld 2005).  The advantages of FSA include automated sample pre-
treatment, removal of interferences and matrix components, preconcentration, the ability 
to change solvents on- the-fly, increased sample throughput, and reduced reagent 
consumption (Luque de Castro 1992).  A full, detailed description of flow scintillation 
analysis principles and applications is available in a chapter of the Handbook of 
Radioactivity Analysis (L'Annunziata 2003).  However, to our knowledge, there is no 
literature dedicated to the determination of 90Sr at low levels (<1000 DPM per sample) or 
in urine bioassay samples by these techniques.   
In this research, we describe the development of an FSA by HPEC method for the 
separation and quantification of 90Sr from various dilutions of urine matices.  The 
extractive resin used in this work was Sr-Spec resin, developed and previously described 
by Horwitz (Horwitz 1992).  The resin consists of the compound, 4,4’(5’)-bis(tert-
butylcyclohexano)-18-crown-6, impregnated on polymer support beads, and serves as the 
stationary phase where the strontium is retained and eluted.  A stopped-flow counting 
technique developed by Grate and Egorov was used to improve the detection limits 
(Grate 1996; Egorov 1998b; Grate 1999b).  The stopped-flow technique improves 
method sensitivity by extending, indefinitely, the residence time of the largest part of the 
sample zone within the flow cell, allowing a statistically meaningful number of counts to 
accumulate before the sample is permitted to exit the detector.  An automated column 
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packing device, described in a previous work by the authors, was used to maintain the 
reproducibility of resin packing from column to column (Peterson 2007).  This work 
characterizes the effectiveness of the technique for low level 90Sr detection while 
optimizing several counting parameters for the determination of 90So in simulated urine 
bioassay samples.  Using the techniques and methods described here, there is no need for 
90Y ingrowth correction, sample handling is minimized, and radioactive samples are not 
moved from one room to another.  The method presented also has the advantage of being 
much easier to operate. 
EXPERIMENTAL 
High Performance Extraction Chromatography System: A Dionex GP50 gradient 
pump (Dionex, Sunnyvale, CA) was configured with a Rheodyne 7725i dual mode 
analytical injector and a 2000 μL sample loop (Precision Flow Products, Lake Elsinore, 
CA).  A 2500 μL Gastight syringe (Hamilton Co, Reno, NV) was used to inject samples 
into the loop.  Sr-Spec resin (EIChroM Industries, Inc., Darren, IL) of bead size 50-100 
μm was slurried overnight with deionized water (18 MΩ Nanopure Water System, 
Barnstead, Dubuque, IA) and packed into one of two PEEK lined columns, 4.6mm I.D. x 
30mm or 150mm, hardware (Alltech Associates, Deeerfield, IL) using an Alltech Model 
1666 slurry packer.  The packing pressure was 1000 psi and the calculated volume of the 
resin was 0.499 mL for the 3cm columns, and 2.49 mL for the 15cm columns.  Elution 
schemes for the HPEC system were manually programmed into the gradient pump and 
controlled through the instrument interface.  The scheme used for this procedure was 
adapted from established methods (Grate 1996; Grate 1999b) and can be seen in Table 
4.1.  The separation of 90Sr from other ions using Sr-Spec resin has been previously 
characterized, showing that Sr can be loaded onto the resin with 2-8M HNO3 (Horwitz 
1992).  While it is desirable to use the lowest molarity of nitric acid possible to preserve 
 55
the life of the column, the presence of potassium at concentrations ≥ 0.03M can have a 
significant suppressing effect on Sr retention (Horwitz 1992).  Since K is expected to be 
present in significant quantities in urine samples, 8M nitric must be used to load the Sr, 
since the selectivity of the resin for Sr over potassium is highest for this molarity. 
Table 3.1: Gradient used in this study. 
t(MIN) ELUENT(mL/MIN) COMPOSITION C.TAIL(mL/MIN) COMMENTS
0 1.00 8M HNO3 0.0 Inject/Load 
4 1.00 Water 2.0 Stripping 
28 2.50 8M HNO3 0.0 Re-condition 
30 0 N/A 0.0 End Cycle 
On-Line Liquid Scintillation Counting: Flow scintillation analysis was 
accomplished using a β-Ram 4B (IN/US Systems Inc., Tampa, FL).  This model 
possesses an internal cocktail pump and can be fitted with flow cells of various types and 
sizes.  All experiments in this work were done using a 2500 μL liquid flow cell.  The 
device was configured with the HPEC so that the column effluent was mixed with the 
scintillator in controllable ratios.  The detector counting parameters were controlled using 
Scint Flow SA software (IN/US) and Laura Lite 3.4 (IN/US) run on desktop PC and 
connected to the detector by a serial port.  The detector was signaled to begin cocktail 
flow and counting by a closed contact connection to the analytical injector when it was 
turned to the “inject” position.  The detector integration time, ti, was 6s to allow enough 
counts to accumulate for each data point.  Figure 3.1 shows a block diagram of the flow 
scintillation analysis system. 
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Figure 3.1: A Block Diagram of the Flow Analysis System 
Off-Line Liquid Scintillation Counting: All off-line liquid scintillation counting 
was performed using a Tri Carb 2750 TR/LL Liquid Scintillation Analyzer (Packard 
Instrument Co., Meriden, CT).   
Reagents and Standards: All chemicals used were analytical grade.  Deionized 
water was used in all dilutions.  A low-viscosity liquid scintillation cocktail (In-Flow 2:1, 
IN/US) was used for all flow scintillation measurements because this cocktail can be 
mixed with eluents at low ratios without gelling.  Ultima Gold LLT (Packard) cocktail 
was used for all off-line liquid scintillation counting.  Standard 90Sr/90Y solutions were 
prepared by evaporating aliquots of in-house standards to dryness and dissolving the 
residue in measured volumes of 8M nitric acid. 
Urine Matrix Preparation: Samples were prepared to simulate urine bioassay from 
patients with 90Sr exposure by mixing portions of water spiked with 90Sr with a urine base 
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(provided by the Centers for Disease Control and Prevention, Atlanta, GA).  The 
resulting samples contained the desired levels of 90Sr and dilute concentrations of other 
urine matrix components.  Even at a dilute strength, there are still significant levels of 
salts and organic compounds present to reasonably simulate bioassay samples. 
RESULTS AND DISCUSSION 
90Sr Observation: The first setting that requires optimization is 90Sr channel 
window setting so that the 90Sr peak area is counted, minimizing the contribution from 
90Y and background noise.  2500 μL of a solution of a known activity of 90Sr/Y was 
mixed with cocktail at a 2:1 ratio and manually injected directly into the flow cell.  The 
pulse hight analysis feature of the β-RAM was used to determine the spectral appearance 
of the 90Sr/Y within the instrument.  This spectrum is shown below in Figure 3.2. 
 






































































































Figure 3.2: The spectral appearance of 90Sr/Y within the β-RAM. Most of the signal 
occurs within channels 0-600. 
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The bulk of the activity can be found in channels 0-600, with some high energy 
counts registering in channels 700-900 (presumably from 90Y).  Since the energy 
spectrum of beta particle emissions is a continuum from 0-βMax, we cannot expect to fully 
resolve the emissions from 90Sr and 90Y.  Nevertheless, the contribution of 90Y to the 90Sr 
can be minimized by setting the upper channel threshold at channel 600.  While 90Sr 
counts can be expected to register in all channels <600, it is practical to exclude channels 
0 and 1 because a significant amount of background signal can be found in these channels 
(data not shown).  Therefore, we have concluded that the optimum 90Sr counting window 
is 2-600 channels and this counting window was used for all subsequent experiments. 
In order to determine the time at which the 90Sr peak elutes from the column 
under the gradient scheme shown in Table 4.1, a test injections of the analyte were made.  
In this test, 2112 dpm of 90Sr was injected with a volume of 2mL.  Unfortunately, our 
first attempts to profile the 90Sr peak position using the 3cm columns were not 
reproducible.  The peak position was found to drift from 10 minutes on the first run, to 14 
minutes on the second run, to 19 minutes for the third run.  On the fourth run the column 
failed to retain the 90Sr, which eluted with the unretained 90Y.  Figure 3.3 depicts four 
analysis cycles of identical 90Sr/Y traces and shows how the peak drifts until the column 
fails.  The reason for the variation of the column performance and failure is likely that the 
extractive ligand is lost as its octanol solvent dissolves into the mobile aqueous phase.  
This theory was first postulated by Grate when his group noticed a similar effect 
following their 1996 work.  Their subsequent 1999 publication on the optimization of 
90Sr determination by FSA demonstrated that the saturation of the reagents with octanol 




Figure 3.3: Sample chromatograms showing the 90Y and 90Sr peak locations over the 
course of 4 analysis cycles for a 3cm column.  The 90Y peak is more or less 
consistent, while the 90Sr peak drifts.  The column finally fails on the 4th 

























































The use of reagents saturated in octanol was not desirable in this research because 
of the added complexity of creating, maintaining, and storing mixed phased reagents.  
There is also the potential problem of creating a mixed waste stream that is hazardous 
and radioactive.   Therefore, we decided to try larger 15cm columns, which would 
contain more resin, to obtain more reproducible results and longer column life.  
 
Figure 3.4: Sample chromatograms showing the 90Y and 90Sr peak locations over the 
course of 16 analysis cycles for a 15cm column.  The 90Y peak is more or 
less consistent, while the 90Sr peak drifts slightly.  The column finally, failed 





















































The timing and level of drift of the 90Sr peak in the 15cm is not ideal, but it is 
acceptable for our purposed of timely and consistent analysis.  On a new 15cm column, 
the 90Sr peak occurs at approximately 15 minutes.  This is longer than the 10 minute time 
for the 3cm column, which will lead to a longer analytical cycle.  Nevertheless, the 
column lifetime is extended by more than five fold.  We therefore deem the trade off 
between increased analysis time and reduced column consumption acceptable.  An added 
benefit of using the larger column was that the peak shape was improved compared to the 
shorter column.  Figure 3.5 shows the number of counts for the peak 6 seconds versus 
various activities of 90Sr for the 3cm and 15cm columns. 
 
Figure 3.5: Peak heights versus various activities of 90Sr for 3cm and 15cm columns.   
Sr-90 Peak Counts for 3cm and 15cm Columns
y = 0.0369x + 20.146
R2 = 0.9793























Transient-Flow 90Sr Quantification: The strontium elutes from the column in a 
sample zone, where it is mixed on-the-fly with scintillation cocktail at the recommended 
ratio of 2:1 prior to entering the detector flow cell (Grate 1996; Grate 1999b).  The flow 
cell consists of a calibrated volume of optically transparent Teflon tubing that is placed 
within a fixed geometry between two photomultiplier tubes.  Scintillations from the 
radiation are “seen” by the detector only when the sample zone present in the flow cell.  
Assuming that there is no secondary mixing in the flow cell, the residence time, tr, of the 




t cr =                                                       (3.1) 
where, Vc, is the volume of the flow cell and, F, is the combined flow rate of the 
eluent/cockatil mixture.  In this work, a 2500 μL flow cell was used with a combined 
scintillator/eluent flow rate of 3mL/min.  Therefore, the residence time used in all 
calculations is 50s, or 0.83 min.  For transient flow counting the peak area is summed and 
the background count for the area is subtracted to derive a net number of counts for the 






C =     (Transient-Flow)                  (3.2) 
If a known activity of  90Sr is introduced to the system, the net count rate can be related to 
the sample activity, Adpm, to determine the effective efficiency, Ees (which combines the 
efficiency of the separation and the detector). 
 
 dpmesCPM AEC =      (Transient-Flow)            (3.3) 
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Using the above relations, we can create a calibration curve for the detector and 
analyte of interest by injecting various 90Sr activities and plotting the resulting net peak 
areas, see Figure 3.6.  The slope of the line is related to the effective efficiency, Ees, by 
dividing the slope by the sample residence time, tr.   
Sr-90 Calibration Curve























Figure 3.6: A calibration curve of detector response to various levels of 90Sr activity as 
determined by transient-flow counting.  The fact that the value for R2 is 
close to unity and that the intercept is near zero indicates that there is a 
highly linear detector response for this analyte.  Error bars represent 3σ.   
The efficiency as determined by the slope of the calibration curve was found to be 
102.5 (± 6)%.  Thus, 90Sr is detected with very high efficiency.  Any real value of the 
effective efficiency >100% may be due to diffusion of the sample zone within the flow 
cell, or residual luminescence within the cell for a short time after the sample zone has 
left.  Nevertheless, detection of 90Sr by transient counting methods can be considered 
highly efficient and accurate.   
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Due to the high detection efficiency, transient flow counting is a reliable 
technique for the determination of 90Sr down to low levels.  With an average background 
of 4.1 cpm and the typically encountered peak shape, we estimate that the lower level of 
detection for this technique is 47 dpm, with the level of quantification being 156 dpm.  
Computer-based methods of peak detection, included with the software used in this 
research, are useful for identifying and quantifying peaks resulting from this level of 
activity.  Figure 3.7 shows detector traces for various levels of 90Sr activity. 






















Figure 3.7: Detector traces for various activities of 90Sr as determined by transient-flow 
counting and a 3cm column.  Traces as low as 264 dpm are visually 
apparent.  Computer-aided peak finders are helpful for detecting lower 
activities of 90Sr. 
 
Stopped-Flow 90Sr Quantification:  Assuming no secondary mixing or phase 
separation effects in the flow cell, the fraction of the sample zone present in the flow cell 
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D max=                                                        (3.5)  
Where, Cmax, is the number of net counts per update time at peak maximum and, ti, is the 
detector update time.  Using the value determined from Dm, a sample of known activity 
may be run using stopped-flow counting to determine the effective efficiency of the 
technique.  Once Dm and Ees are determined, samples of unknown activity may be 
counted and the resulting values of CPM can be related back to an activity.  In this work, 
Dm was determined to be 0.084 (± 0.004)  and Ees was 1.025 (± 0.06) for aqueous 
samples: 
 
dpmesmCPM AEDC =     (Stopped-Flow)                  (3.6) 
The value for Dm can also be found by plotting Cmax versus Adpm (similar to Figure 3.5, 
but not shown) and noting the slope of the trendline, which is proportional to Dm.   
Stopped-flow counting was not actually used in any of the research in this 
chapter, because low detection limits were obtainable by transient-flow counting means.  
However, stopped-flow counting is essential for detecting lower efficiency isotopes at the 
lowest activities. 
Urine Matrix Effects:  Urine matrix effects on 90Sr determination were studied to 
determine the suitability of this technique for rapid urine bioassays analysis.  To this end, 
2mL simulated bioassay samples created using a urine base and various activities of 90Sr.  
Solutions of 2,112 dpm, 1,056 dpm, and 264 dpm 90Sr were prepared in 10x, 5x, and 2x 
urine dilutions as well as for full strength urine.   These samples were then processed 
using the elution scheme shown in Table 3.1 and a 15cm column.    
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Table 3.2: Simulated urine bioassay result.  All recoveries activities are within one 
standard deviation of the activities administered. 
URINE CON., % A (dpm) DETERMINED A (dpm) RECOVERY (%) 
10 2112 2200 (±140) 104 (±6.6) 
10 1056 1076 (±72) 102 (±6.9) 
10 264 285 (±24) 108 (±9.1) 
20 2112 2217 (±141) 105 (±6.7) 
20 1056 975 (±66) 92.4 (±6.3) 
20 264 272 (±23) 103 (±8.8) 
50 2112 2125 (±136) 101 (±6.4) 
50 1056 1071 (±72) 101 (±6.8) 
50 264 268 (±23) 101 (±8.8) 
100 2112 2095 (±134) 99.2 (±6.3) 
100 1056 1000 (±68) 94.7 (±6.4) 
100 264 237 (±21) 89.6 (±7.9) 
 
Recoveries of 90Sr in all urine matrices were quantitative, with only a minor 
decline in recovery in full strength urine.  In addition, these urine data highly conform to 
the existing calibration curve (data not shown) in Figure 3.6.  This suggests that similar 
limits of detection and quantification apply to samples in a urine matrix.  These results 
show excellent potential for applications of this technique to real urine bioassay samples.  
The ability to tolerate up to 2mL of full strength urine, while performing a nearly 
quantitative separation and detection of 90Sr in just 30 minutes is highly desirable from 
the standpoint of simplicity and expediency.  
 67


































Figure 3.8: Maximum 90Sr peak height for various urine concentrations.  Peak height 
declines with increasing urine concentration as a result of peak broadening. 
One irregularity that was noted in the processing of urine matrix samples was a 
decline in the maximum 90Sr peak heights with increasing urine concentration.  This 
indicates that the peaks are becoming increasingly broad with increasing urine 
concentration, though not broad enough to significantly affect the overall peak area 
determination.  For the purposes of transient-flow counting, this type of peak broadening 
is inconsequential.  However, any attempts at stopped-flow counting would need to 
consider the affect the decline in maximum peak height would have at the concentration 
of urine utilized.  This effect would also negatively impact detection limits for the 
stopped-flow counting technique, since peak maxima would be reduced with respect to 
background.  Figure 3.8 depicts this behavior. 
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CONCLUSIONS 
An automated computer controlled system for the separation and simultaneous 
detection of 90Sr was optimized for aqueous and simulated urine bioassay samples.  An 
optimal counting window for 90Sr with the β-RAM flow scintillation analyzer was 
established.  Columns of 3cm and 15cm were examined for reproducibility and column 
life, where it was determined that the 15cm column was superior.  This column was 
capable of accommodating up to 16 analytical cycles with little 90Sr peak drift.  In 
addition, peak shape was improved by transitioning from a 3cm to 15cm column though 
it was necessary to add 5 minutes to the detection cycle.  A calibration curve of detector 
response to various low activity samples was plotted and shown to be highly linear for 
both aqueous and urine samples.  The resulting lower limit of detection by transient-flow 
counting was estimated to be 47 dpm, while the lower level of quantification was 
estimated to be 156 dpm.  The time for total analysis and column washing and 
reconditioning was 30 minutes for transient-flow counting.   
The results of the simulated urine bioassay experiments were highly encouraging, 
with no loss of recovery for urine samples diluted to 50% and little loss of recovery for 
fully concentrated urine samples.  Some peak broadening, with associated decrease in 
peak maximum counts, was noted.  We intend to conduct further research into optimizing 
column parameters (length, resin size, and packing pressure) for urine bioassays.  We 
also anticipate experimenting with octanol saturated reagents, as suggested by Grate, to 
determine the suitability of this technique to enhance column performance and 
reproducibility.   
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Chapter 4:  Flow Scintillation Analysis of 210Po 
An automated procedure for the determination of 210Po in aqueous matrices has 
been developed using a technique called flow scintillation analysis (FSA).  This 
technique employs high performance extraction chromatography (HPEC) and an on-line 
liquid scintillation counter to provide automated separation and simultaneous detection of 
low levels of 210Po.  Using Sr-Spec resin, 210Po was concentrated on the column from the 
matrix and potential radiological interferences with 2M HCl and selectively eluted with 
6M nitric acid and instantly quantified by FSA.  A counting technique called stopped- 
flow detection was used to improve detection limits.  The lowest limit of quantification 
achieved by this technique was 100 dpm, or 1.67 Bq, per sample for a 30 minute stopped 
flow counting time.  The total analysis time is 60 min per sample.  Dilute urine samples, 
spiked with 210Po, were also processed by this method to test the application of this 
technique for bioassay monitoring.  The advantages of FSA are faster analysis, greater 
precision, reduced labor commitment, and improved safety due to the fact that chemical 
and radiological hazards are mostly contained and automated.  The stopped-flow 
counting techniques employed are advantageous in that sensitivity is improved and 
scintillation cocktail is conserved. 
INTRODUCTION 
210Po is considered to be one of the most toxic naturally occurring radionuclides 
(Al-Masri 2004) and a major contributor of natural radioactivity in human foodstuffs, 
contributing an estimated annual effective dose of 11 μSv per year—22% of the total 
average effective dose (UNSCEAR 2000).  Recently, 210Po was identified as poisoning 
agent in the high profile death of Alexander Litvinenko in London, England on 
November 23rd, 2006 (Harrison 2007).  Since this time, government health agencies have 
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been working with radioanalytical laboratories to develop rapid methods of 210Po analysis 
that could be used to screen large numbers of people for uptake.  The most convenient 
excretion pathway of 210Po for analysis is through the urine, where approximately 1% of 
the body burden is cleared per day (Stannard 1964).  Currently, separation and analysis is 
performed manually in two separate and distinct time-consuming and labor-intensive 
processes.  In addition, these methods expose technicians to chemical hazards and 
unsealed sources of radioactivity.  For this reason, a rapid and automated combined 
separation and detection technique is desired for the determination of 210Po in an aqueous 
matrix. 
210Po is a virtually pure α-emitter (5304 keV, 100% intensity) with a half-life of 
138.38 days and a specific activity of 4.60 Ci/mg, which decays to the stable isotope 
208Pb (KAPL 2002).  210Po can only be determined isotopically by alpha spectrometry, a 
valuable technique due to its excellent energy resolution, compact size, and low 
background (Matthews 2007).  However, there are some disadvantages to using alpha 
spectrometry including lengthy source preparation methods.  Even when utilizing 
polonium’s well-known ability to autodeposite, the reported mean deposition time is 5-6 
h (Matthews 2007).  In addition, polonium is notorious for its ability to “creep,” whereby 
an unsealed source will distribute itself and contaminate the area it surrounds (Roessler 
2007).  As a result, contamination of alpha spectrometers can be a potentially serious 
problem for large batch samples of 210Po.  Finally, the count times that are often 
employed for alpha spectrometry can add up to 24 hours to the procedure, and can cause 
a bottle neck in the batch analysis if the capacity of the lab is limited.  Therefore, an 
automated analytical technique that is capable of rapid sample screening is a desirable 
capability to compliment alpha spectrometry.   
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Flow scintillation analysis (FSA) with high performance extraction 
chromatography (HPEC) is a technique that has evolved from its progenitors, sequential 
injection (Ruzicka 1990; Ivaska 1993; Christian 1994) and flow injection (Ruzicka 1988; 
Ruzicka 1994).  This technique employs a gradient pump and a column packed with an 
extractive resin, coupled with an on-line liquid scintillation counter.  In this manner, the 
wet chemistry separation is combined with the detection instrumentation.  The process 
allows for the analyte to be concentrated on the stationary phase, which is housed in a 
chromatography column, and eluted in a sample zone that is carried by the mobile phase 
to the detector flow cell.  Variations on this technique for the analysis of several 
radionuclides are numerous: 90Sr (Grate 1996; Grate 1999b; Paulenova 2001; Roane 
2003; Fjeld 2005), 99Tc (Egorov 1998; Grate 2005), actinides (Reboul 2002; Roane 2002; 
Hughes 2003; Fjeld 2005).  The advantages of FSA include automated sample pre-
treatment, removal of interferences and matrix components, preconcentration, the ability 
to change solvents on- the-fly, increased sample throughput, and reduced reagent 
consumption.  A full and detailed description of flow scintillation analysis principles and 
applications is available in a chapter of the Handbook of Radioactivity Analysis 
(L'Annunziata 2003). However, to our knowledge, there is no literature on the 
determination of 210Po by these techniques.   
In this paper, we describe the development of an FSA by HPEC method for the 
separation and quantification of 210Po.  The extractive resin used in this work was Sr-
Spec resin, developed and previously described by Horwitz (Horwitz 1992b).  The resin 
consists of the compound, 4,4’(5’)-bis(tert-butylcyclohexano)-18-crown-6, impregnated 
on polymer support beads, and serves as the stationary phase where the polonium is 
retained and eluted.  A stopped-flow counting technique developed by Grate and Egorov 
was used to improve the detection limits (Grate 1996; Egorov 1998b; Grate 1999b).  The 
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stopped-flow technique improves method sensitivity by extending—indefinitely—the 
residence time of the largest part of the sample zone within the flow cell, allowing a 
statistically meaningful number of counts to accumulate before the sample is permitted to 
exit the detector.  An automated column packing device, described in a previous work by 
the authors, was used to maintain the reproducibility of resin packing from column to 
column (Peterson 2007).  This work characterizes the effectiveness of the technique 
while optimizing several counting parameters for the determination of low levels of 210Po 
in aqueous samples.  In addition, limited experimentation was done to demonstrate the 
feasibility of utilizing this technique for urine bioassay samples. 
EXPERIMENTAL 
High Performance Extraction Chromatography System: A Dionex GP50 gradient 
pump (Dionex, Sunnyvale, CA) was configured with a Rheodyne 7725i dual mode 
analytical injector and a 2000 μL sample loop (Precision Flow Products, Lake Elsinore, 
CA).  A 2500 μL Gastight syringe (Hamilton Co, Reno, NV) was used to inject samples 
into the loop.  Sr-Spec resin (EIChroM Industries, Inc., Darren, IL) of bead size 50-100 
μm was slurried overnight with deionized water (18 MΩ Nanopure Water System, 
Barnstead, Dubuque, IA) and packed into a PEEK lined column, 4.6mm I.D. x 30mm, 
hardware (Alltech Associates, Deeerfield, IL) using an Alltech Model 1666 slurry packer.  
The packing pressure was 1000 psi and the calculated volume of the resin was 1.99 mL.  
Elution schemes for the HPEC system were manually programmed into the gradient 
pump and controlled through the instrument interface.  The scheme used for this 





Table 4.1: Gradient used in this study. 
Time(min) Eluent(mL/min) Composition Cocktail(mL/min) Comments 
0 1.00 2M HCl 0.0 Inject/Load 
5 1.00 6M HNO3 2.0 Stripping 
12.5 0.0 N/A 0.0 Counting 
42.5 1.00 6M HNO3 2.0 Strip Cont. 
45 1.50 Water 0.0 Wash 
50 1.35 2M HCl 0.0 Condition 
60 0.0 N/A 0.0 End Cycle 
 
On-Line Liquid Scintillation Counting: Flow scintillation analysis was 
accomplished using a β-Ram 4B (IN/US Systems Inc., Tampa, FL).  This model 
possesses an internal cocktail pump and can be fitted with flow cells of various types and 
sizes.  All experiments in this work were done using a 2500 μL liquid flow cell.  The 
device was configured with the HPEC so that the column effluent was mixed with the 
scintillator in controllable ratios.  The detector counting parameters were controlled using 
Scint Flow SA software (IN/US) run on desktop PC and connected to the detector by a 
serial port.  The detector was signaled to begin cocktail flow and counting by a closed 
contact connection to the analytical injector when it was turned to the “inject” position.  
The detector integration time, ti, was 6s to allow enough counts to accumulate for each 




Figure 4.1: A Block Diagram of the Flow Analysis System 
 
Off-Line Liquid Scintillation Counting: All off-line liquid scintillation counting 
was performed using a Tri Carb 2750 TR/LL Liquid Scintillation Analyzer (Packard 
Instrument Co., Meriden, CT).   
Reagents and Standards: All chemicals used were analytical grade.  Deionized 
water was used in all dilutions.  A low-viscosity liquid scintillation cocktail (In-Flow 2:1, 
IN/US) was used for all flow scintillation measurements because this cocktail can be 
mixed with eluents at low ratios without gelling.  Ultima Gold LLT (Packard) cocktail 
was used for all off-line liquid scintillation counting.    A 210Po working standard was 
prepared from a well-aged 210Pb standard (Amersham International, Amersham, UK) 
using a method adapted from a plutonium separation procedure (Talvitie 1971).  
Originally in 1M nitric acid, an aliquot of the 210Pb solution was evaporated to a just dry 
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state on a hotplate at 90 °C.  It should be noted that polonium solutions must not be 
heated over 100 °C because losses of polonium occur at temperatures above this point, 
with more than 90% of polonium lost due to volatization at temperatures greater than 300 
°C (Martin 1969). 
The 210Pb residue was brought up with a volume of 9M HCl.  A 5 mL resin bed of 
Bio-Rad AG 1-X4 (Bio-Rad, Hercules, CA) in HCl was prepared in a Teflon column.  
After conditioning the column with three 15mL 9M HCl washes, the sample was loaded 
onto the column at a rate of 3 mL/min.  Three additional washes of 15 mL of 9M HCl are 
then run through the column.  210Pb is not retained on the column and is found in the 45 
mL of HCl load solution.  210Bi is then removed from the column by stripping with 7.5M 
HNO3 at a rate of 3 mL/min and can be found in the first 50 mL of strip effluent.  Finally, 
210Po is eluted in a subsequent addition of 100 mL of 7.5M HNO3 at a rate of 3 mL/min.  
Working stock solutions of 210Po can then be prepared from this product. 
Urine Matrix Preparation: Samples were prepared to simulate urine bioassay from 
patients with 210Po exposure by mixing portions of water spiked with 210Po with a urine 
base (provided by the Centers for Disease Control and Prevention, Atlanta, GA).  The 
resulting samples contained the desired levels of 210Po and dilute concentrations of other 
urine matrix components.  Even at a dilute strength, there are still significant levels of 
salts and organic compounds present to reasonably simulate bioassay samples. 
RESULTS AND DISCUSSION 
Preparation of the 210Po Stock:  The original intent of the Talvitie separation 
procedure used here was to remove polonium from biological samples so that plutonium 
could be analyzed.  Nevertheless, we have determined that this method is also effective at 
separating the 210Pb/210Bi/210Po decay series into its component isotopes.  The 210Pb 
standard solution was originally prepared over 15 years prior to the time of separation, 
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allowing sufficient time for secular equilibrium to be established with its daughters.  
Using the previously described method, polonium separation from the aged 210Pb solution 
was accomplished with an 89.0% recovery.  Analysis of aliquots of the 210Pb, 210Bi, and 
210Po fraction solutions were done by the off-line liquid scintillation analyzer.  The three 
isotopes studied can easily be identified by observing their spectral energies and peak 
shapes.  Samples of the Bio-Rad column effluent were collected at regular intervals and 
counted with the mean results of duplicate runs shown in Table 4.2. 
Table 4.2: Percent of each isotope recovered in the column effluent.  Lead is not 
retained on the column and is found entirely within the effluent of the HCl 
load solution.  Bismuth is found entirely within the first 50 mLs of the nitic 
strip.  Polonium is eluted with subsequent additions of nitric acid, with 
diminishing returns after 150 mLs of nitric acid.   
ACID, VOL. mL % OF RECOV. 210Pb % OF RECOV. 210Bi % OF RECOV. 210Po 
HCl, 0-45 100 0 0 
HNO3, 0-25 0 53.5 0 
HNO3, 26-50 0 46.5 0 
HNO3, 51-75 0 0 43.6 
HNO3, 76-100 0 0 39.4 
HNO3, 101-125 0 0 11.4 
HNO3, 126-150 0 0 8.6 
HNO3, 151-175 0 0 2.5 
HNO3, 176-200 0 0 2.0 
HNO3, 201-225 0 0 1.6 
All of the fractions that contained polonium were then combined and evaporated 
to near dryness to concentrate the polonium and drive off the nitric acid.  The residue was 
then brought up in 100 mL of 1M HCl in a volumetric flask.  Aliquots of this solution 
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were mixed with Ultima Gold at a ratio of 1:15 and counted via standard off-line liquid 
scintillation counting for 1,000 minutes.  The final working standard was determined to 
have an activity of 468 dpm/mL (± 3.7 dpm).  Since 210Po has a reasonably short half-life, 
the actual stock activity needs to be recalculated on a daily basis to correct for loss due to 
radioactive decay.   
210Po Observation:  The first setting that requires optimization is 210Po channel 
window setting so that only the 210Po peak area is counted, minimizing background noise.  
2500 μL of a solution of a known activity of 210Po was mixed with cocktail at a 2:1 ratio 
and manually injected directly into the flow cell.  The pulse hight analysis feature of the 
β-RAM was used to determine the spectral appearance of the 210Po within the instrument.  


































































































Figure 4.2: The spectral appearance of 210Po within the β-RAM. Most of the signal 
occurs within channels 100-350. 
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While the optimum channel setting would appear to be with a window of 100-350 
channels, there was significant loss of efficiency at this setting during actual runs.  This 
may be due to increased quench occurring in actual samples.  Extra quench may be 
present due to organic components of the column washing off and/or as a result of freshly 
mixed on-the-fly cocktail eluent solutions.  Therefore, it was necessary to utilize a 
counting window of 0-350 channels to restore the desired counting efficiency.   
In order to determine the time at which the 210Po peak elutes from the column 
under the gradient scheme shown in Table 4.1, a test injection of the analyte was made.  




 Figure 4.3: Sample chromatogram showing the 210Po peak location.  Note, that two 
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The 210Po peak occurs in two parts at approximately the 9 minute mark and the 12 
minute mark.  The persistent occurrence of two distinct peaks may be due to different 
complexes of the polonium with various matrix and solid phase constituents.  While this 
situation is not ideal for optimum counting, the major peak can be targeted for analysis 
and allowances for the activity of the total polonium output can be accounted for by an 
efficiency correction.  Thus, the flow of the system can be stopped at the 12.5 minute 
mark so that the peak maximum—and most of the total peak area—is within the flow cell 
during the stopped flow counting time.   
Transient-Flow 210Po Quantification: The polonium elutes from the column in a 
sample zone (or in this case, two sample zones), where it is mixed on-the-fly with 
scintillation cocktail at a specified ratio prior to entering the detector flow cell.  The flow 
cell consists of a calibrated volume of optically transparent Teflon tubing that is placed 
within a fixed geometry between two photomultiplier tubes.  Scintillations from the 
radiation are “seen” by the detector only when the sample zone present in the flow cell.  
Assuming that there is no secondary mixing in the flow cell, the residence time, tr, of the 




t cr =                                                       (4.1) 
where, Vc, is the volume of the flow cell and, F, is the combined flow rate of the 
eluent/cockatil mixture.  For transient flow counting the peak area is summed and the 
background count for the area is subtracted to derive a net number of counts for the peak, 






C =     (Transient-Flow)                  (4.2) 
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If a known activity of  210Po is introduced to the system, the net count rate can be related 
to the sample activity, Adpm, to determine the effective efficiency, Ees (which combines 
the efficiency of the separation and the detector). 
 
 dpmesCPM AEC =      (Transient-Flow)            (4.3) 
In this way, the figure of merit, FM, described by Knoll, can be determined for any given 








=                                                 (4.4) 
Counting Parameter Optimization: The effects of different loading and eluent 
solutions were studied to determine the optimum conditions for retaining and stripping 
210Po from the column.  Previous works cite the optimum loading solution for polonium 
on the Sr-Sprec resin to be 2M HCl and the optimum strip solution to be 6M HNO3 
(Vajda, 1997, Vrecek, 2004). These concentrated strong acids can be detrimental to the 
life of the column and system parts.  Therefore, we sought to determine the merit of using 
more dilute reagents in our work.  Data relating to polonium behavior with Sr-Spec resin 
shows that polonium is not retained for very high and very low molarities of nitric acid 
(eichrom.com).  After loading 210Po on the column with 2M HCl, various strip reagents 
were applied to determine the optimum eluent.  Solutions of 8M HNO3, 6M HNO3, 0.5 M 
HNO3, 0.1M HNO3, and water were used to strip 210Po from the column.  A plot of the 























Figure 4.4: Figures of merit resulting from the 210Po peak resulting from various 
eluents.  The 6M HNO3 strip solution is clearly the best reagent to remove 
polonium from the Sr-Spec resin. 
The superior strip reagent is 6M HNO3.  While water was a better eluent than low 
molarities of nitric acid, it is significantly inferior to 6M HNO3.  It was, therefore, 
determined to continue using 6M HNO3 as the eluent for all subsequent trails. 
An unfortunate consequence of the gradient scheme is that the 2M HCl, used to 
load the 210Po, is destructive to the stainless steel components and plastic seals of the on-
line detector.  It was, therefore, desirable to determine if a lower molarity of HCl or any 
molarity of HNO3 (which is less destructive to the components concerned) could be used 
to effectively load the 210Po onto the column.  Columns were loaded with 0.5M HCl, 1M 
HCl, 0.5M HNO3, 1M HNO3, and 1.5M HNO3 and stripped with 6M HNO3 to determine 
the optimum loading reagent.  A plot of the resulting figures of merit for the peaks 





















Figure 4.5: Plots of the figures of merit for the peaks resulting from various load 
solutions. 
As expected, the greater the molarity of HCl that is used, the better the retention, 
and subsequent elution of polonium.  While none of the nitric acid molarities can be 
recommended for use as a load solution, 1M HCl may be used effectively as a load 
solution.  The use of 1M HCl over 2M HCl may result in an extension of the column life 
and a reduction of steel and plastic corrosion.   
The best cocktail/eluent ratio must also be determined to optimize the 210Po 
analysis.  This was done by determining the 210Po efficiencies resulting from 
cocktail/eluent ratios of: 1, 1.75, 2, and 3. Background activity values were also obtained 
for these ratios so that figure of merit could be determined.  Figure 4.6 shows the results 







































Figure 4.6: Plots of effective efficiency and figure of merit at peak maximum for 
various cocktail/eluent ratios.  The optimum ratio is between 1.75 and 2. 
The optimum cocktail/eluent ratio is between 1.75 and 2.  The range is small and 
insignificant; either a ratio of 1.75 or 2 could be used effectively.  The figure of merit 
resulting from higher or lower ratios drops quickly.  It is interesting to note that while 
detection efficiency increases for a ratio of 3, the figure of merit depreciates due to the 
increase in background that also results. 
Stopped-Flow 210Po Quantification: The optimum counting conditions were 
utilized in the final stopped-flow counting experiments.  Using the known position of the 
210Po peak, flow could be stopped at the peak maximum point and held indefinitely in the 
flow cell for counting.  For the purposes of this research a stopped-flow counting time of 
30 minutes was used to collect enough counts for low level 210Po determination.  A 
background count was conducted to determine the average background activity and the 
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standard deviation of this activity.  To demonstrate the principle of stopped-flow 
counting, a plot of identical traces are shown via transient-flow and stopped-flow in 
Figure 4.7. 
 

























Figure 4.7: A trace of 210Po as determined by transient-flow counting and by stopped-
flow counting.  
Assuming no secondary mixing or phase separation effects in the flow cell, the 
fraction of the sample zone present in the flow cell at the peak maximum, Dm, can be 






D max=                                                        (4.5)  
where, Cmax, is the number of net counts per update time at peak maximum and, ti, is the 
detector update time.  Using the value determined from Dm, a sample of known activity 
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may be run using stopped-flow counting to determine the effective efficiency of the 
technique.  Once Dm and Ees are determined, samples of unknown activity may be 
counted and the resulting values of CPM can be related back to an activity.  In this work, 
Dm was determined to be 0.068 (± 0.003) and Ees was 0.615 (± 0.07). 
 
dpmesmCPM AEDC =     (Stopped-Flow)                  (4.6) 
The usefulness of transient-counting methods for radionuclide determination is 
limited to samples with relatively high activities (>500 dpm) due to the uncertainty 
introduced by the low number of counts observed.  Radiation counting errors are 
proportional to the square root of the number of decay events, assuming Poisson 
statistics, and therefore increase dramatically with a low number of observed counts.  
One can reason that increasing the residence time of the sample in the flow cell will 
reduce uncertainties and improve sensitivities, since more counts will be observed.  
Therefore, by stopping the flow of the system while the peak maximum is in the detector, 
sample residence time can be increased indefinitely to accumulate as many counts as 
desired.  The results are lower detection limits and reduced uncertainty in the results.   
Various levels of 210Po activity were injected into the system to determine if these 
levels register an average activity that is more than 3 standard deviations from the 
background count rate of 2.2 (± 0.22) CPM .  The results are shown in Figure 4.8. 
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Figure 4.8: Various activities of 210Po determined by stopped-flow counting.  While not 
shown for clarity, a trace of 104 DPM registered an average CPM of 4.2. 
Given the efficiency, peak fraction, and background level, the limit of detection, 
LD, was determined to be 8 DPM of 210Po per sample.  The limit of quantitation, Lq, was 
determined to be 84 DPM. 
Finally, a plot was made to show the calibration curve of the detector and its 
response to various levels of 210Po.  This plot is used to determine if there are any non-
linear effects in the detector response that would cause detection limits to deviate from 
theoretical values.  This plot is shown in Figure 4.9. 
 87
 
Figure 4.9: A calibration curve of detector response to various levels of 210Po activity as 
determined by stopped-flow counting.  Non-linear detector responses seem 
to persist for activities of < 400 DPM.  Three possible trendlines are shown. 
A) Includes all points, y = 1.0398x -104.24, R2 = 0.93. B) Includes activities 
>400 DPM, y = 1.4781x -407.2, R2 = 0.9702. C) Includes activities <400 
DPM, y = 0.5002x +16.1, R2. 
There is a definite non-linear appearance to the distribution of the calibration 
curve, indicating that the detector is biased to low values for the range of activities 
studied.  This not a surprising result, given that the FSA is an instrument that is designed 
for radiolabeling experiments, where activities are typically in the range of nCi-mCi 
(2,200 to 2.2 x 109 dpm) per sample.  The main trendline, shown in Figure 4.9, includes 
all the data points and is within one standard deviation of all activities tested, except for 
those with an activity of 419 DPM.  In an effort to better model the detector response, the 
calibration curve can be broken into two parts.  In Figure 4.9, line B, models activities 
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linear may be indicative of two competing processes that are introducing systematic error 
in the detector, one that is most prevalent for higher activities and one that dominates at 
lower activities.  The factors that influence this behavior is presently unknown to the 
authors, however, we believe that results from samples within the activity range studied 
are still valid, given proper consideration of the identified biases.  Given the evidence of 
the system bias, we recommend revising the limit of quantification upward to 100 DPM 
per sample. 
Urine Bioassay: Finally, the optimized counting techniques were applied to the 
urine bioassay samples to determine the effects of the urine matrix on the anticipated 
results.  Two samples were run with the results of this trial shown in Table 4.3. 
Table 4.3: Dilute urine bioassay results.  The bias corrected activities of the samples 
are shown with their determined recoveries.  Both sample recoveries are 
within one standard deviation of expected values.  For the 10x dilution with 
417 DPM, calibration curve C was used to correct for the bias.  For the 5x 
dilution with 500 DPM, calibration curve B was used.  
U. DIL. A (dpm) DETERMINED A (dpm) BIAS CORRECTED A (dpm) RECOVERY, % 
10x 417 228 (± 31) 424 (± 57) 102 (± 14) 
5x 500 353 (± 45) 514 (± 66) 103 (± 13) 
 
Recoveries were excellent for the two urine samples once the bias corrections were 
applied.  This indicates that the discontinuous calibration curve theory has merit and that 
good results can be obtained from its use in aqueous and dilute urine matrices.  One 
important point to note is that a shift in the peak position occurred for the 5x dilute urine 
sample.  The peak maximum was shifted from the expected 12.5 minute mark to 14.2 
minutes.  More work needs to be done to determine if there is any consistent peak 
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shifting for a range of urine concentrations.  In addition more work is needed to 
determine any effects of more concentrated urine matrices on polonium recovery. 
CONCLUSIONS 
An automated computer controlled system for the separation and simultaneous 
detection of 210Po was created and optimized for aqueous samples.  A method of 210Po 
recovery from well-aged 210Pb solutions was detailed.  Obtaining 210Po from 210Pb is an 
easy and convenient way of maintaining a stock of 210Po without having to be concerned 
with significant decay of the stock activity over time.  A loading and elution protocol was 
developed and optimized for acid concentration to permit effective loading and elution of 
210Po.  Cocktail/eluent ratios were also optimized to obtain results with the best figures of 
merit.  An optimal counting window for 210Po with the β-RAM flow scintillation analyzer 
was also established.  A calibration curve of detector response to various low activity 
samples was plotted and a non-linearity in the curve was noted.  A discontinuous 
calibration curve was deemed to be the best fit for the data.  Detector biases for activities 
above and below 400 DPM were identified.  The system allows for quantification of 
210Po in samples with at least 100 DPM of activity, using the stopped-flow counting 
technique and a 30 minute count time.  The time for total analysis and column washing 
and reconditioning was 60 minutes.  While no experiments were performed in this work 
to determine column longevity, we believe that a column life of 10 cycles, as determined 
elsewhere, can be recommended here (Vajda 1997; Vreček 2003).  The feasibility of 
analysis of 210Po in dilute urine matrices was also briefly examined, with encouraging 
results.  Much more work is needed to study the method efficacy for urine analysis of 
210Po and to optimize counting parameters.   
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Chapter 5:  Flow Gamma Analysis of 60Co and 137Cs 
An automated method for the determination of 60Co and 137Cs in aqueous samples 
by a new technique, called flow gamma analysis (FGA) was examined.  This new 
technique detects the activity of gamma-emitting nuclides in a flowing system with a 
NaI(Tl) detector.  FGA is closely related to the similar method of flow scintillation 
analysis (FSA), which was also used in this work to determine 60Co and 137Cs.  By 
employing high performance extraction chromatography (HPEC) to separate the analytes 
from the sample matrix and carry them to a flow cell, they can be counted by gamma 
spectroscopy.  The all-in-one system would enable the separation of certain gamma-
emitting nuclides from matrix constituents and possible interferences by using columns 
filled with extractive chromatographic resin.  In this work, Eichrom’s Sr-Spec resin 
(which cobalt and cesium have not affinity for) was used to clean up the sample stream 
prior to gamma counting.  While the advantages of removing Sr, Po, and certain actinides 
has negligible effect on the effectiveness of 60Co and 137Cs determination by gamma 
counting, there are several scenarios where it may be of interest to remove these gamma 
emitters to facilitate 90Sr, 210Po, and actinide determination by other methods.  To this end 
we have examined the feasibility of 60Co and 137Cs detection by FGA.  We also examined 
FSA as a method for low-level 60Co and 137Cs determination with applications to 
bioassay.  Advantages to this method over traditional methods of bioassay gamma 
analysis include rapid quantification, and simplified batch sample processing.  
Disadvantages of the technique as it is currently developed include high detection limits 
and poor energy resolution.  These disadvantages may be mitigated by future work that 
would continue to optimize the detector setup and counting parameters. 
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INTRODUCTION 
Many gamma-emitting radionuclides are formed as byproducts of nuclear power 
generation, and weapons production.  Two of the most significant gamma-emitting 
isotopes are 60Co and 137Cs because these nuclides are produced in relatively large 
quantities and have relatively long half-lives.  60Co is a β/γ emitter with a half-life of 5.27 
years (βmax = 317.88 keV, γ1 = 1173.24 keV, γ2 = 1332.5 keV) that produces two 
energetic gamma rays with each disintegration, decaying into stable 60Ni (KAPL 2002).  
137Cs is also β/γ emitter with a half-life of 30.07 years (βmax = 514 keV, γ = 661.66 keV) 
that produces one energetic gamma ray in 94.4% of its transitions as it decays to 137mBa 
which emits the 662 keV gamma ray with a half-life of 2.55 minutes as it transitions to 
stable 137Ba (KAPL 2002).   
In addition to being found in nuclear waste streams, these isotopes have found 
wide-spread uses in medicine and industry.  Curie-level quantities of 60Co and 137Cs are 
used as radiation therapy sources, sterilizers for food and medical equipment, x-ray 
machine, thickness gauges, and to check pipe welding.  Because of the availability of 
high-level sources of these isotopes, there is great concern for public health if there 
should be an industrial accident or terrorist event involving these isotopes. 
Recent history has already witnessed the devastating effects of an accidental 
release of 137Cs from a discarded teletherapy source in Goiania, Brazil in 1987.  Members 
of the public who tried to salvage the medical equipment unknowingly ruptured a vessel 
containing approximately 1400 Ci of 137Cs and spread its contents among friends and 
family members, causing some of them to become sick with radiation poisoning.  About 
112,000 people were sequestered in the Olympic stadium and surveyed with hand meters; 
250 were identified as contaminated, 50 of which were further monitored, including 20 
that were hospitalized, of which 4 died as a result of their exposure (IAEA 1998).  Both 
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whole body in vivo counting and in vitro counting of patient excreta were done assess 
internal uptake and Prussian Blue (ferric ferrocyanide) was administered to some patients 
to enhance elimination.   
Because of the potential for future accidental releases or the intentional terrorist 
use of a radiological dispersal device (RDD) involving 60Co or 137Cs, there would be 
great usefulness for a rapid urine bioassay method capable of detecting these 
radionuclides.  To this end, we have examined the feasibility of using a new technique, 
called flow gamma analysis (FGA) to separate 60Co and 137Cs from the urine matrix and 
simultaneously detect these nuclides using a flow-through NaI(Tl) detector.  This system 
would be capable of processing large batches of urine samples and providing rapid 
results, while preserving the gamma-emitting analytes for further analysis.   
Existing methods of determining gamma-emitting nuclides in urine bioassays 
involve placing urine samples into vessels of standardized geometries for which 
backgrounds and efficiencies are well characterized; where the best sensitivities are 
achieved by evaporating 24-hour void samples down to small volumes or residues (AEC 
1971; Rich 1990).  Since the gamma rays emitted by 60Co and 137Cs are not significantly 
attenuated by the urine residue or high concentrations of salts, it is feasible to maximize 
counting efficiency by condensing large samples.  However, the process of evaporating a 
24-hour void (Reference Man 24-hour urine void is 1440 mL (Cember 1996)) is slow, 
since boiling of the samples during evaporation is avoided.  While counting of the 24-
hour void in its entirety is possible, counting efficiency is sacrificed and no further 
analysis on the urine can be done while the sample is counted. 
Therefore, it would be advantageous to have a method that could accomplish a 
rapid preliminary analysis of a small sample of uncondensed urine to aid in triaging 
patients by identifying those with the most activity in their urine.  This may be 
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accomplished by FGA.  Due to the fact that the flow cell size and its placement with 
respect to the detector are constant, the counting geometry is fixed and variable amounts 
of sample can be counted without compromising the known counting parameters.   
Detection of gamma-emitters in a flowing system has been previously 
accomplished by various scintillation methods.  This is typically accomplished by using 
specialized counting flow cells, e.g., Cerenkov, BGO (Anonymous 1995), CaF2 
(Anonymous 1995), and PET (Takei 2001).  Homogeneous liquid flow cells have also 
been used to detect various gamma emitters(Fjeld 1995; Desmartin 1997; Egorov 1998b).  
However, these systems often employ only rudimentary multi-channel analysis, capable 
of discriminating between up to two radionuclides, whose gamma emission energies are 
well separated.  These methods instead rely on chromatograms and previous knowledge 
of chromatographic behavior of analytes to determine the identity of an observed peak.  
This precludes most types of multi-isotopic analysis when two or more analytes co-elute.  
This is the case with 60Co and 137Cs and the Sr-Spec resin; neither analyte has any affinity 
for the resin and so they both elute with the passing of the sample zone through the 
column and are thus unresolvable chromatographically (Horwitz 1992b).   
An instrument capable of performing more sophisticated multi-channel analysis is 
needed to be able to discriminate between 60Co and 137Cs based on gamma emission 
energy rather than chromatography.  NaI(Tl) detectors are able to accomplish such 
energy discrimination.  The full-with-half-max of a typical NaI(Tl) detector at the 137Cs 
emission peak, 662 keV, is approximately 56 keV (Friedlander 1981).  While this 
resolution is worse than that of a typical germanium detector by a factor of 30, it is 
nonetheless suitable for our goals of resolving 60Co and 137Cs (Kahn 2007).   
Flow NaI(Tl) counters are available commercially and are primarily utilized in the 
pharmaceutical and biotechnology fields for counting radio-labeled compounds.  
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However, the activities of radio-labeled compounds that are typically used in these 
applications is on the order of mCi, which is much high than levels that would be found 
urine bioassays of even those with lethal uptake of 60Co or 137Cs.  Therefore, it is 
uncertain if a flow gamma detector that was designed for use with radio-labeled 
compounds can be used for much lower activity urine bioassay samples.  In addition, 
these instruments are built for chromatographic purposes and function as gross gamma 
counters with the advantage of improved counting efficiency.  Therefore, it was 
necessary to modify one of these instruments with an after market amplifier and multi-
channel analyzer to convert the gross gamma output signal from the detector into a signal 
that could create a gamma energy spectrum.   
In this paper we describe the modification of a commercially available flow 
gamma counter into one that can be used to obtain a gamma spectrum of analytes as they 
travel through the flow cell.  The purpose of utilizing a Sr-Spec chromatography column 
with these analytes is to show analysis of 60Co and 137Cs may be performed in 
conjunction with the previously described 90Sr and 210Po determination by FSA.  We also 
examined the possibility of determining 60Co and 137Cs by FSA to detect the associated 
beta particles of these analytes.  While, transient-flow counting was the method of flow 
analysis used in the experiments presented in this paper, stopped-flow counting may also 
be used to achieve better detection limits for these analytes (Grate 1996; Egorov 1998b; 
Grate 1999b).  
EXPERIMENTAL 
High Performance Extraction Chromatography System: A Dionex GP50 gradient 
pump (Dionex, Sunnyvale, CA) was configured with a Rheodyne 7725i dual mode 
analytical injector and a 2000 μL sample loop (Precision Flow Products, Lake Elsinore, 
CA).  A 2500 μL Gastight syringe (Hamilton Co, Reno, NV) was used to inject samples 
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into the loop.  Sr-Spec resin (EIChroM Industries, Inc., Darren, IL) of bead size 50-100 
μm was slurried overnight with deionized water (18 MΩ Nanopure Water System, 
Barnstead, Dubuque, IA) and packed into one of two PEEK lined columns, 4.6mm I.D. x 
30mm or 150mm, hardware (Alltech Associates, Deeerfield, IL) using an Alltech Model 
1666 slurry packer.  The packing pressure was 1000 psi and the calculated volume of the 
resin was 0.499 mL for the 3cm columns, and 2.49 mL for the 15cm columns.  Samples 
were loaded with 1 mL/min of 8M HNO3 and were not retained by the resin.  The column 
effluent was either fed directly into the FGA for gamma counting or mixed with 
scintillation cocktail at a 2:1 scintillatior/eluenet ratio. 
On-Line Liquid Scintillation Counting: Flow scintillation analysis was 
accomplished using a β-Ram 4B (IN/US Systems Inc., Tampa, FL).  This model 
possesses an internal cocktail pump and can be fitted with flow cells of various types and 
sizes.  All experiments in this work were done using a 2500 μL liquid flow cell.  The 
device was configured with the HPEC so that the column effluent was mixed with the 
scintillator in controllable ratios.  The detector counting parameters were controlled using 
Scint Flow SA software (IN/US) and Laura Lite 3.4 (IN/US) run on desktop PC and 
connected to the detector by a serial port.  The detector was signaled to begin cocktail 
flow and counting by a closed contact connection to the analytical injector when it was 
turned to the “inject” position.  The detector integration time, ti, was 6s to allow enough 
counts to accumulate for each data point.  
Flow Gamma Counting: A tandem NaI(Tl) gamma counting unit was obtained 
from (IN/US Systems) and interfaced to function with the support of our β-Ram 4B as the 
intelligent front end of the system.  The tandem gamma counter consists of a Bicron 
(Saint-Gobain Crystals, Newbury, OH) well-type thallium-activated NaI detector.  The 
crystal dimensions were 1.5” dia. x 2” long with a well of approximately 5/8” dia. x 1.5” 
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deep.  This detector was optically coupled via a quartz light-guid to a 1.5” dia. PMT.  The 
thickness of the aluminum casing on the well was 0.005” to permit maximum penetration 
of low-energy gamma rays.  The detector was placed within a single piece of formed lead 
shielding (~35 lbs.) that was approximately 4” x 4” with a 2” dia. hole cut in the center to 
accommodate the detector.  The detector comes in a casing with its in-house high voltage 
supply and pre-amplifier.  The detector out put is intended to connect to the β-Ram 4B, 
where the signal is processed as a gross gamma count.  Instead, the detector output signal 
was split, with one end going to the β-Ram 4B and the other end going to an after market 
amplifier and multi-channel analyzer.  The amplifier used was an Ortec (Ortec, Oak 
Ridge, TN) positive NaI detector interface module (DIM).  This was connected to an 
Ortec DSpec Pro multi-channel analyzer.  Typical counting parameters were a high 
voltage setting of 600 V, a rise time of 6 μs, and 1024 channels.  Acquisition and analysis 
were performed using Maestro 32 v. 6.05 MCA Emulator (Ortec).  The detector was 
energy calibrated using a mixed 60Co and 137Cs.  The detector was periodically re-
calibrated and pole-zeroed when the peak position drifted. 
 
Figure 5.1: Block diagram of the FSA and FGA units. 
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Figure 5.2: NaI(Tl) efficiency curve. 
Detector background was established by performing a 1000 minute count with no 
source present in the well and noting background counts in the regions of interest (ROIs) 
that were previously established for 60Co and 137Cs.  Net counts for each peak were 
determined by averaging the counts in 4 channels to the left and right of the peak 
continuum and subtracting this average count per channel from the peak ROIs.  An 
efficiency curve (Figure 5.2) for the detector was determined by placing known activities 
of in-house 60Co and 137Cs liquid standards in the flow cell and counting for 30 minutes 
















R2 = 0.9846 
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geometry were 8.28% for the 662 keV 137Cs γ, 1.92% for the 1173 keV 60Co γ, and 
1.56% for the 1332.5 keV 60Co γ.  Figure 5.3 shows a 200 μL gamma flow cell. 
 
 
Figure 5.3: 200 μL gamma flow cell.  The sample flows in one end and out the other.  
The metal spacer ensure that the flow cell is positioned within the well of 
the NaI(Tl) counter.  Larger cells may also be accommodated. 
Reagents and Standards: All chemicals used were analytical grade.  Deionized 
water was used in all dilutions.  A low-viscosity liquid scintillation cocktail (In-Flow 2:1, 
IN/US) was used for all flow scintillation measurements because this cocktail can be 
mixed with eluents at low ratios without gelling.  Ultima Gold LLT (Packard) cocktail 
was used for all off-line liquid scintillation counting.  Standard 60Co and 137Cs solutions 
were prepared by evaporating aliquots of in-house standards to dryness and dissolving the 
residue in measured volumes of 8M nitric acid. 
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RESULTS AND DISCUSSION 
60Co and 137Cs Chromatography Observation:  Individual high activity samples of 
either 60Co or 137Cs were injected into the syringe port and loaded onto the Sr column 
with 1mL/min 8M nitric acid for 10 minutes.  The column effluent was mixed with 
scintillation cocktail at a scintillator/eluent ratio of 2:1 to detect beta particle activity.  
Because the βmax energy of 60Co and 137Cs (318 keV and 514 keV) are similar to that of 
90Sr (546 keV), a previously established 90Sr counting window of 0-600 channels was 
used to observe these isotopes.   This experiment allowed us to determine the peak 
position and form of the 60Co and 137Cs elution; samples are shown in Figure 5.4.  Both 
60Co and 137Cs peaks can be found entering the flow cell approximately 3.5 minutes after 
sample injection; a finding that is consistent with no significant retention on the column.  
However, 60Co peaks were generally somewhat broader than 137Cs, indicating that cobalt 
may have some minimal interaction with the resin.  Since 60Co and 137Cs effectively co-
elute from the column, there is no way to resolve these peaks chromatographically using 




Figure 5.4: Detector traces of 60Co and 137Cs observed by FSA.  2170 dpm of 137Cs and 
1662 dpm of 60Co both elute approximately 3.5 minutes after injection.  60Co 
peaks were generally somewhat broader than 137Cs peaks. 
Static 60Co and 137Cs Gamma Spectrometry Observation:  Gamma spectroscopy 
by NaI(Tl) is able to resolve the γ-ray emissions of 60Co and 137Cs by γ energy 
discrimination because the associated gamma peaks are well-separated.  Figure 5.5 shows 
a typical gamma spectrum of a source that contains both 60Co and 137Cs.  The observed 
137Cs peak occurs at an energy of 662 keV and has a full-with-half-max (FWHM) of 68 
keV, while the 1173 and 1332 keV 60Co peaks have FWHM of 78 and 90 keV 
respectively.  These peaks did drift from their energy calibrated locations from day to day 
and needed to be recalibrated regularly.  This is presumably due to drift in the high 
voltage, which can significantly affect the peak channel position for a NaI(Tl) detector 
























Figure 5.5: The γ-ray energy spectrum of a mixed 137Cs/60Co source.  Regions of 
interest (ROIs) are bounded by red lines.  
The established ROIs for the 60Co and 137Cs peaks were observed during a 1000 
minute background count that was conducted with no sources present in the detector.  
The ROIs were integrated in for background spectra to determine the number of 
background counts that can be expected for each ROI.  By applying the efficiency 
calibration of each isotope (efficiency curve reported in Figure 5.2) to the background 
cpm in each ROI, we determined the background dpm for each γ-ray.  The results of 






Table 5.1: Background activity for 60Co and 137Cs. 
GAMMA E. (keV) BKGND (cpm) EFF. (%) BKGND A (dpm) 
662 29.8 (± 0.2) 8.28 (±0.3) 360 (± 13) 
1173 8.78 (± 0.09) 1.92 (±0.06) 457 (±15) 
1332.5 4.66 (± 0.07) 1.56 (± 0.05) 299 (± 11) 
From these background activity rates, we can determine the critical limit, and 
limits of detection and quantification for static counting of these isotopes for this 
detector.  These limits a shown in Table 5.2 for a hypothetical 30 minute count time. 
Table 5.2: Critical, detection, and quantification limits for a 30 minute count of a 60Co 
or 137Cs source, using the NaI(Tl) detector. 
GAMMA E. (keV) LC (dpm) LD (dpm) LQ (dpm) 
662 28 (± 1) 59 (± 2) 192 (± 7) 
1173 66 (± 2) 136 (± 4) 495 (±16) 
1332.5 59 (± 2) 123 (± 5) 480 (± 18) 
Transient Gamma Counting of 60Co and 137Cs:  The ultimate goal of developing a 
flow gamma analysis system is to detect 60Co and 137Cs flowing system.  This is an 
inherently more difficult detection problem than static gamma counting because the 
radioactive sample zone has only a limited time that it can be “seen” by the detector as it 
passes through the flow cell.  Assuming that there is no diffusion of the sample zone in 






t cr =                                                       (5.1) 
where, Vc, is the volume of the flow cell and, F, is the combined flow rate of the eluent.  
In this work, 200 and 1750 μL flow cells were used with an eluent flow rate of 1mL/min.  
Therefore, the residence time used in all calculations is 12s for the 200µL flow cell and 
105s for the 1750µL flow cell.  We attempted to collect both chromatographic 
information, using the tandem gamma detector for its intended purpose, and to collect 
spectral information, using the modified detector output.  Collecting chromatographic 
data proved impossible for the low activity levels utilized in these experiments.  This was 
mainly due to the very high background gross gamma count rate of the NaI(Tl) that the 
chromatography measurement uses.  These backgrounds were typically on the order of 
8,000 cpm because counts of any energy were registered.   
The γ-ray energy spectra were also of limited use.  This was due to the fact that 
only minimal counts were registered in the ROIs during the short residence time of the 
sample zone.  Using the background ROI count rates, isotope efficiency information, and 
flow cell residence times, we can determine the limits of detection for 60Co and 137Cs for 
different sized flow cells.  These data are shown in Table 5.3.  These limits assume a 
1mL/min eluent flow rate.  It is not supprising to see that as the flow cells get larger, 
detection limits for 60Co and 137Cs are lowered.  Nevertheless, these detection limits are 
still higher than is desirable for bioassay monitoring.  Better data may be obtained by 
utilizing a larger NaI(Tl) detector (3” diam. x 3” crystal) to improve the γ-ray detection 
efficiency.  Also, the addition of more Pb shielding for the detector would improve 
detection limits by lowering the background count rate.   
Table 5.3: Detection limits for transient-flow counting of a 60Co or 137Cs samples, 
versus different flow cell volumes for the NaI(Tl) detector. 
 104
GAMMA E. (keV) 200 µL (DPM) 1750 µL (DPM) 2500 µL (DPM) 
662 2026 (± 67) 539 (± 18) 440 (± 15) 
1173 6032 (± 177) 1408 (± 41) 1134 (±33) 
1332.5 6353 (± 258) 1370 (± 56) 1092 (± 44) 
Transient-Flow Quantification of 60Co and 137Cs by FSA:  Having failed to 
achieve lower detection limits for 60Co and 137Cs by FGA, we turned to FSA as an 
alternative detection method for these isotopes.  As was previously shown, samples 
containing both 60Co and 137Cs cannot be resolved into their isotopic composition by this 
method.  However, if there is previous knowledge that the sample contains either only 
60Co or only 137Cs, then this method may be used to quantify the isotope in question.   
In this work, a 2500 μL flow cell was used with a combined scintillator/eluent 
flow rate of 3mL/min.  Therefore, the residence time used in all calculations is 50s.  For 
transient flow counting, the peak area is summed and the background count for the area is 
subtracted to derive a net number of counts for the peak, Cn.  The net CPM for the peak 






C =     (Transient-Flow)                  (5.2) 
If a known activity of 60Co or 137Cs is introduced to the system, the net count rate can be 
related to the sample activity, Adpm, to determine the effective efficiency, Ees (which 
combines the efficiency of the separation and the detector). 
 
 dpmesCPM AEC =      (Transient-Flow)            (5.3) 
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Using the above relations, we can create a calibration curve for the detector and 
analyte of interest by injecting various 60Co or 137Cs activities and plotting the resulting 
net peak areas, see Figures 5.6 and 5.7.  The slope of the line is related to the effective 
efficiency, Ees, by dividing the slope by the sample residence time, tr. 


























Figure 5.6: 60Co calibration curve.  y= 0.723x -260, R2 = 0.9926.  Error bars are 3σ. 
            



























Figure 5.7: 137Cs calibration curve.  y= 0.762x -414, R2 = 0.9954.  Error bars are 3σ. 
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Figures 5.6 and 5.7 indicate that the detection of these isotopes are detected with 
high efficiency (87% (±4) for 60Co and 91% (±5) for 137Cs), but with a pronounced bias 
effect that suppresses detector response.  This is most likely due to quench effects which 
can be significant for the 8M HNO3 eluent (Grate 1999b).  Correction for the bias can 
easily be compensated for by using the calibration curve equations, derived from Figures 
5.6 and 5.7, however, overall detection limits are adversely affected by the bias.  We 
estimate that the detection limit for 60Co by FSA is 494 (±25) dpm, while the detection 
limit for 137Cs by this method is 729 (±36) dpm.  So while better detection limits are 
obtained for 60Co by FSA, FGA is a superior method of detection for 137Cs, if similarly 
sized flow cells are used for each method. 
CONCLUSIONS 
An automated method for the determination of 60Co and 137Cs in aqueous samples 
by a new technique, called flow gamma analysis (FGA) was examined.  This method 
attempted to combine rapid chromatographic separation techniques with the γ energy 
discrimination properties of a NaI(Tl) detector.  This would enable the determination of 
β/γ emitting nuclides that co-elute from the column; a determination is not possible with 
established FSA techniques.  However, due to low the detection efficiency of the NaI(Tl) 
detector used in these experiments, the FGA detection limits for 60Co and 137Cs were 
undesirably high; 1134 (±33) dpm for 60Co and 440 (± 15) for 137Cs for a 2500 µL 
gamma flow cell.  We also conducted experiments to determine these isotopes by FSA, 
even though we could not resolve samples with mixtures of the two analytes.  Better 
detection limits were achieved for 60Co, 494 (±25) dpm, by this method; however, worse 
detection limits found for 137Cs, 729 (±36) dpm.  Determination by FSA was primarily 
hampered by an encountered detector response bias that inhibited the determination of 
these analytes at lower levels. 
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The authors believe that chemical quenching of the scintillation process by the 
high concentration of nitric acid eluent, 8M, may be to blame for this effect.  It is possible 
that by lowering the molarity of nitic acid, less bias will be encountered.  We believe that 
we can reduce the load solution nitric acid concentration to 3M, and still be able to 
achieve retention of 90Sr, a possible interference.   
The authors also believe that NaI(Tl) detection efficiency can be improved with 
the addition of extra lead shielding.  If a large lead brick cave is built around the detector 
the background count rate can be expected to drop, thereby enhancing the signal to noise 
ratio when a source is present.  The addition of a copper or cadmium liner for the detector 
cave would also further reduce background.  This modification can be made easily and 
without much added cost.  Further, we believe that the use of a detector with a larger 
NaI(Tl) crystal would improve γ-ray detection efficiency since γ-ray stopping power is 
proportional to the crystal thickness.  A well-type NaI(Tl) detector with a 3” diam. x 3” 
crystal is capable of approximately 32% absolute detection efficiency for the 662 keV γ 
of 137Cs and approximately 25% absolute detection efficiency for the 1332 keV γ of 60Co 
(Kahn, 2007).  This modification would be more costly that the previous, but would have 
the added bonus of accommodating larger gamma flow cells in the larger well. 
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Chapter 6:  Optimization of Actinide Analysis By HPEC and ICP-MS 
A procedure for the separation and detection of trace levels of actinides using 
high performance extraction chromatography (HPEC) and inductively coupled plasma 
mass spectrometry (ICP-MS) has been optimized.  Using Eichrom’s TRU resin, a mixture 
of five actinides (232Th, 238U, 237Np, 239Pu, and 243Am) can be separated and detected by 
mass in under four minutes.  Several method parameters were optimized in this research 
including: resin size, column length, packing pressure, and eluent flow rate.  Experiments 
were also conducted to examine the feasibility of reducing or eliminating oxalic acid 
from the elution scheme.  The use of large quantities of oxalic acid in combination with 
ICP-MS is undesirable in that this reagent causes a residue buildup on the cones of the 
mass spectrometer.  Overtime, this buildup reduces the performance of the mass 
spectrometer.  A rapid and automated method of trace actinide separation and detection 
has applications in a number of areas including environmental monitoring, bioassays, 
expedited routine analysis, and emergency response situations. 
INTRODUCTION 
The ability to detect trace levels of actinides in biological samples has long been a 
concern of the nuclear industry, the national lab complex, and public health officials.  
This is because actinides are most toxic once inside the body where their long biological 
half-life and alpha radiation is extremely damaging.  Actinides can enter the body via 
ingestion, inhalation, or wounds, and exposure to even small amounts can cause severe 
health hazards (Price 1973).  Analytical techniques that can determine the isotopic 
composition of internally deposited actinides are critically important because isotopic 
information is most useful in determining dose calculations, and location the uptake 
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occured.  Isotopic determination of actinides is also valuable for a number of other 
purposes, such as nuclear forensics and nonproliferation monitoring.  
Some commonly utilized techniques for determining isotopic actinide content of 
samples are alpha spectrometry, thermal ionization mass spectrometry (TIMS), 
accelerator mass spectrometry (AMS), and neutron activation analysis (NAA).  These 
techniques can be problematic in terms of extensive sample preparation time (alpha 
spectrometry) or very expensive, high maintenance equipment (TIMS, AMS, NAA).  
Inductively coupled plasma mass spectrometry (ICP-MS) is a lower cost, more 
commonly available technique that is extremely useful and widely used for actinide 
analysis (Lariviere 2006).  This technique has the advantage of requiring very little 
sample preparation (for aqueous samples) and producing fast multi-isotopic analysis with 
detection limits reported into the low ppq levels for several actinides, including: 232Th, 
238U, 237Np, 239Pu, and 241Am (Baglan 2004; Pointurier 2004).  A comparison of ICP-MS 
to various other analytical techniques has shown this method to be superior in many 
aspects (Dacheux 1997).  However, the capabilities of ICP-MS are often limited by the 
presence of isobars (which produce unresolvable interferences) and polyatomic 
interferences (some of which are shown in Table 6.1) (Alonso 1995; Egorov 2001).   
 Table 6.1: Commonly encountered actinide polyatomic interferences. 
 
ISOBARS POLYATOMIC IONS
236U and 236Np 230ThH and 231Pa 
238U and 238Pu 236UH and 237Np 
241Pu and 241Am 237NpH and 238U 
242Pu and 242Am 238UH and 239Pu 
 240PuH and 241Am 
  242PuH and 243Am 
While the best sensitivities are realized only in “neat” solutions, samples with 
complex matrices such as environmental (soil, seawater) or biological (urine) samples 
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reduce sensitivities.  This is due to the fact that an increase in the number of matrix 
molecules in the sample stream leads to increasing interferences.  Therefore, it is 
necessary to remove as many matrix components as possible prior to analysis and to use 
techniques which separate isobars and potential polyatomic interferences.  This 
necessitates the separation of the actinide elements in the sample stream to as large a 
degree as possible prior to detection.    
Techniques for actinide separation have been developed and applied to alpha 
spectrometry for many years, while applications to ICP-MS have been more recent 
(Boulyga 2001).  These methods typically involve lengthy, labor-intensive procedures, 
and there would be great benefit in the development of a fast, automated separation 
procedure that feeds directly into a mass spectrometer.  Previously demonstrated methods 
involve the use of resins to load analytes onto a column, where they are separated from 
matrix elements, and then separate them by individually eluting them (Epov 2005).  The 
most commonly used form of this technique is the chromatography column (Choppin 
1995).  A very effective form of chromatographic separation is through the use of organic 
liquid extractants (a product of earlier liquid-liquid extraction techniques) that have been 
immobilized onto polymer beads.  Several varieties of these types of extractive resins are 
commercially available from Eichrom, including: TEVA, U/TEVA, TRU, and Sr.  
Recently our group demonstrated the rapid separation of five actinides (Th, U, Np, Pu, 
and Am) on columns packed with either U/TEVA or TRU resin (Hang 2004; 2005).  This 
method enabled the pre-concentration of these analytes onto the column from large 
volume samples.  The separations took approximately 12 minutes to completely resolve 
these analytes using manually packed 30 cm columns.  Equilibration times and hold times 
for the injection increased the total analytical cycle time to nearly 30 minutes.  In 
addition, this separation method utilized a relatively large quantity of oxalic acid (~0.1g 
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per cycle) to fully remove the analytes from the column.  The use of this much oxalic 
acid is detrimental to performance of the mass spectrometer since it degrades 
performance and necessitates frequent cleaning and retuning of the instrument.   
 In this study we packed columns TRU resin using a commercial slurry packer.  
This enables us to pack columns uniformly and reproducibly.  The use of a slurry packer 
also enables us to optimize the columns and packing conditions.  In this study we have 
optimized these separations to reduce or eliminate the oxalic acid in the separation.  We 
also examine various parameters on the separation including resin size, packing pressure, 
column length and flow rate. 
EXPERIMENTAL 
Instrumentation:  Ion chromatography was performed using a high performance 
ion chromatograph (DX-600, Dionex, Sunnyvale, CA).  The IC was equipped with an 
autosampler (AS50, Dionex) capable of injections up to 1 ml.  Elemental detection and 
identification of the IC eluent was accomplished by a quadrapole ICP-MS (Elan 6100, 
Perkin Elmer, San Jose, CA).  Typical parameters for the ICP-MS were: 0.75 L/min 
nebulizer gas flow, 10.25 V Lens Voltage, 1225 W ICP-RF power, -2200 V Analog Stage 
Voltage.  The ICP was equipped with a concentric glass nebulizer and a cyclonic spray 
chamber (Perkin Elmer).  The process of sample injection, separation, and detection was 
automated through the Chromeleon management system (Dionex) and the ICP-MS 
software was triggered to collect data through a contact closure.  Data was collected by 
peak hopping between the major actinide masses (Th232, U235, U238, Np237, Pu239, Am243). 
Reagents and Materials:  Trace metal grade nitric acid was obtained from Fisher 
Scientific (Pittsburgh, PA).  Oxalic acid eluent was purchased from Dionex and diluted to 
the recommended concentration (80 mM oxalic acid, 100 mM tetramethyl ammonium 
hydroxide, and 50 mM potassium hydroxide).  Deionized water (18 MΩNanopure Water 
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System, Barnstead, Dubuque, IA) was used to dilute acids and standards to the desired 
concentrations 
 Ion chromatography columns were prepared using a resin containing octylphenyl-
N,N-diisobutyl carbamoylphosphine oxide adsorbed onto the packing beads, which are 
made of polymethylmethacrylate.  This resin is commonly called TRU resin and was 
obtained from Eichrom Technologies (Darien, IL).  These resins were supplied with three 
different particle sizes; 20-50 µm, 50-100 µm, and 100-150 µm.  The resins were packed 
into PEEK lined column hardware (Alltech Associates, Deeerfield, IL) using an Alltech 
model 1666 Slurry Packer.  Columns were prepared in 30 cm, 10 cm, and 3 cm lengths. 
Standard solutions of Np237, Pu239, and Am243 were obtained from Isotope 
Products (Valencia, CA).  These standards are normally sold with a specific activity (i.e. 
2 µCi/mL), so these values were converted to ppm values so that all standards would be 
prepared with similar values.  A standard 1000 ppm ICP-MS solution of Th was obtained 
from Alfa Aesar (Ward Hill, MA).  A standard 1000 ppm ICP-MS solution of U was 
obtained from SPEC Certiprep (Methchen, NJ).  The thorium solution was confirmed to 
contain 100% of Th232, the uranium solution was confirmed to contain approximately 
0.7% U235 and 99.3% U238 (natural uranium concentrations).  All actinides were diluted to 
a stock solution of 50 ppt in water with 5% nitric acid. 
Column Preparation:  Columns were prepared using a commercial slurry packer 
in order to improve the reproducibility of the packing from column to column.  The slurry 
packer contains a pneumatic amplification pump which enables a low pressure gas supply 
to be amplified into the liquid of the slurry.  The amplification is approximately 1:100.  
To pack a column the resin was first suspended in approximately 25 ml of deionized 
water.  The slurry was mixed overnight prior to packing.  The column and exit frit were 
then attached to the reservoir, into which the packing slurry was added.  The reservoir 
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was topped off with deionized water and the fluid lines from the slurry packer were 
attached to the reservoir.  After the lines were primed, the air pressure was adjusted to the 
desired level and the solvent flow was turned on.  The slurry packer was allowed to pack 
each column for approximately five minutes.  After the pressure was bled off, frits were 
installed and the column was rinsed with a flow of 3M nitric acid. 
RESULTS AND DISCUSSION 
Optimization of Columns:  The primary purpose of this study is to optimize the 
separation of actinides on columns packed with TRU resin.  For most testing, the oxalic 
acid was removed from the gradient as a way to reduce the amount of organic impurities 
put into the mass spectrometer.  Once the oxalic acid was removed from the eluent, the 
primary parameter that was to be optimized is the retention time.  The amount of 
resolution that will be required will depend largely on the isobaric interferences that are 
present for each analyte.  For instance, it is necessary to separate uranium and plutonium 
to reduce the isobaric interference from 238UH and 239Pu.  It will not be necessary to 
separate Am from Th as they will not interfere with each other.  With these limitations in 
mind, it was also determined that the amount of hydrochloric acid that needed to be used 
was around 35%. Table 6.2 shows the various gradients used in this study.  The gradient 
used previously by our group (Hang 2004) is Gradient 1, the gradient with all oxalic acid 
removed is Gradient 2.  A third gradient with a small amount of oxalic acid was also 






Table 6.2: Elution gradients used in this work. 













-11 3 3M HNO3 
-2 3 3M HNO3 






































































Packing Pressure:  The slurry packer that was used enables columns to be packed 
easily and reproducibly.  Part of the process in packing high-efficiency columns 
efficiently is in determining the optimal packing pressure for the packing material being 
used in a particular application.  The slurry packer that we used is capable of generating 
pressures well over 10,000 psi, however very high pressure would crush the polymeric 
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resin material on which the active stationary phase is adsorbed to.  For our use we packed 
columns at or below 3000 psi (liquid pressure).  We initially packed four columns at 3000 
psi and separated the actinides using Gradient 1.  This produced very reproducible 
columns (data not shown).  In order to test the effect of packing pressure on the column 
performance we packed three columns 30 cm long at pressures varying from 1000 psi 
(the low limit of the slurry packer), up to 3000 psi.  We then separated the five actinides 
on each column using Gradient 2, as seen in Figure 6.1. 
      






























Figure 6.1: Separation of actinide analytes on 30 cm long TRU resin (50-100 µm) 
packed at pressures between 1000 psi and 3000 psi.  Separation using 
Gradient 2 in Table 6.2. 
 116
This data demonstrates several points.  First, without the oxalic acid the 
selectivity between the different actinides is significantly reduced and the actinide peaks 
tend to co-elute.  Second, the faster flow rate combined with the faster gradient causes all 
five actinides to be eluted in under six minutes, which is approximately twice as fast as 
our previous study.  The data presented in Figure 1 also demonstrates that the effect of a 
higher packing pressure is to improve the selectivity between the analytes and thus 
improve the separation.  The likely reason for this improvement is that as the resin 
becomes better packed at higher pressure, there is less void volume in the column, 
improving the separation.  We expect that because a relatively soft polymer is used as the 
support material that very high packing pressures are unrealistic because the beads would 
compress and ruin the resin.   
Column Length:  Another parameter that is expected to have a significant effect 
on the separation is the column length.  As the column length increases there is a larger 
number of theoretical plates available to enable a good separation.  This is simply an 
effect of there being less material in a shorter column resulting in less opportunities for 
the analytes to interact with the packing material.  A longer column also increases the 
amount of time that is required for the separation and it also results in broader peaks that 
result from the band broadening process that occurs within the column. 
In order to test the effect of column length, we packed three different columns 
with the same packing material and under the same packing conditions (50-100 µm resin, 
3000 psi packing pressure).  The column lengths were 30 cm, 10 cm and 3 cm.  Each 
column was then used to separate the five actinides under the same gradient conditions 
(Gradient 2).  Figure 6.2 shows the effect of column length on the retention of three 
different actinides (Pu, Am, Np).   
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Figure 6.2: Separation of Pu, Am, and Np on columns of 30 cm, 10 cm, and 3 cm.  
Columns were packed with TRU resin (50-100 µm) at a pressure of 3000 
psi.  Separation using Gradient 2 in Table 2. 
As expected, the shorter column results in a shorter retention time, decreasing 
from 4.5 minutes to 2 minutes for plutonium and decreasing from 2.5 minutes to under 1 
minute for neptunium.  For the 30 cm column the peak shape is generally poorer than for 
the shorter columns.  This is probably because the gradient is relatively fast; by the time 
the gradient is over the analytes are still on the column and they will re-equilibrate under 
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the less favorable conditions, resulting in significant band broadening.  Figure 6.3 shows 
the effect of the column length on the complete separation of all five actinides.  The 30 
cm column produces a very poor separation of the analytes for the reasons discussed 
above.  The 10 cm and 3 cm columns both produce reasonable separations of the analytes 
in under 4 minutes.  While these separations do not fully separate all of the analytes, it 
does a good job of separating most of the analytes that will produce isobaric interferences 
with each other.  The main analytes that can interfere with one another and are not fully 
resolved are the plutonium and the uranium.  These two analytes are separated a little 
better in the 3 cm column, and there is no major advantage to using the 10 cm column, so 
the 3 cm column is preferred for the remainder of the tests. 
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Figure 6.3: Separation of actinide analytes on columns of 3 cm, 10 cm, and 30 cm.  
Columns were packed with TRU resin (50-100 µm) at a pressure of 3000 
psi.  Separation using Gradient 2 in Table 6.2. 
Resin Size:  Another parameter that can be controlled in examining the 
performance of the resin for separating the actinide analytes is the resin size.  In LC it has 
been demonstrated many times that improved performance is obtained with smaller 
packing materials.  Commercial packings for analytical applications are typically in the 
range of 3-5 µm.  This small size requires that the packing material be composed of non-
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compressible silica materials.  The resin used in this study is composed of a polymeric 
methacrylate backbone, which is compressible.  In addition the resin is only available in 
relatively large sizes.  With these limitations in mind, we packed three 3 cm columns 
with each of the resin sizes under identical conditions.  The columns were then used to 
separate the actinide series.  These results are presented in Figure 6.4.  For all three 
columns the complete separation is obtained in under 4 minutes, although again the 
separation does not produce a baseline separation of all analytes.  This data shows that as 
smaller resin is used the result is sharper and more well defined peak shapes.  The 
improvement from the 50-150 µm resin to the 20-50 µm resin is not as pronounced, but 
the peak shape for the uranium is improved.  
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Figure 6.4: Separation of actinide analytes on columns packed with different sizes of 
TRU resin (100-150 µm, 50-100 µm, 20-50 µm).  All columns were 3 cm 
long and were packed with a packing pressure of 3000 psi.  Separation using 
Gradient 2 in Table 6.2. 
Flow Rate:  The flow rate of the eluents through the column is a parameter that 
has multiple effects on the separation.  For one, increasing the flow rate will increase the 
backpressure that the pump produces when pumping the eluent through the column.  An 
increasing flow rate will also decrease the amount of time that the eluent is in the column.  
This results in a shorter retention time for all analytes.  Another result is that there is less 
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time in which the analytes can come into equilibrium with the stationary phase on the 
resin.  Because full equilibrium is not achieved, the resolution of the separation will be 
reduced and peak shapes will be affected to differing degrees.  



















Figure 6.5: Flow rate versus pressure.  Note the good linearity up to very 
high flow rates. 
In order to demonstrate these effects, we separated all five actinides on a 3 cm 
long TRU column with a 50-100 µm resin.  These separations were carried out at flow 
rates ranging from 1 ml/min up to 8 ml/min.  Figure 6.5 shows that the backpressure 
increases linearly with increasing flow rate.  This indicates that the resin is not 
compacting or deforming even at pressures up to approximately 1300 psi.  Because the 
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structure of the underlying resin is not changing, we can assume that the stationary phase 
should still be performing adequately up to these pressures.   



























Figure 6.6: Retention of Americium on a 3 cm long TRU column (50-100 
µm, 3000 psi packing pressure) at flow rates between 1 ml/min up to 8 
ml/min. 
Figure 6.6 shows the effect of increasing the flow on the retention of a single 
analyte, americium.  This figure shows that as the flow is increased, the analyte has a 
shorter and shorter retention time.  Also, as the flow is increased, the peak also becomes 
narrower.  Both of these observations are what should be expected as the equilibration 
time is decreased due to a shorter residence time of the analyte in the column.   
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Figure 6.7: :  Separation of actinides on a 3 cm long TRU column (50-100 µm, 3000 psi 
packing pressure).  Flow rates were 2 ml/min, 3 ml/min, 4 ml/min and 8 
ml/min. 
Figure 6.7 shows the separation of the actinides at several flow rates.  At the 
lowest flow rate (2 ml/min) the actinides separate with some co-elution of the Th/U/Pu.  
As the flow rate is increased, the peak shapes become better and there becomes better 
separation between the actinides.  At the highest flow rates there is very little selectivity 
between the actinides.  It should be noted that at is that at the highest flow rates, the peaks 
for plutonium and uranium became very distorted.  This is because very high flow rates 
are not ideal for the nebulizer of the ICP-MS.  These high flow rates overload the system.  
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The analytes that are in the spray chamber then take longer to be removed from the 
system, resulting in broad and overloaded peaks. 
Calibration Curve:  In addition to being able to separate the actinide analytes it is 
important to determine how much analyte needs to be injected in order for it to be 
detected in the ICP-MS.  In order to build calibration curves, different volumes of the 50 
ppt standard was injected onto a 3cm long column with 20-50 µm resin.  The maximum 
number of counts was plotted versus the amount of actinide injected in pg (data not 
shown).  The amount that was injected was converted to the mass of each actinide that 
was injected, ranging from 2.5 pg up to 50 pg.  The injected mass correlated very well 
with the detected amount of actinide that was injected onto the column (r2>0.98).  From 
this data, we can also determine the detection limits by determining the amount of noise 
for each actinide spectra.  The detection limit can be assumed to be 3 times higher than 
the noise level.  We can then use the linear equation for the calibration curve to determine 
at what amount of analyte this signal will be obtained.  We therefore estimate the 
detection limits to be below 1 pg. 
Improving Rapid Separation:  Although it is possible to get a basic separation 
without using a strong stripping agent in the eluent (such as oxalic acid), it has become 
clear that this is not completely sufficient to enable a satisfactory separation between the 
plutonium and uranium.  In order to get a better separation, we devised an optimal 
separation gradient for a short (3 cm) TRU column that would include the minimum 
amount of oxalic acid that would enable a separation.  This gradient is shown in Table 6.2 
as gradient 3.  The modified gradient puts less than 0.002 g of oxalic acid on the column, 
which is more than 50 times less oxalic acid then Gradient 1.  This lesser amount of 
oxalic acid will therefore allow several hundred analytes to be run before the mass 
spectrometer will have to be cleaned.   
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Figure 6.8: :  Separation of actinides using Gradient 3 in Table 2.  Column used was 3 cm 
long TRU column (50-100 µm, 3000 psi packing pressure). 
The separation of the five actinides was tested on three 3 cm columns with all 
three resin sizes tested.  The resulting separations were better in all cases.  Figure 8 shows 
the separation of the five actinides on the 3 cm column packed with 50-100 µm resin.  
This data shows a marked improvement in the separation between the uranium and the 
plutonium.  The thorium and the plutonium are still not well separated, but this is less of 
a concern considering that these two analytes should not produce isobaric interferences 
with one another. 


























In this work, several parameters associated with an on-line separation of actinide 
compounds utilizing ICP-MS detection have been optimized.  First, it was determined 
that the selectivity between different actinides is significantly reduced with the use of 
oxalic acid.  However, the use of a smaller amount of oxalic acid does permit satisfactory 
selectivity, while reducing the need for instrument maintenance.  Second, it was 
determined that packing columns under pressure is better than manually packing.  
Columns that are pressure packed elute the five actinides twice as fast as those packed 
manually; this likely due to the fact that there is less void space in the column.  We 
determined that while longer columns improve actinide separation, they also increase the 
overall separation time and result in unacceptably broader peaks.   For this reason we 
recommend using a column of 3-10 cm rather than a 30 cm column.  Smaller resin 
particle size results in sharper, more well defined peaks, though the improvement from 
50-150 μm to 20-50 μm is slight.  Faster flow rates result in shorter actinide retention 
time and narrower peaks, though peaks become distorted for flow rates > 4 mL/min and 
nebulizer efficacy decreases at higher flow rates.  For the optimized parameter settings, 
we were able to achieve detection limits below 1 pg. 
Using these improved preparation conditions we anticipate being able to improve 
the automated separation of actinides for emergency bioassay samples.  Future research 
will consist of examining the properties of other resins and applying results to the 
separation of actinides from a human urine matrix.  
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Chapter 7:  Actinide Separation and Electrodeposition Using HPEC 
A method for the rapid separation of actinides from aqueous samples for 
electrodeposition by high performance extraction chromatography (HPEC) was 
developed.  Successful actinide analysis by alpha spectrometry requires that samples 
containing mixtures of actinides be separated and prepared into counting sources in 
which no interfering isotopes coexist.  The system relies on the actinide adsorption 
characteristics of Eichrom’s TRU-Spec resin and a fraction collector to separate a mixed 
actinide solution (229Th, NatU, 237Np, 238Pu, and 243Am) into groupings that are convenient 
for electrodeposition.  The elution profile of the actinides studied was first established 
and optimized by mass counting using an inductively coupled plasma mass spectrometer 
(ICP-MS).  By knowing the identity and timing of the elution peaks as they exit the 
column, time windows in a fraction collector were programmed to collect the peak 
fractions into the appropriate beaker.  The samples were then electrodeposited and 
counted via alpha spectrometry to verify and quantify the isotopes present in each 
collection beaker.  Actinide separation time was reduced from 8 hours to just 15 minutes.  
The method was shown to effectively separate U, Pu, and Th.  Neptunium and americium 
separations were less successful and will require further research to optimize their 
separations. 
INTRODUCTION 
Mass spectrometry is an extremely useful technique for actinide determination 
due to the low level of sample preparation that is required, relative to alpha spectrometry.  
The determination of naturally occurring and anthropogenic radionuclides by inductively 
coupled plasma mass spectrometry (ICP-MS) has gained recognition over the last 15 
years, relative to radiometric techniques, particularly for actinide analysis, which 
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comprise some 88% of the published literature of radionuclide detection by ICP-MS from 
1989-2005 (Lariviere 2006).  Sensitivities, with regard to activity measurements by mass 
counting, diminish with the half-life of the isotope to be analyzed.  Previous work in this 
group has shown that, under ideal conditions, ICP mass techniques are suitable for 
analysis of alpha emitters with half-lives of >70 years (Gonzales 2005).  However, under 
most practical conditions, isotopes with half-lives of <500 years are often difficult to 
quantify.  While sensitivities by other mass counting techniques (TIMS, RIMS, and 
AMS) are orders of magnitude below those for ICP-MS, these instruments are available 
in only a very few number of laboratories (Lariviere 2006).  Therefore, there is an 
important set of actinides for which alpha spectrometry remains the best analytical 
technique for trace and ultra trace analysis required for environmental and in vitro 
bioassay monitoring.   
Isotopic identification and quantification of alpha emitters is accomplished 
through the detection of characteristic alpha particle energies by a surface barrier 
detector.  Because alpha particles are severely attenuated by sample matrices, they must 
be chemically isolated and deposited as “massless” samples by electrodeposition to create 
counting sources.  In addition, the alpha particle energies of many actinides are 
energetically similar and cannot be resolved if they coexist within a source due to the 
typical alpha detector resolution of 18 keV (L'Annunziata 2003).    In practice, alpha-
emitters may need a separation of >50 keV to be comfortably quantified due to 
attenuation from non-ideal counting sources and high-efficiency counting techniques. 
Therefore, interfering actinides must be separated from each other as well as the sample 
matrix by a complicated and labor-intensive process that usually takes two working days 
to accomplish (ASTM 2005a; 2005b).   
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Table 7.1 presents half-life and alpha particle energy data for the most commonly 
encountered alpha-emitting actinides.  From this table, it can be seen that spectral 
interferences may be encountered for a number of nuclides.  Of particular significance are 
238Pu/241Am and 234U/237Np.  These nuclides are often found together in samples that are 
products of nuclear fuel or weapons processes.  The problem of 238Pu/241Am analysis is 
particularly acute due to the fact that both of these nuclides are difficult to detect at trace 
levels by other analytical means (mass spectrometry and gamma spectrometry).  
Therefore, the efficacy of the separation of americium and plutonium is of greatest 
importance in developing an automated actinide separation system. 
Table 7.1: Commonly encountered alpha-emitting actinides. 



















































































A faster, automated technique for performing actinide separations would be 
valuable in reducing sample processing time, reducing costs, and increasing sample 
throughput.  Several important isotopes are too high in specific activity to be detected by 
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ICP-MS at the trace and ultra trace levels.  These include: 228Th, 232U, 238Pu, 241Am, and 
various curium and californium isotopes.  Such a system would expedite the analysis of 
these isotopes.  Potential applications would be environmental monitoring, bioassay 
monitoring, and routine analytical work.  In addition, there is the potential application of 
using this method in field-analytical work.  Since mass spectrometers are not portable, 
these techniques would be ideal for the analysis of all actinides in remote locations or in 
emergency response situations. 
To achieve these goals, we have examined a method by which a mixed actinide 
solution, which has previously been separated from its matrix, can be separated into 
sample fractions of non-interfering isotopes that are ready for electrodeposition and 
counting.  This separation is achieved by high performance extraction chromatography 
(HPEC).  This technique relies on the actinide sorption properties of an extractive resin 
and a programmable gradient pump to administer an elution scheme to retain and 
separate individual actinides.  Variations on this technique have been used extensively for 
actinide analysis (Alonso 1995; Fjeld 1995; Smith 1995; Grate 1996; Desmartin 1997; 
Egorov 1998a; Coates 2001; Unsworth 2001; Reboul 2002; Stricklin 2002; Hang 2004; 
Fjeld 2005; Grate 2005; Hang 2005; Peterson 2007).  The column effluent was first 
paired with a mass spectrometer to determine the elution profile and timing of the 
actinide peaks.  This practice has been used in other notable works (Thompson 1986; 
Hollenbach 1994; Aldstadt 1996; Egorov 2001; Hang 2004; 2005; Peterson 2007).  By 
knowledge of the elution peak identity and timing, a fraction collector was programmed 
with time windows to collect each actinide fraction into a designated beaker.  Fraction 
collection of actinides in this manor has also been used elsewhere (Egorov 1998b; Grate 
1999b).  The samples were then electrodeposited and counted by alpha spectrometry to 
verify and quantify the expected isotopes.   
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The resin used in this work is Eichrom’s TRU-Spec resin, developed and 
characterized by Horwitz (Horwitz 1990; Horwitz 1993b).  This resin has high absorption 
characteristics for Pu(IV), Th(IV), Np (IV) and U(VI), a lower affinity for Am (III), and 
minimal retention of Np(V) in 3M nitric acid.  Neptunium and americium are eluted with 
dilute concentrations of HCl and oxalic acid.  Plutonium, thorium and uranium are eluted 
with additional oxalic acid.  Optimization of actinide separations using this resin and 
ICP-MS has been done by the authors, demonstrating the feasibility of actinide by 
actinide separation using this HPEC technique (Hang 2004; Peterson 2007). 
The advantages of the automated actinide separation method outlined in this work 
are many.  The length of the actinide separation step in the over all analysis can be 
reduced from 8 hours to just 15 minutes, resulting in significant increases in sample 
throughput and reduced labor costs.  The number of reagents used in the analysis has 
been reduced.  The technique is simpler and safer to use due to the fact that the handling 
of chemical and radiological hazards is automated.  This technique has many applications 
including environmental, bioassay, and routine analysis of short-lived actinides.  In 
addition, it has the potential application of being field deployable for emergency response 
situations where actinide analysis is required. 
EXPERIMENTAL 
  High Performance Extraction Chromatography System: A Dionex GP50 gradient 
pump (Dionex, Sunnyvale, CA) was configured with a Rheodyne 7725i dual mode 
analytical injector and a 2000 μL sample loop (Precision Flow Products, Lake Elsinore, 
CA).  A 2500 μL Gastight syringe (Hamilton Co, Reno, NV) was used to inject samples 
into the loop.  Ion chromatography columns were prepared using a resin containing 
octylphenyl-N,N-diisobutyl carbamoylphosphine oxide adsorbed onto the packing beads, 
which are made of poly(methyl methacrylate).  This resin is commonly called TRU-Spec 
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resin and was obtained from Eichrom Technologies (Darien, IL) and had particle sizes of 
50-100 μm.  This resin was packed into a PEEK lined column, 4.6mm I.D. x 150mm, 
hardware (Alltech Associates, Deeerfield, IL) using an Alltech Model 1666 slurry packer.  
The packing pressure was 1000 psi and the calculated volume of the resin was 9.97 mL.  
Elution schemes for the HPEC system were manually programmed into the gradient 
pump and controlled through the instrument interface.  The scheme used for this 
procedure can be seen in Table 7.2. 
Table 7.2: Gradient used in this study. 
TIME (MIN) FLOW (mL/MIN) ELUENT COMP. COMMENTS 
-11 3 3M HNO3 Column Conditioning
0 1.5 2M HCl, 50%; H2O, 10%; H2C2O4, 40% 
Injection, 
Actinide Loading 
6 1.5 2M HCl, 0.5%; H2O, 59.5%; H2C2O4, 40% 
Actinide Stripping 
13 1.5 2M HCl, 50%; H2O, 10%; H2C2O4, 40% 
End Analysis Cycle 
Mass Spectrometer System:  Ion chromatography was performed using a high 
performance ion chromatograph (DX-600, Dionex, Sunnyvale, CA).  The IC was 
equipped with an autosampler (AS50, Dionex) capable of injections up to 1 ml.  
Elemental detection and identification of the IC eluent was accomplished by a quadrapole 
ICP-MS (Elan 6100, Perkin Elmer, San Jose, CA).  Typical parameters for the ICP-MS 
were: 0.75 L/min nebulizer gas flow, 10.25 V Lens Voltage, 1225 W ICP-RF power, -
2200 V Analog Stage Voltage.  The ICP was equipped with a concentric glass nebulizer 
and a cyclonic spray chamber (Perlin-Elmer).  The process of sample injection, 
separation, and detection was automated through the Chromeleon management system 
(Dionex) and the ICP-MS software was triggered to collect data through a contact 
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closure.  Data was collected by peak hopping between the major actinide masses (232Th, 
235U, 238U, 237Np, 239Pu, 243Am).  Thorium and plutonium isotopes are different than those 
studied in the rest of this work, because these isotopes facilitated mass detection.  All 
elution characteristics for other isotopes of the same element are identical. 
Reagents and Standards:  Trace metal grade nitric acid was obtained from Fisher 
Scientific (Pittsburgh, PA).  Oxalic acid eluent was purchased from Dionex and diluted to 
the recommended concentration (80 mM oxalic acid, 100 mM tetramethyl ammonium 
hydroxide, and 50 mM potassium hydroxide).  Deionized water (18 MΩ, Nanopure 
Water System, Barnstead, Dubuque, IA) was used to dilute acids and standards to the 
desired concentrations 
Standard solutions of 237Np, 239Pu, and 243Am were obtained from Isotope 
Products (Valencia, CA).  These standards are normally sold with a specific activity (i.e. 
2 μCi mL-1, equal to 74,000 Bq mL-1), so these values were converted to ppm values so 
that all standards would be prepared with similar values.  A standard 1000 ppm ICP-MS 
solution of Th was obtained from Alfa Aesar (Ward Hill, MA).  A standard 1000 ppm 
ICP-MS solution of U was obtained from SPEC Certiprep (Methchen, NJ).  The thorium 
solution was confirmed to contain 100% 232Th, the uranium solution was confirmed to 
contain approximately 0.7% 235U and 99.3% 238U (natural uranium concentrations).  All 
actinides were diluted to a stock solution of 50 ppt in water with 5% nitric acid.  Further 
standards were prepared from dilutions of the stock solution.   
For the main experiments, solutions of 229Th, NatU, 237Np, 238Pu, and 243Am were 
prepared from in-house stock solutions with an activity range of 7.35-13.63 dpm/ml.  The 
collected actinide fractions were spiked with the appropriate tracers from the in-house 
stock solutions of the following isotopes: 230Th, 236U, 239Pu, 241Am.  No trace for 237Np 
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was available so the deposition yield of this isotope was estimated from yields of co-
deposited actinides.   
Fraction Collector: The fraction collector used in this work was a Foxy 200 (Isco 
Inc., Lincoln, NE).  This unit was plumbed directly in-line with column using PEEK 
tubing.  The collection vessels were disposable 30 mL Pyrex beakers.  The collection 
protocol was manually programmed into the fraction collector’s user interface and was 
based on time windows as established by previous mass spectrometer profiling.  The 
fraction collection protocol was manually initiated at time=0 as described in Table 7.2.  A 
diagram of the sample separation and collection system is shown in Figure 7.1. 
 
                           
Figure 7.1: A diagram showing the actinide separation and fraction collection system. 
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Electrodeposition System: The electrodeposition system used for this work was an 
in-house, custom-built unit that consisted of a plastic cell holder, platinum wires, and a 
power supply, capable of administering 0.6A to each of 16 cells.  The samples were 
electrodeposited on 5/8” (1.59 cm) stainless steel planchettes (A.F. Murphy Die & 
Machine Co., Quincy, MA) for 2 hours.  A description of the sulfate-based electrolyte 
and the electrodeposition method is provided by LANL SP-318, R.0 (Plionis, 2005).   
Alpha Detection System:  The alpha detection system used for all alpha 
spectrometry measurements was an Ortec EG&G model 920E 16 input MCB Ethernim 
(Ortec, Oak Ridge, TN).  The detectors were Canberra model 7401 alpha spectrometers 
with a 450 mm detector face (Canberra, Meriden, CT).  The electrodeposited counting 
sources were positioned at the top pedestal height and spectra were acquired using the 
Ortec acquisition system, Maestro for Windows model A65-B32 v.6.01.  The spectra 
were then analyzed using Ortec’s Alpha Vision v5 software. 
RESULTS AND DISCUSSION 
The separation of mixed actinide samples was first profiled by mass spectrometry 
to determine the timing and characteristics of the actinide peaks.  A chromatogram of the 
normalized detector response for each actinide is shown in Figure 7.2. 
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Figure 7.2: A chromatogram of the normalized mass spectrometer detector response to 
the actinides studied.  Note that small portions of the neptunium peak are 
seen in the region of Pu and Th elution.  This figure also shows fraction 
collection time windows for the collection of the actinide peaks into four 
separate samples for electrodeposition. 
The elution profile, as determined by the mass spectrometer, demonstrates that 
there is adequate separation between the actinides to effectively resolve each element and 
facilitate fraction collection of select groups of actinides.  Figure 7.2 shows approximate 
time windows for fraction collection that would conveniently group the actinides for 
electrodeposition.  The first time window would direct the column effluent to a waste 
container and contains no significant amounts of actinides.  The second time window 
collects and isolates the neptunium and americium into a separate beaker.  The third time 
window would group plutonium and thorium into another counting sample.  Finally, a 
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fourth counting window would provide for the collection of uranium, which is deposited 
as its own counting source.  Table 7.3 shows the parameters of the fraction collection 
windows.  











1 0:0 4:10 None N/A 
2 4:10 7:30 237Np and 243Am 241Am 
3 7:30 10:50 238Pu and 229Th 239Pu and 230Th
4 10:50 14:10 234U and 238U 236U 
 
This actinide grouping is convenient, it takes advantage of the natural elution 
sequence and each actinide pair can be counted together without producing spectral 
interferences (see Table 7.1).  Some high specific-activity actinides, for which this 
technique was specifically designed, were not used in experiments testing the efficacy of 
this technique.  228Th was not used because of potential interferences with 238Pu and 229Th 
was used instead.  232U was not used because this nuclide inevitably contains significant 
activities of its daughter 228Th; and natural uranium was used instead.  237Np is the only 
alpha-emitting isotope of any significance of this actinide, therefore it had to be used in 
this study and could not be traced with the addition of another neptunium isotope.  241Am 
was not used because of interferences with 238Pu, and 243Am was used instead.  Since we 
wanted to be able to tell if there was any spillover of one Am into Pu, or visa versa, we 
needed nuclides that we could distinguish from one another. 
Triplicate runs of single isotope solutions were conducted.  The contents of each 
collection window were electrodeposited to create counting sources.  Since each fraction 
collected was spiked with the appropriate isotope, a peak for this nuclide should be seen 
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in each sample.  However, the nuclide present in the sample is expected to be seen in 
only one counting source, which would correspond to the appropriate collection window.  
The results of a typical thorium solution run are shown in Figure 7.3.   
 
 
Figure 7.3: The results of a typical Th solution run.  Each spectrum shows counts versus 
energy (keV).  Windows 1, 2, and 4 show only the tracer, 230Th, as expected.  
Window 3 shows both the tracer and the nuclide in the sample, 229Th. 
The results from the triplicate runs of each isotope solution are shown in Table 
7.4.  Window 1 contained no detectable amounts of any radionuclide.  This result was 
expected from the elution profile shown in Figure 7.2.  This portion of the eluent need not 
be collected and may be diverted to waste.  Window 2 was intended to contain neptunium 
and americium fractions.  This window was found to contain 58.6% of the total recovered 
neptunium and 22.0% of the total recovered americium.  Window 3 was intended to 
contain plutonium and thorium fractions.  This window was found to contain 29.7% of 
the total recovered neptunium, 78.0% of the total recovered americium, 98.0% of the 
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total recovered plutonium, and 100% of the total recovered thorium.  Window 4 was 
intended to contain the uranium fraction.  This window was found to contain 11.3% of 
the total recovered neptunium, 2.0% of the total recovered plutonium, and 100% of the 
total recovered uranium.  Blank runs were conducted between each sample run to 
determine the extent of any carryover.  The only detectable carryover of any nuclides 
from one run to another was for plutonium, where 0.38% of the total plutonium from the 
previous run was detected.  A second blank run showed no detectable amount of 
plutonium. 
Table 7.4: The total recovered actinide fraction in each collection window.  
WINDOW 237Np % 243Am % 238Pu % 229Th % NATU % 
1 NDA NDA NDA NDA NDA 
2 58.6 22.0 NDA NDA NDA 
3 29.7 78.0 98.0 100 NDA 
4 11.3 NDA 2.0 NDA 100 
There was spillover of neptunium into all of the windows that contained actinides, 
with the majority of neptunium being present in the intended window.  This result is not 
entirely unexpected.  As can be seen in Figure 7.2, minor neptunium peaks can be seen at 
~7:30 minutes and ~11:00 minutes into the run.  This could account for the presence of 
neptunium within windows 3 and 4.  These distinct peaks may be the result of different 
neptunium oxidation states being present within the neptunium sample solution.  The 
major neptunium oxidation state is +5, but it may also exist in the +3, +4 and +6 
oxidation state (Lieser 2001).  Actinide solutions are subject to disproportionation, 
whereby a solution consisting of a single oxidation state will revert to multiple oxidation 
states over time, depending on acid concentration and the presence of other complexing 
agents (Katz 1986).  This effect may be responsible for the multiple elution peaks 
observed in the chromatogram (Figure 7.2) and in the electrodeposited actinide fractions 
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(Table 7.4).  The major elution peak (and the one found in Window 1) is likely Np(V), 
which is not retained by TRU resin.  The first minor peak, found at approximately 7:30 
min in the chromatogram, is likely Np(IV), which is retained similarly to Pu(IV) and 
Th(IV) by the TRU resin.  The fact that the neptunium co-eluted with the Th and Pu 
fractions lends credence to the theory that this species is Np (IV).  The second minor 
peak, found at ~11:00 min in the chromatogram, could be Np(VI).  There is no data on 
the retention of Np(VI) on the TRU resin, but it is plausible that this species could co-
elute with U(VI) and be found in Window 4.   
Unpublished data from experiments performed in our group have shown that the 
addition of NaNO3 to the sample prior to analysis can act to reduce higher neptunium 
oxidation states to Np(IV).   The addition of this reducing agent to sample solutions may 
improve the results of our work by forcing all neptunium into the +4 state, which would 
then co-elute with the plutonium and thorium fractions found in Window 3.  The 
codeposition of Th, Np, and Pu is not ideal, but is acceptable from the standpoint on of 
spectral interferences.  The characteristic alpha energy of 237Np (4788 keV) is ~57 keV 
from 229Th (4845 keV) and ~101 keV from 230Th (4687 keV).  The spectral peaks of 
these isotopes should be resolvable under counting conditions that optimize FWHM, 
however, some efficiency would be sacrificed. 
Spillover of americium from Window 2 to Window 3 was also problematic.  The 
result of this spillover is not likely to be due to oxidation state effects since americium 
exists only in the +3 state under commonly encountered conditions.  This spillover is like 
the result of the timing of the collection windows.  It is likely that the transition from 
Window 2 to Window 3 was occurring at the time that americium was being eluted.  
Experiments incrementally extending the length of the second collection window would 
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optimize the collection of americium.  In this way the critical separation of americium 
and plutonium could be accomplished.   
CONCLUSION 
A system was developed that facilitated the automated separation of actinides by 
HPEC and the collection of actinide fractions into convenient counting groups for 
electrodeposition and counting by alpha spectrometry.  The separation and collection of 
Pu, Th, and U was successfully demonstrated.  Neptunium was found in all three 
collection windows that contained detectable levels of actinides.  This was attributed to 
oxidation state effects whereby Np(V) was collected in the appropriate window, while 
Np(IV) was collected with the Pu and Th fractions and Np(VI) was collected with the U 
fraction.  The addition of NaNO3 could reduce higher oxidation states of neptunium to 
Np(IV), whereby it would be eluted and codepisted with the Pu and Th fractions.  
Spillover of americium into the Pu and Th collection window was also shown to occur.  
We anticipate that this could be corrected by incrementally increasing the length of the 
second counting window until Pu or Th begins to spill over into Window 2.  In this way, 
the collection window for americium may be optimized. 
The system described in this work has many potential applications.  This 
technique could provide trace actinide analysis (environmental, bioassay, etc.) of high 
specific activity isotopes where analysis by ICP-MS is not possible, e.g. 228Th, 232U, 
238Pu, 241Am, and various curium and californium isotopes.  This system could also be 
used for routine radioanalytical work, where separations that used to take 8 hours can be 
accomplished in under 15 minutes.  Finally, this system could be used in a mobile 
laboratory for in-field analysis for environmental monitoring or emergency response 
situations; since mass spectrometers are not mobile. 
 143
Chapter 8:  Health Physics Implications 
The previous chapters have discussed several rapid analytical techniques for a 
variety of radionuclides with applications to urine bioassays.  These disparate methods 
are united by the project goal of creating analytical components which could be used to 
assay victims of a radiological dispersal device (RDD or “dirty bomb”) and determine 
their level and type of uptake.  To this end, we need to examine how the detection limits 
achieved by the featured analytical techniques are related to the medical well-being of 
people with a radiological uptake.  Health physics is the area of environmental health 
engineering that deals with the protection of individual and population groups against the 
harmful effects of radiation (Cember 1996).  Further, this field studies how to estimate 
levels of internally deposited radioactivity and relate this quantity to potential adverse 
health effects; a practice which is commonly called internal dosimetry.  The dose 
associated with the radiological uptake can then be related to immediately observable 
health effects or the long term risk of developing cancer, through a complex process of 
modeling.  Certain levels of radiological uptake necessitate medical intervention to 
attempt to remove the internally deposited radionuclides before they inflict their full 
potential for damage; a practice which typically involves chelation therapy.  Chelation 
therapy is painful and carries its own risk of adverse health effects and should not be 
applied proactively to any population which might have an exposure (Guilmette 2007).  
Therefore, the limits of detection for various techniques of determining radionuclide 
uptake in the body (either rapid or otherwise) have important implications for the practice 
of health physics and dictating the need for medical intervention.  The following chapter 
provides a brief outline of internal dosimetry practices and relates the detection limits of 
previously described techniques to their implications for health phyisics.   
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INTERNAL DOSIMETRY PRACTICES 
 The need to protect workers and the general population from radiological hazards 
was first recognized in 1915 by the British Roentgen Society, which introduced proposals 
for radiation protection even though the concept of absorbed dose was not recognized 
until 1953 (Hall 2000).  Since that time, government bodies have been issuing guidance 
for estimating “dose factors,” or “dose coefficients” for the assessment of biological harm 
done by radiation.  However, these dose-based parameters do not in themselves directly 
relate to the risk of developing an adverse health effect such as mortality (death in any 
way hastened by exposure) or morbidity (cancer—fatal or otherwise).  Mortality and 
morbidity are probabilistic effects of radiation exposure and it is, therefore, impossible to 
predict with absolute certainty whether a given dose will result in either event.  By 
modeling the exposure of a large enough population, we can obtain a population averaged 
risk assessment for mortality and morbidity for a given radiation dose.    
Modeling the risk of radiation dose for the general public is an extremely difficult 
task that is complicated by five factors:   
1. Each of the over 3,000 known isotopes have a unique set of physical 
parameters that need to be modeled: half-life, radiation types, 
energies, branching ratios, etc, which contribute to dose estimates. 
2. There are varying routes of exposure (inhalation, food, water, external 
exposure) that result in different metabolic rates and pathways. 
3. Isotopes of the over 100 known elements behave differently within 
the human body and will be dispersed and deposited accordingly.  
Further, organs within the body have varying levels of sensitivities to 
radiation and predispositions to forming cancers. 
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4. There is a large range in body size and metabolic function within the 
general population that makes it hard to apply one model across all 
age and gender groups. 
5. There is great difficulty in identifying small increases radiologically 
derived cancer when the incidence of non-radiological cancer is high. 
The first point is most easily addressed since copious amounts of physical data 
exist for most isotopes.  Tabulating the physical data for individual isotopes is made 
easier by limiting the scope of dosimetry modeling to the over 800 radionuclides with 
half-lives greater than 10 minutes.  For the purposes of dosimetry modeling, the most 
useful physical parameters are half-life, decay mode, branching ratios, radiation energies, 
and the buildup of any radiological daughter products.  This information is most easily 
accessible from online libraries (Nudat 2007; TON 2007). 
Modeling of exposure pathways is more complicated.  The main exposure 
pathways are inhalation, ingestion, and external exposure.  External exposure rates are 
most easily derived by actual irradiation of a phantom based on the Reference Adult 
standing with no shielding or by modeling the interaction of radioactive emissions on a 
representation of this phantom using Monte Carlo simulations (EPA 1993).  The model 
for exposure by inhalation is divided into three classes of inhaled particulates: Type F, M, 
and S, representing fast, medium and slow rates of absorption into the blood stream of 
these particulates one in the lungs (ICRP 1994; ICRP 1995; ICRP 1996).  The modeling 
assumes that the activity median aerodynamic diameter (AMAD) of the inhaled particles 
is 1 µm.  Ingestion of radionuclides is modeled in a few different matrices for which dose 
factors for each radionuclide are based: tap water (ICRP 1996), food (ICRP 1996), and 
cow’s milk (UNSCEAR 1982).   
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Biokinetic models are used to determine the dispersion, deposition, and excretion 
rates of radionuclides within the body.  To accomplish this, two basic systems are 
modeled: the respiratory tract and the gastrointestinal (GI) tract.  After radionuclides 
enter the lungs or the GI tract, their absorption into the blood stream is dictated by a 
fractional absorption coefficient, f.  Fractional absorption coefficients for each 
radionuclide are tabulated for the respiratory tract (ICRP 1994; 1995b; 1996) and GI 
tract, respectively (ICRP 1989; 1993; 1995a; 1995b).  These models also track the 
migration of radionuclide from these systems to their target organs in the body and, 
finally, their excretion pathway.  The excretion pathways modeled are urine and feces.   
The same ICRP publications that describe the above biokinetic models for the 
standard Reference Man also provide figure to augment calculations for various 
populations that are not accurately modeled by Reference Man.  Factors are given to 
modify the standard model for reference male and female persons for the following age 
groups: 3 months, 1 year, 5 years, 10 years, 15 years, and adult (17 years and older).  In 
this way general population models are modified to be more relevant for specific 
segments of the population. 
Relating radiation dose factors to mortality and morbidity risk rates is probably 
the most difficult aspect of modeling.  Modelers start by examining cancer mortality data 
for the US population (NCHS 1992; 1993b; 1993a; 1997) and averaging rates over a 
stationary population.  Then, known data on radiation dose rates and cancer incidence are 
considered.  Much of the existing data on radiation-induced cancer in humans comes 
from following cohorts of populations with known exposure, such as workers involved in 
an industrial accident and noting incidences of cancer.  Perhaps the most important cohort 
is the atomic bomb survivors of Hiroshima and Nagasaki; a group of about 270,000 
individuals with a wide range of doses ranging from slightly above background to several 
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grays (Cember 1996).  By plotting cancer incidences and mortality rates against known 
radiation doses and linear no-threshold (LNT) dose response curve is generated.  The 
LNT model is weighted heavily by data in the high dose range, and there is considerable 
uncertainty in the response for doses less than 0.2 grays (Hall 2000).  However, experts 
have recently validated the LNT model for estimating risk for these low doses (NRPB 
1993; UNSCEAR 1993; 1994; NCRP 1997).  This does not rule out the possibility that 
the LNT model seriously over or underestimates the risk for low doses of radiation.  
Other experts provide some justification for a net beneficial effect of low doses of 
radiation (Luckey 1990; Jaworowski 1995; Goldman 1996).  Despite the uncertainty, for 
the purposes of this work we will use the LNT model for all risk assessments. 
This chapter relies heavily on a recent EPA document, Cancer Risk Coefficients 
for Environmental Exposure to Radionuclides for mortality and morbidity risk rates for 
the radionuclides studied in the previous chapters (EPA 1999).  This report provided 
mortality and morbidity risk rates (Bq-1) for each radionuclide via inhalation and 
ingestion pathways.  In addition, fractional absorption coefficients for each radionuclide 
via each pathway were also provided.  These factors are specific for the adult Reference 
Man model and were determined by Keith Eckerman et al. at the Oak Ridge National 
Laboratory (ORNL) using the DCAL (Dose and Risk Calculation) software developed at 
ORNL.  Urine excretion data for each radionuclide via each pathway was obtained from 
the library of the MONDAL3 internal dosimetry software (Ishigure 2007), which is 
available online for free use at the following website, 
nirs.go.jp:8080/anzendb/RPD/gpmd.php.    
Using these data we were able to generate tables featuring the concentration of a 
particular radionuclide that would be expected to be found the urine of a patient with a 
given exposure one day after intake.  Two tables are provided for each isotope; the first is 
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for the default inhalation model (typically, Type M particles) and the other is for 
ingestion based on contaminated tap water.  These tables also identify the mortality and 
morbidity risk for each level of intake.  Also, since most bioassay methods concentrate 
urine samples for better sensitivities, the expected radionuclide activities (Bq/mL) were 
provided for various degrees of concentration.  Finally, we then identified which 
analytical methods provide the detection limits necessary for quantifying the expected 
radionuclide activities.  These tables are too large and numerous to fit in this chapter so 
they can be found in Appendix A. 
In addition, uncertainties in the inhalation and ingestion risk coefficients for each 
radionuclide are discussed when that data was available.  These uncertainties are graded 
on an A-F (with A as the most confident and F as the least) scale based on the confidence 
in the underlying assumptions that were used to create the factors.  
90SR RISK ASSESMENT 
90Sr is a well-studied radionuclide due to the fact that it is produced in significant 
quantities by nuclear fission.  The inhalation model for 90Sr has a grade of D.  For this 
model, the biokinetics model was deemed equal in confidence to the risk model; both are 
given greater confidence than the deposition model.  The dominant cancer site for this 
mode is the lungs which, are significantly more affected than the secondary cancer site, 
bone marrow.  Uncertainty in estimating lung dose is due to uncertainty in the range of 
particles that are classified as Type M.  The GI uptake and skeletal biokinetics are 
considered to be well characterized.  The potential migration of the 90Y daughter product 
adds to dose uncertainty in certain tissues.   
The ingestion model is given a grade of B.  For this model, the biokinetics model 
is given equal confidence as the risk model.  The dominant cancer site is bone marrow 
which is significantly more affected than the secondary cancer site, the colon.  The GI 
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uptake and skeletal biokinetics are reasonably well characterized.  Some information is 
available for migration of 90Y from90Sr; the risk estimate for leukemia is relatively 
insensitive to remaining uncertainties concerning 90Y. 
90Sr was evaluated by flow scintillation analysis in chapter 3 of this work, where a 
quantification limit of 47 dpm per sample was established.  Though no experiments were 
conducted to determine 90Sr by ICP-MS or TIMS, we can assume detection limits of 1 pg 
and 1 fg, respectively.  For 90Sr, these concentrations are equivalent to 306 dpm/mL and 
0.306 dpm/mL, respectively.  While FSA is a better analytical tool than ICP-MS, it is not 
as good as TIMS.   
Table A.1 shows the inhalation risk analysis of 90Sr.  The inhalation of 3.52 x 108 
Bq of  90Sr is considered a fatal intake.  The fractional absorption of 90Sr via this pathway 
is 0.1, 0.848% of the body burden is cleared through the urine per day.  Thus, we can 
expect to find 207 dpm of 90Sr per mL of urine in this patient.  Without concentration, 
this level of 90Sr can be detected by TIMS and FSA using just 1 mL of urine.  If the full 
1440 mL of urine is concentrated and analyzed, ICP-MS can detect 90Sr in patients with 
uptake sufficient to cause a 1 in 500 chance of mortality; FSA can detect uptakes 
expected to cause a 1 in 1,000 chance of mortality; TIMS can detect uptakes causing a 1 
in 500,000 chance of mortality.   
Table A.2 shows the ingestion risk analysis of 90Sr.  The ingestion of 6.62 x 108 
Bq of 90Sr is considered a fatal intake.  The fractional absorption of 90Sr via the GI tract is 
0.3 and 5.65% of the body burden is cleared through the urine per day.  We can expect to 
find 7,800 dpm of 90Sr per mL of urine in this patient, an amount detectable by all 
reviewed techniques.  For the concentration of a 24 hour urine sample, ICP-MS can 
detect 90Sr in patients with a 1:10,000 chance for mortality; FSA can detect uptakes 
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causing a 1 in 50,000 chance of mortality.  TIMS can detect a uptake causing 1 in 
1,000,000 chance of mortality using only 50 mLs of urine from exposed patients. 
210Po RISK ASSESMENT 
210Po is a radionuclide that has garnered attention recently due to the recent high 
profile murder of former Russian KGB officer, Alexander Litvinenko.  It is estimated that 
Mr. Litvinenko received approximately 2 x 1010 Bq of 210Po by ingestion, causing him to 
die twenty-two days after intake (Guilmette 2007).  210Po was not identified as the 
poisoning agent until 23 days after Mr. Litvinenko was poisoned (Guilmette 2007).  
Though it is not know whether early identification of 210Po as the poisoning agent could 
have prevented his death, it would have been enormously helpful to aid his diagnosis.   
Models of 210Po uptake by inhalation or ingestion are not well known.  It is known 
that polonium is virtually evenly distributed within the body after absorption, where it 
infiltrates all soft tissues.  210Po was evaluated by flow scintillation analysis in chapter 4 
of this work, where a quantification limit of 100 dpm per sample was established for this 
technique.  Though no experiments were conducted to determine 210Po by ICP-MS or 
TIMS, we can assume detection limits of 1 pg and 1 fg, respectively for these techniques.  
For 210Po, these concentrations are equivalent to 9,970 dpm/mL and 9.97 dpm/mL, 
respectively.  We also evaluated alpha spectrometry as a detection technique for this 
isotope.  Alpha spectrometry has detection limits of approximately .01 pCi  (.022 dpm) 
per sample.   
Table A.3 shows the inhalation risk analysis of 210Po.  The inhalation of 3.41 x 
106 Bq of 210Po is considered a fatal intake.  The fractional absorption of 210Po via this 
pathway is 0.1 and approximately 1.0% of the body burden is cleared through the urine 
per day.  We can expect to find 2.37 dpm of 210Po per mL of urine in this patient.  Alpha 
spectrometry is able to detect levels 210Po that can be expected from patients with a 1 in 
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100 chance of mortality using 1 mL of unconcentrated urine, making it the best analytical 
tool for 210Po detection.  The best rapid method of 210Po detection is FSA which can 
detect levels of 210Po expected to be found in a full 24 hour urine sample from patients 
with a 1 in 20 chance of mortality.   
Table A.4 shows the ingestion risk analysis of 210Po.  The ingestion of 9.8 x 107 
Bq of 210Po is considered a fatal intake.  The fractional absorption of 210Po via the GI tract 
is 0.1 and approximately 1.0% of the body burden is cleared through the urine per day.  
We can expect to find 68.1 dpm of 210Po per mL of urine in this patient, an amount 
detectable by alpha spectrometry and TIMS.  For the concentration of a 24 hour urine 
sample, ICP-MS can detect 210Po in patients with a 1 in 5 chance for mortality; FSA can 
detect uptakes causing a 1 in 500 chance of mortality and TIMS can detect an uptake 
causing 1 in 5,000 chance of mortality.  Using only 500 mLs of urine from exposed 
patients, alpha spectrometry can detect 210Po uptake in patients with a 1 in 1,000,000 
chance of mortality. 
SHORT-LIVED GAMMA  EMITTER RISK ASSESMENT 
Short-lived gamma emitters are significant in that they pose an external radiation 
hazard due to their energetic and penetrating gamma rays.  Safeguarding the general 
population from an RDD involving short-lived gamma emitters can be largely 
accomplished by establishing a safe parameter to which all members of the public should 
be evacuated.  The risk posed by the internal deposition of gamma emitters is less than 
that for alpha or beta emitters, because a large fraction of the emitted gammas will leave 
the body without causing ionization.  For this reason, there is generally a higher tolerance 
for these radionuclides in the body though fatal amounts of these isotopes could still be 
administered with a properly configured RDD. 
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60Co 
60Co is used medically for radiation therapy as implants and as an external source 
of radiation exposure. It is used industrially as a leveling gauge and to examine welding 
seams to detect flaws.  60Co is also used to irradiate food and to sterilize medical 
equipment.  For the inhalation model (grade C), the biokinetics model is given the same 
amount of confidence as the risk model, which is given greater confidence than the 
deposition model.  The dominant cancer site is the lung, which is much more affected 
than the secondary cancer site, the colon.  Lung doses vary considerably as the absorption 
rate varies within Type M particles.  The typical GI intake is moderately well established.  
Whole body retention of absorbed Co is reasonably well known, but distribution is less 
well characterized. 
For the ingestion model (grade B) the biokinetics model is given the same amount 
of confidence as the risk model.  The dominant cancer site is colon due to the dose from 
unabsorbed activity that is excreted through the feces.  The typical GI uptake moderately 
well established.  Whole body retention is reasonably well known, but distribution is less 
well characterized.   
60Co was evaluated by flow gamma analysis in chapter 5 of this work, where a 
quantification limit of 500 dpm per sample was established for this technique.  Though 
no experiments were conducted to determine 60Co by ICP-MS or TIMS, we can assume 
detection limits of 1 pg and 1 fg, respectively for these techniques.  For 60Co, these 
concentrations are equivalent to 2510 dpm/mL and 2.51 dpm/mL, respectively.  While 
FGA is a better analytical tool than ICP-MS, it is not as good as TIMS.   
Table A.5 shows the inhalation risk analysis of 60Co.  The inhalation of 1.03 x 109 
Bq of 60Co is considered a fatal intake.  The fractional absorption of 60Co via this 
pathway is 0.1 and 1.29% of the body burden is cleared through the urine per day.  
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Therefore, we can expect to find 925 dpm of 60Co per mL of urine in this patient.  
Without concentration, this level of 60Co can be detected by TIMS and FGA using just 1 
mL of urine.  If the full 1440 mL of urine is concentrated and analyzed, ICP-MS can 
detect 60Co in patients with uptake sufficient to cause a 1 in 500 chance of mortality; 
FGA can detect uptakes expected to cause a 1 in 1000 chance of mortality and TIMS can 
detect uptakes causing a 1 in 500,000 chance of mortality.   
Table A.6 shows the ingestion risk analysis of 60Co.  The ingestion of 2.35 x 109 
Bq of 60Co is considered a fatal intake.  The fractional absorption of 60Co via the GI tract 
is 0.1, 2.75% of the body burden is cleared through the urine per day.  Therefore, we can 
expect to find 2,110 dpm of 60Co per mL of urine in this patient, an amount detectable by 
FGA and TIMS.  For the concentration of a 24 hour urine sample, ICP-MS can detect 
60Co in patients with a 1 in 1,000 chance for mortality: FGA can detect uptakes causing a 
1 in 5,000 chance of mortality and TIMS can detect an uptake causing 1 in 1,000,000 
chance of mortality. 
137Cs 
137Cs is used in small amounts as a check source of some radiation detection 
equipment, such as GM counters and liquid scintillation counters. In larger amounts, 
137Cs is used in medical radiation therapy devices for treating cancer and in industrial 
gauges that detect the flow of liquid through pipes and that measure the thickness of 
materials.  For the inhalation model (grade C), the biokinetics model is given the same 
amount of confidence as the risk model, which is given greater confidence than the 
deposition model.  The data indicate high absorption and fairly uniform distribution of 
absorbed cesium.  The systemic biokinetics of cesium are well established by data in 
humans, but the potentially rapid migration of 137mBa from 137Cs yields moderate 
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uncertainty to doses to some tissues.  There are no dominant cancer sites for 137Cs due to 
the wide distribution of this isotope in the body. 
For the ingestion model (grade A) the risk model is given greater confidence than 
the biokinetics model.  It is known that the GI uptake is relatively complete and that the 
absorbed cesium is fairly uniformly distributed in the body.  The systemic biokinetics of 
cesium are well established, but the potentially rapid migration of 137mBa from 137Cs 
yields moderate uncertainty to doses to some tissues.  Again, there are no dominant 
cancer sites. 
137Cs was evaluated by flow gamma analysis in chapter 5 of this work, where a 
quantification limit of 500 dpm per sample was established for this technique.  Though 
no experiments were conducted to determine 137Cs by ICP-MS or TIMS, we can assume 
detection limits of 1 pg and 1 fg, respectively for these techniques.  For 137Cs, these 
concentrations are equivalent to 193 dpm/mL and 0.193 dpm/mL, respectively.  Both 
ICP-MS and TIMS are better analytical tools for 137Cs detection than FGA.   
Table A.7 shows the inhalation risk analysis of 137Cs.  The inhalation of 3.12 x 
109 Bq of 137Cs is considered a fatal intake.  The fractional absorption of 137Cs via this 
pathway is 1 and 0.0639% of the body burden is cleared through the urine per day and we 
can expect to find 1,380 dpm of 137Cs per mL of urine in this patient.  Without 
concentration, this level of 137Cs can be detected by all methods evaluated using just 1 
mL of urine.  If the full 1440 mL of urine is concentrated and analyzed, ICP-MS can 
detect 137Cs in patients with uptake sufficient to cause a 1 in 10,000 chance of mortality: 
FGA can detect uptakes expected to cause a 1 in 1000 chance of mortality and TIMS can 
detect uptakes causing a 1 in 1,000,000 chance of mortality using just 250 mLs of urine.   
Table A.8 shows the ingestion risk analysis of 137Cs.  The ingestion of 1.22 x 109 
Bq of 137Cs is considered a fatal intake.  The fractional absorption of 137Cs via the GI tract 
 155
is 1 and 1.58% of the body burden is cleared through the urine per day and we can expect 
to find 13,300 dpm of 137Cs per mL of urine in this patient, an amount detectable by all 
methods that were evaluated.  For the concentration of a 24 hour urine sample, ICP-MS 
can detect 137Cs in patients with a 1 in 50,000 chance for mortality: FGA can detect 
uptakes causing a 1 in 10,000 chance of mortality and TIMS can detect a uptake causing 
1 in 1,000,000 chance of mortality using just 25 mLs of urine. 
ACTINIDE RISK ASSESMENT 
The actinide isotopes evaluated in this study are all alpha emitters with varying 
degrees of gamma emission.  The main threat to public from an RDD involving any of 
these actinides is from internal uptake where their short-range—but damaging—alpha 
radiation causes significant harm.  Risk assessments were made for the inhalation and 
ingestion of 9 actinide isotopes: 233U, 235U, 238U, 237Np, 238Pu, 239Pu, 242Pu, 241Am, and 
243Am.  These isotopes have many commonalities that contribute to their risk assessment. 
 
1. Alpha decay is the decay mode that is overwhelmingly responsible for 
the assessed dose. 
2. The specific activity for these isotopes is generally very low, with the 
exception of 238Pu and to a lesser extent, 241Am, and 243Am, resulting 
in mass detection being superior to radiometric detection. 
3. Fatal intakes of these nuclides by inhalation are 2 orders of 
magnitudes lower than those for ingestion. 
4. Fractional absorption by both inhalation and ingestion are very low; 
0.02 for uranium isotopes and 0.0005 for all other actinides.  This 
results in disproportionately less of the actinides clearing the body 
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through the urine than for the other, more easily metabolized 
radionuclides in this study. 
Inhalation and ingestion risk assessments for the actinides can be found in Tables 
A.9-A.26 in Appendix A. 
CONCLUSIONS 
The ability to determine radionuclides in urine bioassays is critical for the 
effective and timely management of exposed persons.  Table 8.1 summarizes the tables 
found in the Appendix and gives information regarding radionuclide activity in urine for 
fatal doses and doses expected to cause a 1 in 1 million chance of mortality.  The 
capability to detect these levels of activity in urine is particularly important for scenarios 
that involve large uptakes to a large number of people, such as an industrial accident or 
an RDD event.  There are several analytical tools available for the determination of 
radionuclides in urine bioassays, including: Alpha spectrometry, TIMS, ICP-MS, FSA, 
and FGA.  In addition, there are other methods of in vivo and in vitro assays for 
radionuclides such as traditional gamma spectroscopy for urinalysis, whole body in vivo 
counting and fecal analysis.  Some of these methods are rapid (ICP-MS, FSA, FGA, and 
in vivo counting) while others are slow (fecal analysis, alpha spectrometry, TIMS, and 
traditional gamma spectrometry uninalysis).  Though there are many factors to be 
considered when choosing the optimum technique for determining the uptake of 
radioactive material.  For example, fecal analysis, while inconvenient for both the patient 
and the analyst, may provide superior results for ingested radionuclides, which have a 
low fractional absorption coefficient, such as actinides.  This is because most of the 
actinide activity that is ingested is unabsorbed by the body and passes in the feces. 
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Table 8.1: Summary of urine health physics data.  The table shows the activity of each 
isotope that would be expected in urine from patients with a lethal dose and 
from those with a 1 in 1M chance of mortality for inhalation and ingestion. 
ISOTOPE INHAL. LD URINE A (Bq/mL) 
INHAL. 1:1M MORT. 
URINE A (Bq/mL) 
ING. LD URINE 
A (Bq/mL) 
ING. 1:1M MORT. 
URINE A (Bq/mL) 
90Sr 2.07E+02 2.07E-04 7.80E+03 7.80E-03 
210Po 2.37E+00 2.37E-06 6.81E+01 6.81E-05 
60Co 9.25E+02 9.25E-04 2.11E+03 2.11E-03 
137Cs 1.38E+03 1.38E-03 1.33E+04 1.33E-02 
233U 8.12E-01 8.12E-07 9.02E+01 9.02E-05 
235U 9.31E-01 9.31E-07 9.16E+01 9.16E-05 
238U 1.01E+00 1.01E-06 1.01E+02 1.01E-04 
237Np 3.89E-03 3.89E-09 7.08E-05 7.08E-11 
238Pu 7.62E-05 7.62E-11 3.30E-04 3.30E-10 
239Pu 7.69E-05 7.69E-11 3.21E-04 3.21E-10 
242Pu 8.17E-05 8.17E-11 3.38E-04 3.38E-10 
241Am 6.99E-04 6.99E-10 3.66E-03 3.66E-09 
243Am 7.27E-04 7.27E-10 3.68E-03 3.68E-09 
In managing a mass uptake of a potentially harmful amount of radionuclides, one 
must balance the need for fast results with the need for the best sensitivities.  
Unfortunately, these needs often are conflicting.  One solution to this conundrum may be 
a two stage analytical approach, whereby a rapid analytical technique is used to screen 
and triage patients to identify those with the most uptake and the most immediate need 
for medical attention.  Then, as time allows, samples are analyzed by the more sensitive 
and time-consuming methods to confirm the preliminary assessment and to provide a 
prognosis to those with lesser amounts of uptake.  One must also consider the cost and 
availability of some techniques, particularly TIMS analysis.  While TIMS has proven to 
be the best analytical method for radionuclide determination for all but 210Po and 238Pu, 
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there are very few TIMS instruments available in the U.S. and analytical costs can range 
from $4,000-$8,000 per sample.  By comparison, alpha spectrometry is a widely 
available technique with a cost of less than $500 per sample.  The cost for the ICP-MS, 
FSA, and FGA are expected to be similar or less than the cost of alpha spectrometry.   
 The poisoning of Mr. Litvinenko with 210Po focused world attention on the 
dangers of intentional releases of high levels of radioactive material; reigniting fears of 
terrorism involving RDDs.  Aside from the death of Mr. Litvinenko, the most alarming 
aspect of this case was that 210Po was not identified as the poisoning agent until 23 days 
after he was poisoned; clearly demonstrating the need for rapid analytical techniques, 
even if they lack the best sensitivities.  During the time after the poisoning, but before his 
death, Mr. Litvinenko, having ingested approximately 100 lethal dose-equivalents of 
210Po was effectively an RDD.  In addition to traditional excretion pathways, 210Po is also 
excreted via sweat, where approximately 0.01-0.1% of the total body burden is cleared 
per day (Harrison 2007).  A trail of detectable amounts of 210Po was left around London 
by Mr. Litvinenko and those persons thought to have poisoned him, prompting the 
concern that members of the public may have received an uptake of 210Po.  Faced with 
the prospect of tens of thousands of people exposed to 210Po, the British National Health 
Service (NHS) began fielding calls from concerned citizens.  In the aftermath, 2,655 
people contacted the NHS with concerns; 799 were found to be legitimately concerned 
and were offered testing, of which 738 accepted; but only 17 people tested above the 
level of concern (6mSv or approximately 2,400 Bq ingested) (Guilmette 2007).   
The case of Mr. Litvinenko illustrates one further point: Even if an amount of 
radioactive material is released that could theoretically kill hundreds of people, spreading 
it in a way that it effects its maximum damage would be difficult.  In the event of an 
actual RDD, we may find that the result is more mass disruption than mass destruction.  
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In this case, calming public fears becomes an important priority for public health 
agencies.  Here too, rapid screening methods for radionuclides have the potential to be 
invaluable because of the potential to allay public fears and to identify those in true need 
of medical intervention. 
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Chapter 9:  Conclusions and Recommendations 
The preceding research was commissioned in an effort to provide public health 
agencies with instrumentation and techniques for the rapid determination of several 
radionuclides of concern in urine or aqueous matrices.  Several analytical methods were 
investigated including: flow scintillation analysis (FSA) for the determination of 90Sr, 
210Po, 60Co, and 137Cs; flow gamma analysis (FGA) for the determination of 60Co, and 
137Cs; inductively-coupled mass spectrometry for the determination of actinides; and 
chromatography-aided separation of actinides for electrodeposition.  High performance 
extraction chromatography (HPEC) was utilized in conjunction with all of the previously 
mentioned detection methods.   This technique enables automated radionuclide separation 
by passing the sample stream through a chromatographic resin that incorporates 
extractive ligands that have different retention characteristics for different metal ions.  As 
a result all of the methods developed in this work have a high degree of automation, 
which, generally, increases sample through put by reducing labor costs and eliminating 
time-consuming procedures.  The expediency of developed techniques is further 
enhanced by coupling detector systems to the HPEC output, providing simultaneous 
separation and detection in most cases.  Thus, a several components of a comprehensive 
multi-radionuclide analysis system with combined detection capability were developed.   
In addition, the individual research projects that comprise this effort have added to the 
cumulative knowledge of field of radioanalytical chemistry by developing new 
techniques and by examining novel applications of existing techniques.  While the 
research described herein accomplishes many of the project’s objectives, ideas for 
continued research into further realization of these goals will be discussed later in this 
chapter. 
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CONCLUSIONS OF RESEARCH EFFORTS 
 
Flow Scintillation Analysis of 90Sr:  An automated computer controlled system 
for the separation and simultaneous detection of 90Sr was optimized for aqueous and 
simulated urine bioassay samples.  An optimal counting window for 90Sr with the β-RAM 
flow scintillation analyzer was established.  Columns of 3cm and 15cm were examined 
for reproducibility and column life, where it was determined that the 15cm column was 
superior.  This column was capable of accommodating up to 16 analytical cycles with 
little 90Sr peak drift.  In addition, peak shape was improved by transitioning from a 3cm 
to 15cm column; however, it was necessary to add 5 minutes to the detection cycle.  A 
calibration curve of detector response to various low activity samples was plotted and 
shown to be highly linear for both aqueous and urine samples.  The resulting lower limit 
of detection by transient-flow counting was estimated to be 47 dpm, while the lower level 
of quantification was estimated to be 156 dpm.  The time for total analysis and column 
washing and reconditioning was 30 minutes for transient-flow counting.   
The results of the simulated urine bioassay experiments were highly encouraging; 
with no loss of recovery for urine samples diluted to 50% and little loss of recovery for 
fully concentrated urine samples.  Some peak broadening, with associated decrease in 
peak maximum counts, was noted.   
Flow Scintillation Analysis of 210Po:  An automated computer controlled system 
for the separation and simultaneous detection of 210Po was created and optimized for 
aqueous samples.  A method of 210Po recovery from well-aged 210Pb solutions was 
detailed.  Obtaining 210Po from 210Pb is an easy and convenient way of maintaining a 
stock of 210Po without having to be concerned with significant decay of the stock activity 
over time.  A loading and elution protocol was developed and optimized for acid 
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concentration to permit effective loading and elution of 210Po.  Cocktail/eluent ratios were 
also optimized to obtain results with the best figures of merit.  An optimal counting 
window for 210Po with the β-RAM flow scintillation analyzer was also established.  A 
calibration curve of detector response to various low activity samples was plotted and a 
non-linearity in the curve was noted.  A discontinuous calibration curve was deemed to 
be the best fit for the data.  Detector biases for activities above and below 400 DPM were 
identified.  The system allows for quantification of 210Po in samples with at least 100 
DPM of activity, using the stopped-flow counting technique and a 30 minute count time.  
The time for total analysis and column washing and reconditioning was 60 minutes.  
While no experiments were performed in this work to determine column longevity, we 
believe that a column life of 10 cycles can be recommended.  The feasibility of analysis 
of 210Po in dilute urine matrices was also briefly examined, with encouraging results.   
Flow Gamma Analysis of 60Co and 137Cs:  An automated method for the 
determination of 60Co and 137Cs in aqueous samples by a new technique, called flow 
gamma analysis (FGA) was examined.  This method attempted to combine rapid 
chromatographic separation techniques with the γ energy discrimination properties of a 
NaI(Tl) detector.  This would enable the determination of β/γ emitting nuclides that co-
elute from the column; a determination is not possible with established FSA techniques.  
However, due to low the detection efficiency of the NaI(Tl) detector used in these 
experiments, the FGA detection limits for 60Co and 137Cs were undesirably high; 1134 
(±33) dpm for 60Co and 440 (± 15) for 137Cs for a 2500 µL gamma flow cell.  We also 
conducted experiments to determine these isotopes by FSA, even though we could not 
resolve samples with mixtures of the two analytes.  Better detection limits were achieved 
for 60Co, 494 (±25) dpm, by this method; however, worse detection limits found for 
137Cs, 729 (±36) dpm.  Determination by FSA was primarily hampered by an encountered 
 163
detector response bias that inhibited the determination of these analytes at lower levels.  
The authors believe that chemical quenching of the scintillation process by the high 
concentration of nitric acid eluent, 8M, may be to blame for this effect.   
Optimization of actinide analysis by HPEC and ICP-MS:  In this work several 
parameters associated with an on-line separation of actinide compounds utilizing ICP-MS 
detection have been optimized.  First, it was determined that the selectivity between 
different actinides is significantly reduced with the use of oxalic acid.  However, the use 
of a smaller amount of oxalic acid does permit satisfactory selectivity, while reducing the 
need for instrument maintenance.  Second, it was determined that packing columns under 
pressure is better than manually packing.  Columns that are pressure packed elute the five 
actinides twice as fast as those packed manually; this likely due to the fact that there is 
less void space in the column.  We also determined that while longer columns improve 
actinide separation, they also increase the overall separation time and result in 
unacceptably broader peaks.   For this reason we recommend using a 3-10 cm column 
rather than a 30 cm column.  We also showed that smaller resin particle size results in 
sharper, more well defined peaks, though the improvement from 50-150 μm to 20-50 μm 
is slight.  We also demonstrated faster flow rates result in shorter actinide retention time 
and narrower peaks, though peaks become distorted for flow rates > 4 mL/min and 
nebulizer efficacy decreases at higher flow rates.  For the optimized parameter settings 
we able to achieve detection limits below 1 pg. 
Actinide separation and electrodeposition using HPEC:  A system was developed 
that facilitated the automated separation of actinides by HPEC and the collection of 
actinide fractions into convenient counting groups for electrodeposition and counting by 
alpha spectrometry.  The separation and collection of Pu, Th, and U was successfully 
demonstrated.  Neptunium was found in all three collection windows that contained 
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detectable levels of actinides.  This was attributed to oxidation state effects whereby 
Np(V) was collected in the appropriate window, while Np(IV) was collected with the Pu 
and Th fractions and Np(VI) was collected with the U fraction.  Spillover of americium 
into the Pu and Th collection window was also shown to occur.   
APPLICABILITY OF DEVELOPED METHODS TO HEALTH PHYSICS 
While most of the individual experiments presented in this work appear to stand 
alone as self-contained research efforts, they are all related to the development of rapid 
bioassay methods for determination of radiological uptake, the ultimate project goal.  
Thus, it is important to examine the extent to which each project achieves meaningful 
application to internal dosimetry assessment. 
90Sr was evaluated by flow scintillation analysis in chapter 3 of this work, where a 
quantification limit of 47 dpm per sample was established for this technique.  The 
detection limits for 90Sr by ICP-MS and TIMS was found to be 306 dpm and 0.306 dpm, 
respectively.  Therefore, while FSA is a better analytical tool than ICP-MS, it is not as 
good as TIMS.  However, FSA has the distinction of being the best rapid analysis 
technique for determining 90Sr.  Tables A.1 and A.2 show us that by processing 2 mL of 
straight urine by FSA, we can detect levels of 90Sr from an inhalation uptake that would 
be expected to cause a 1 in 250 chance of mortality and an ingestion uptake that related to 
a 1 in 5,000 chance of mortality.  Therefore, FSA would be a very useful screening 
method to identify and assess patients with moderate levels of 90Sr. 
210Po was evaluated by flow scintillation analysis in chapter 4 of this work, where 
a detection limit of 100 dpm per sample was established for this technique.  The detection 
limits for 210Po by ICP-MS and TIMS was found to be 9,970 dpm and 9.97 dpm, 
respectively.  Alpha spectrometry has a detection limit of 0.022 dpm for 210Po with a 24 
hour count time.  Again, FSA has the distinction of being the best rapid analysis 
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technique for 210Po.  Tables A.3 and A.4 show us that by processing 2 mL of straight 
urine by FSA, we can detect levels of 210Po from an inhalation uptake that would be 
expected to cause a 1 in 2 chance of mortality and an ingestion uptake that related to a 1 
in 20 chance of mortality.  Detection limits for 210Po are much better if more than 2 mL 
of urine is available for concentration on the column. Therefore, FSA would be a very 
useful screening method to identify and assess patients with the most serious levels of 
210Po.   
60Co was evaluated by FGA and FSA in chapter 5 of this work, where a detection 
limit of 1134 dpm was established for FGA and a detection limit of 494 dpm per sample 
was determined for FSA.  The detection limits for 60Co by ICP-MS and TIMS was found 
to be 2510 dpm and 2.51 dpm, respectively.  FSA is also the best rapid determination 
technique for this isotope.  Tables A.5 and A.6 show us that by processing 2 mL of 
straight urine by FSA, we can detect levels of 60Co from an inhalation uptake that would 
be expected to cause a 1 in 100 chance of mortality and an ingestion uptake that related to 
a 1 in 500 chance of mortality.  Therefore, FSA would be a very useful screening method 
to identify and assess patients with serious levels of 60Co. 
137Cs was evaluated by FGA and FSA in chapter 5 of this work, where a detection 
limit of 440 dpm was established for FGA and a detection limit of 729 dpm per sample 
was determined for FSA.  The detection limits for 137Cs by ICP-MS and TIMS was found 
to be 193 dpm and 0.193 dpm, respectively.  For this isotope, ICP-MS is the best rapid 
determination technique.  Tables A.7 and A.8 show us that by processing 2 mL of straight 
urine by ICP-MS, we can detect levels of 137Cs from an inhalation uptake that would be 
expected to cause a 1 in 500 chance of mortality and an ingestion uptake that related to a 
1 in 5000 chance of mortality.  Therefore, ICP-MS would be a very useful screening 
method to identify and assess patients with moderate levels of 137Cs. 
 166
Actinide isotopes were evaluated by ICP-MS in chapter 6 of this work and by 
chromatography-aided electrodeposition in chapter 7.  Detection limits for these actinides 
by alpha spectrometry is 0.022 dpm for all isotopes, assuming that they are deposited in 
counting samples that are free from spectral interferences.  Detection limits are more or 
less constant because backgrounds are uniformly very low and detection efficiency is 
relatively insensitive to the range of alpha particle energies.  The ICP-MS detection limits 
are also fairly constant at 1 pg; though the activity associated with 1 pg varies widely 
with the half-life of the actinide from a low of 7.46 x 10-7 dpm for 238U to a high of 38 
dpm for 238Pu.  Tables A.9-A26 show that for all actinides studied, ICP-MS is the best 
rapid determination technique; it is capable of detecting very low levels of uptake for all 
uranium isotopes studied.  However, this technique is relatively insensitive for 237Np, 
239Pu, 242Pu, 241Am, and 243Am, where it is of limited used unless urine samples are 
significantly concentrated prior to analysis.  ICP-MS is of no use at all in determining 
238Pu levels in patients with even lethal uptakes of this isotope; so TIMS or alpha 
spectrometry must be used if 238Pu uptake is suspected.  While both TIMS and alpha 
spectrometry take 2-3 days to process a sample, alpha spectrometry is likely to be faster 
because of the greater availability of these instruments.  In addition, the technique of 
chromatography aided electrodeposition, developed in chapter 7, may be able to reduce 
sample processing time to a firm 2 days for this method.   
RECOMMENDATIONS FOR INTERPRETATION AND APPLICATION OF THIS RESEARCH 
It is recommended that readers of this work interpret the results and implications 
of this research in a manor that is consistent with the project goals; which are to create 
radionuclide screening techniques that are relevant to urine bioassay samples and that are 
both as rapid and automated as possible.  In this context, the best techniques for our 
purposes are almost never the most sensitive and rigorous techniques available.  In the 
 167
event that the methods and recommendations developed in this work are put into practice 
by a public health agency or an analytical lab, it is important to remember that these 
techniques are intended to be used as rapid screening methods only.  There is great 
benefit in utilizing a rapid analysis method if a mass public uptake is suspected.  This 
allows public health officials to quickly identify persons with the most radioactive uptake 
so that they may be triaged for appropriate medical intervention, if necessary.  However, 
these initial screenings provide only a limited analysis and follow-up screenings should 
be made with the most sensitive techniques available, as time permits.  In this way, the 
results of the rapid screening method can be confirmed or refuted.  In addition, those with 
certain low levels of intake may not be identified in the initial screening (due to high 
detection limits) and may still require some degree of attention.  Therefore, if the rapid 
methods developed herein are used in conjunction subsequent analysis by high sensitivity 
methods, one can be sure that results will be highly expedient and, eventually, highly 
accurate.  This dual screening approach may be the best way to allay public fears in the 
event of an RDD event or accident because in the absence of prompt and credible 
information, people will inevitably fear the worst.   
RECOMMENDATIONS FOR FUTURE RESEARCH 
The results of the analysis of 90Sr in simulated urine bioassays were highly 
encouraging; with no loss of recovery for urine samples diluted to 50% and little loss of 
recovery for fully concentrated urine samples.  Some peak broadening, with associated 
decrease in peak maximum counts, was noted.  We recommend conducting further 
research into optimizing column parameters (length, resin size, and packing pressure) for 
urine bioassays.  We also recomend experimenting with octanol saturated reagents to 
determine the suitability of this approach to enhance column performance and 
reproducibility by preserving the integrity of the stationary phase of the Sr columns. 
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No experiments were performed to determine column longevity with respect to 
210Po analysis.  A recommended column life of 10 cycles was promoted, but there is 
really no data to determine column life with any certainty.  Therefore, we recommend 
that further research be conducted to determine the Sr column life as it applies to 210Po 
analysis.  The feasibility of analysis of 210Po in dilute urine matrices was also briefly 
examined, with encouraging results.  Much more work is needed to study the method 
efficacy for urine analysis of 210Po and to optimize counting parameters.  It is also highly 
recommended that trails involving octanol saturated reagents be conducted to determine 
if there is enhancement of the 210Po peak shape.  Specifically, if one can establish a way 
of forcing 210Po to elute as one peak, instead of two, detection limits would be 
substantially enhanced.  One may also try to employ various oxidizing and reducing 
agents as a sample pre-treatment to determine if multiple oxidation states of polonium are 
causing the analyte to elute in two distinct peaks. 
In the FSA analysis of 60Co and 137Cs, it was postulated that the observed detector 
bias was due to quench effects from the 8M nitric acid used in the load solution.  It is 
possible that by lowering the molarity of nitic acid, less bias will be encountered.  We 
believe that one could reduce the load solution nitric acid concentration to 3M, and still 
be able to achieve retention of 90Sr, a possible interference.   
We also believe that NaI(Tl) detection efficiency can be improved with the 
addition of extra lead shielding.  If a large lead brick cave is built around the detector, the 
background count rate can be expected to drop, thereby enhancing the signal to noise 
ratio when a source is present.  The addition of a copper or cadmium liner for the detector 
cave would also further reduce background.  This modification can be made easily and 
without much added cost.  Further, we believe that the use of a detector with a larger 
NaI(Tl) crystal would improve γ-ray detection efficiency since γ-ray stopping power is 
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proportional to the crystal thickness.  This modification would be more costly that the 
previous, but would have the added bonus of accommodating larger gamma flow cells in 
the larger well. 
Using these improved preparation conditions for actinide analysis by ICP-MS, we 
anticipate one could improve the automated separation of these analytes for emergency 
bioassay samples.  Future research in this area should consist of examining the properties 
of other resins and applying results to the separation of actinides from a human urine 
matrix.  
In the HPEC driven actinide separation for electrodeposition experiment, we 
encountered significant spill over of Am into the Pu/Th collection window.  We 
anticipate that this could be corrected by conducting experiments to incrementally 
increasing the length of the second counting window until Pu or Th begins to spill over 
into Window 2.  In this way, the collection window for americium may be optimized.  
Further, neptunium was found in all three collection windows that contained detectable 
levels of actinides.  This was attributed to oxidation state effects.  The addition of NaNO3 
could reduce higher oxidation states of neptunium to Np(IV), whereby it would be eluted 
and codepisted with the Pu and Th fractions.  Experiments should be done to determine if 
this hypothesis is correct and if the addition of NaNO3 has any effect on Np elution 
behavior.  The system described in this work has many potential applications.  This 
technique could provide trace actinide analysis (environmental, bioassay, etc.) of high 
specific activity isotopes where analysis by ICP-MS is not possible, e.g. 228Th, 232U, 
238Pu, 241Am, and various curium and californium isotopes.  This system could also be 
used for routine radioanalytical work, where separations that used to take 8 hours can be 
accomplished in under 15 minutes.  Finally, this system could be used in a mobile 
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laboratory for in-field analysis for environmental monitoring or emergency response 
situations; since mass spectrometers are not mobile. 
OUTLINE OF WORK DONE BY THE AUTHOR 
Though this work often uses the preposition, “we,” and a narrative tone attributed 
to, “the authors,” most of the work featured herein was done by the sole author of this 
dissertation.  The pluralistic tone of the narrative is in anticipation that several of the 
chapters featured in this work will eventually be published in peer-reviewed journals, 
where multiple authors will be credited.  The purpose of this section is to clearly outline 
what work was done by the author of this dissertation, and to credit that work which was 
not done by the author to the appropriate person or persons.   
Chapters 1 and 2 of this work were researched and written exclusively by the 
author; with comments and recommendations by members of the dissertation committee 
incorporated into the final draft of these chapters.   
Chapters 3, 4, and 5 featured the use of the β-RAM model 4B flow scintillation 
analyzer.  The initial set up of this unit, as well as a very basic tutorial, was provided by 
the vendor.  Since the initial setup, the author has personally made all modifications to 
the unit, flow cells, and associated periphery equipment.  All experiments featured in 
these chapters were conducted exclusively by the author.  In addition, all data analysis 
was done by the author.  Finally, the author singularly wrote all sections of these 
chapters, incorporating input and recommendations by members of the dissertation 
committee. 
Chapter 5 also featured the use of the tandem flow gamma analyzer.  The initial 
setup and of this unit, as well as a very basic tutorial, were provided by the vendor.  Since 
the initial setup of the of the unit, modifications were made to the signal output of the 
NaI(Tl) detector.  The author was aided in these modifications by Kevin Jackman (fellow 
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UT Nuclear Engineering doctoral student and now LANL postdoc) and Vince Melito 
(LANL technician and electrical safety officer).  The author was provided with limited 
labor from these individuals to make the needed modifications and ensure the safety of 
the modified system.  Dr. Jackman also provided a tutorial to the author on operation of 
the detector and good laboratory practices for gamma counting with a NaI(Tl) detector.  
Further, the author sought and received advice from Dr. Jackman on methods for data 
analysis concerning the NaI(Tl) detector; though all calculations were performed by the 
author, alone.   
The work featured in Chapter 6 was largely conducted by Dominic Peterson on 
the mass spectrometer that he setup and maintains.  The author contributed to the work by 
performing experiments testing variable eluent flow rates and noting peak distortions.  
The author also recorded the pressure on the line as the flow rate was adjusted so that any 
compression of the resin could be determined.  This work was eventually published in the 
peer reviewed journal, Journal of Separation Science (Peterson 2007).  The author’s 
name appears second on that publication.  The publication was written and submitted by 
Dr. Peterson, with input and recommendations by the author.  The text and figures 
appearing in Chapter 6 are largely derivative of the aforementioned publication.  Only the 
introduction and conclusion of this chapter are sections that can be solely attributed to the 
author. 
Chapter 7 featured work performed by the author, Edward Gonzales (LANL staff 
member), and Claudine Armenta (LANL technician).  The author was solely responsible 
for setup of the chromatography and fraction collection systems.  The author also 
performed all actinide separations and collections himself.  Mrs. Armenta was 
responsible for electrodepositing most of the collected actinide fractions; though the 
author did perform several, himself, as well.  Mr. Gonzales the performed all alpha 
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counting of these prepared samples using the alpha spectrometers that he maintains.  All 
data analysis was performed by the author.  The author was also solely responsible for 
writing Chapter 7. 
Chapters 8 and 9 were researched and written exclusively by the author; with 
comments and recommendations by members of the dissertation committee incorporated 
into the final draft of these chapters.   
Finally, all chromatography columns were packed by Dr. Peterson, using the 
column packer that he setup and maintains.  Column packing had to be done by Dr. 
Peterson, because he is the only trained and qualified person in the group to operated the 
column packer, which is a pressure hazard.   
IMPACT OF THIS WORK ON THE FIELD 
This body of work evaluates several methods of rapid and automated radionuclide 
detection in urine or aqueous matrices.  Some of these methods are novel (FGA and 
chromatography-aided electrodeposition), while others are novel applications of pre-
existing methods (FSA for determination of 210Po and FSA for determination of bioassay 
levels of 90Sr in urine).  In addition we also present research on the optimization of 
several counting parameters for the established method of actinide detection by ICP-MS. 
While FSA has long been used by the biotech sector for radio-labeling organic 
compounds (mostly with 3H, 14C, 32P, and 22Na), this technique has seen relatively little 
use in the field of radioanalytical chemistry.  The only use of these instruments for 
radiochemistry, that the author is aware of, is at the Pacific Northwest National Lab 
(PNNL) and Clemson University.  Therefore, the author can be credited with bringing 
this underutilized capability to LANL.  In addition, radiochemistry research using this 
instrument has mostly been limited to analysis of high-level nuclear waste; a particularly 
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well-suited type of sample for this instrument, since it was designed to detect with mCi 
levels of activity.   
The author encountered great difficulty adapting this technique for the analysis of 
samples that contained only nCi and pCi levels of activity.  Though, detection limits of 
90Sr and 99Tc have been quoted in some publications, no work has been done with 
samples exclusively in this low activity range.  In addition, this work is the first known 
application of FSA for 90Sr analysis of urine samples.  Since the experiments determining 
90Sr in urine were highly successful, they should have a positive impact on the field. 
This work also featured research describing the first known detection of 210Po by 
FSA.  This analyte is again very popular in the radioanalytical chemistry field, were it is 
notorious for being difficult to work with.  Typical 210Po takes 3 days to accomplish and 
there are only a few labs that will perform this analysis.  This work presents a 210Po 
analysis method that is accomplished in only 1 hour, and features instrumentation that 
completely contains the polonium hazard.  In addition, the high degree of automation 
incorporated into the separation and detection, further improve the safety of 210Po 
analysis.  Therefore, it is reasonable to assume that this work will be well-received and 
have a positive impact on the field. 
The flow gamma analysis of 60Co and 137Cs was less successful at detecting pCi-
nCi levels of these analytes.  However, the techniques developed in this work may be 
better applied to higher activity samples (such as high-level nuclear waste).  
Nevertheless, this is the first attempt known to the author of a system that combines 
chromatography detection with γ-ray energy discrimination.  In addition to FAG, these 
analytes were also quantified by FSA.  While detection peaks attributed to 60Co and 137Cs 
have been observed in other FSA work (nuclear waste samples), these analytes were 
treated as interferences of the target analyte (90Sr or 99Tc) and were never quantified.   
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The research into optimization of actinide analysis by ICP-MS, is no doubt an 
improvement to the collective knowledge of the field.  Optimization research is always 
appreciated, since many established procedures are used for many years without 
improvement.  This work has already been published in a peer reviewed journal, where it 
will likely have a positive impact on the field.   
The research of actinide separation by HPEC for electrodeposition is still very 
much a work in progress since we are still encountering neptunium and americium 
spillover into other collection windows.  However, if this work can be optimized it has 
the potential to be a significant improvement on source preparation for alpha counting.  
Presently, actinide separation takes approximately 8 hours to accomplish, so there would 
be great advantage to the field if a technique can be perfected to accomplish the same 
task in just 15 minutes.   
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Appendix 
Table A.1: 90Sr inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 3.52E+08 3.52E+07 2.07E+02 4.15E+02 2.07E+03 5.18E+03 1.04E+04 2.07E+04 5.18E+04 1.04E+05 2.07E+05 2.99E+05 
53.5 1 in 2 1.76E+08 1.76E+07 1.04E+02 2.07E+02 1.04E+03 2.59E+03 5.18E+03 1.04E+04 2.59E+04 5.18E+04 1.04E+05 1.49E+05 
26.75 1 in 4 8.80E+07 8.80E+06 5.18E+01 1.04E+02 5.18E+02 1.30E+03 2.59E+03 5.18E+03 1.30E+04 2.59E+04 5.18E+04 7.46E+04 
21.4 1 in 5 7.04E+07 7.04E+06 4.15E+01 8.29E+01 4.15E+02 1.04E+03 2.07E+03 4.15E+03 1.04E+04 2.07E+04 4.15E+04 5.97E+04 
10.7 1 in 10 3.52E+07 3.52E+06 2.07E+01 4.15E+01 2.07E+02 5.18E+02 1.04E+03 2.07E+03 5.18E+03 1.04E+04 2.07E+04 2.99E+04 
5.35 1 in 20 1.76E+07 1.76E+06 1.04E+01 2.07E+01 1.04E+02 2.59E+02 5.18E+02 1.04E+03 2.59E+03 5.18E+03 1.04E+04 1.49E+04 
2.14 1 in 50 7.04E+06 7.04E+05 4.15E+00 8.29E+00 4.15E+01 1.04E+02 2.07E+02 4.15E+02 1.04E+03 2.07E+03 4.15E+03 5.97E+03 
1.07 1 in 100 3.52E+06 3.52E+05 2.07E+00 4.15E+00 2.07E+01 5.18E+01 1.04E+02 2.07E+02 5.18E+02 1.04E+03 2.07E+03 2.99E+03 
0.428 1 in 250 1.41E+06 1.41E+05 8.29E-01 1.66E+00 8.29E+00 2.07E+01 4.15E+01 8.29E+01 2.07E+02 4.15E+02 8.29E+02 1.19E+03 
0.214 1 in 500 7.04E+05 7.04E+04 4.15E-01 8.29E-01 4.15E+00 1.04E+01 2.07E+01 4.15E+01 1.04E+02 2.07E+02 4.15E+02 5.97E+02 
0.107 1 in 1000 3.52E+05 3.52E+04 2.07E-01 4.15E-01 2.07E+00 5.18E+00 1.04E+01 2.07E+01 5.18E+01 1.04E+02 2.07E+02 2.99E+02 
0.0214 1 in 5000 7.04E+04 7.04E+03 4.15E-02 8.29E-02 4.15E-01 1.04E+00 2.07E+00 4.15E+00 1.04E+01 2.07E+01 4.15E+01 5.97E+01 
0.0107 1 in 10000 3.52E+04 3.52E+03 2.07E-02 4.15E-02 2.07E-01 5.18E-01 1.04E+00 2.07E+00 5.18E+00 1.04E+01 2.07E+01 2.99E+01 
0.00214 1 in 50000 7.04E+03 7.04E+02 4.15E-03 8.29E-03 4.15E-02 1.04E-01 2.07E-01 4.15E-01 1.04E+00 2.07E+00 4.15E+00 5.97E+00 
0.00107 1 in 100000 3.52E+03 3.52E+02 2.07E-03 4.15E-03 2.07E-02 5.18E-02 1.04E-01 2.07E-01 5.18E-01 1.04E+00 2.07E+00 2.99E+00 
0.000214 1 in 500000 7.04E+02 7.04E+01 4.15E-04 8.29E-04 4.15E-03 1.04E-02 2.07E-02 4.15E-02 1.04E-01 2.07E-01 4.15E-01 5.97E-01 




Table A.2: 90Sr ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 6.62E+08 1.99E+08 7.80E+03 1.56E+04 7.80E+04 1.95E+05 3.90E+05 7.80E+05 1.95E+06 3.90E+06 7.80E+06 1.12E+07 
56.5 1 in 2 3.31E+08 9.93E+07 3.90E+03 7.80E+03 3.90E+04 9.74E+04 1.95E+05 3.90E+05 9.74E+05 1.95E+06 3.90E+06 5.61E+06 
28.25 1 in 4 1.66E+08 4.97E+07 1.95E+03 3.90E+03 1.95E+04 4.87E+04 9.74E+04 1.95E+05 4.87E+05 9.74E+05 1.95E+06 2.81E+06 
22.6 1 in 5 1.32E+08 3.97E+07 1.56E+03 3.12E+03 1.56E+04 3.90E+04 7.80E+04 1.56E+05 3.90E+05 7.80E+05 1.56E+06 2.25E+06 
11.3 1 in 10 6.62E+07 1.99E+07 7.80E+02 1.56E+03 7.80E+03 1.95E+04 3.90E+04 7.80E+04 1.95E+05 3.90E+05 7.80E+05 1.12E+06 
5.65 1 in 20 3.31E+07 9.93E+06 3.90E+02 7.80E+02 3.90E+03 9.74E+03 1.95E+04 3.90E+04 9.74E+04 1.95E+05 3.90E+05 5.61E+05 
2.26 1 in 50 1.32E+07 3.97E+06 1.56E+02 3.12E+02 1.56E+03 3.90E+03 7.80E+03 1.56E+04 3.90E+04 7.80E+04 1.56E+05 2.25E+05 
1.13 1 in 100 6.62E+06 1.99E+06 7.80E+01 1.56E+02 7.80E+02 1.95E+03 3.90E+03 7.80E+03 1.95E+04 3.90E+04 7.80E+04 1.12E+05 
0.452 1 in 250 2.65E+06 7.95E+05 3.12E+01 6.24E+01 3.12E+02 7.80E+02 1.56E+03 3.12E+03 7.80E+03 1.56E+04 3.12E+04 4.49E+04 
0.226 1 in 500 1.32E+06 3.97E+05 1.56E+01 3.12E+01 1.56E+02 3.90E+02 7.80E+02 1.56E+03 3.90E+03 7.80E+03 1.56E+04 2.25E+04 
0.113 1 in 1000 6.62E+05 1.99E+05 7.80E+00 1.56E+01 7.80E+01 1.95E+02 3.90E+02 7.80E+02 1.95E+03 3.90E+03 7.80E+03 1.12E+04 
0.0226 1 in 5000 1.32E+05 3.97E+04 1.56E+00 3.12E+00 1.56E+01 3.90E+01 7.80E+01 1.56E+02 3.90E+02 7.80E+02 1.56E+03 2.25E+03 
0.0113 1 in 10000 6.62E+04 1.99E+04 7.80E-01 1.56E+00 7.80E+00 1.95E+01 3.90E+01 7.80E+01 1.95E+02 3.90E+02 7.80E+02 1.12E+03 
0.00226 1 in 50000 1.32E+04 3.97E+03 1.56E-01 3.12E-01 1.56E+00 3.90E+00 7.80E+00 1.56E+01 3.90E+01 7.80E+01 1.56E+02 2.25E+02 
0.00113 1 in 100000 6.62E+03 1.99E+03 7.80E-02 1.56E-01 7.80E-01 1.95E+00 3.90E+00 7.80E+00 1.95E+01 3.90E+01 7.80E+01 1.12E+02 
0.000226 1 in 500000 1.32E+03 3.97E+02 1.56E-02 3.12E-02 1.56E-01 3.90E-01 7.80E-01 1.56E+00 3.90E+00 7.80E+00 1.56E+01 2.25E+01 






Table A.3: 210Po inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 3.41E+06 3.41E+05 2.37E+00 4.74E+00 2.37E+01 5.93E+01 1.19E+02 2.37E+02 5.93E+02 1.19E+03 2.37E+03 3.41E+03 
53 1 in 2 1.71E+06 1.71E+05 1.19E+00 2.37E+00 1.19E+01 2.96E+01 5.93E+01 1.19E+02 2.96E+02 5.93E+02 1.19E+03 1.71E+03 
26.5 1 in 4 8.53E+05 8.53E+04 5.93E-01 1.19E+00 5.93E+00 1.48E+01 2.96E+01 5.93E+01 1.48E+02 2.96E+02 5.93E+02 8.53E+02 
21.2 1 in 5 6.83E+05 6.83E+04 4.74E-01 9.48E-01 4.74E+00 1.19E+01 2.37E+01 4.74E+01 1.19E+02 2.37E+02 4.74E+02 6.83E+02 
10.6 1 in 10 3.41E+05 3.41E+04 2.37E-01 4.74E-01 2.37E+00 5.93E+00 1.19E+01 2.37E+01 5.93E+01 1.19E+02 2.37E+02 3.41E+02 
5.3 1 in 20 1.71E+05 1.71E+04 1.19E-01 2.37E-01 1.19E+00 2.96E+00 5.93E+00 1.19E+01 2.96E+01 5.93E+01 1.19E+02 1.71E+02 
2.12 1 in 50 6.83E+04 6.83E+03 4.74E-02 9.48E-02 4.74E-01 1.19E+00 2.37E+00 4.74E+00 1.19E+01 2.37E+01 4.74E+01 6.83E+01 
1.06 1 in 100 3.41E+04 3.41E+03 2.37E-02 4.74E-02 2.37E-01 5.93E-01 1.19E+00 2.37E+00 5.93E+00 1.19E+01 2.37E+01 3.41E+01 
0.424 1 in 250 1.37E+04 1.37E+03 9.48E-03 1.90E-02 9.48E-02 2.37E-01 4.74E-01 9.48E-01 2.37E+00 4.74E+00 9.48E+00 1.37E+01 
0.212 1 in 500 6.83E+03 6.83E+02 4.74E-03 9.48E-03 4.74E-02 1.19E-01 2.37E-01 4.74E-01 1.19E+00 2.37E+00 4.74E+00 6.83E+00 
0.106 1 in 1000 3.41E+03 3.41E+02 2.37E-03 4.74E-03 2.37E-02 5.93E-02 1.19E-01 2.37E-01 5.93E-01 1.19E+00 2.37E+00 3.41E+00 
0.0212 1 in 5000 6.83E+02 6.83E+01 4.74E-04 9.48E-04 4.74E-03 1.19E-02 2.37E-02 4.74E-02 1.19E-01 2.37E-01 4.74E-01 6.83E-01 
0.0106 1 in 10000 3.41E+02 3.41E+01 2.37E-04 4.74E-04 2.37E-03 5.93E-03 1.19E-02 2.37E-02 5.93E-02 1.19E-01 2.37E-01 3.41E-01 
0.00212 1 in 50000 6.83E+01 6.83E+00 4.74E-05 9.48E-05 4.74E-04 1.19E-03 2.37E-03 4.74E-03 1.19E-02 2.37E-02 4.74E-02 6.83E-02 
0.00106 1 in 100000 3.41E+01 3.41E+00 2.37E-05 4.74E-05 2.37E-04 5.93E-04 1.19E-03 2.37E-03 5.93E-03 1.19E-02 2.37E-02 3.41E-02 
0.000212 1 in 500000 6.83E+00 6.83E-01 4.74E-06 9.48E-06 4.74E-05 1.19E-04 2.37E-04 4.74E-04 1.19E-03 2.37E-03 4.74E-03 6.83E-03 




Table A.4: 210Po ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 9.80E+07 9.80E+06 6.81E+01 1.36E+02 6.81E+02 1.70E+03 3.40E+03 6.81E+03 1.70E+04 3.40E+04 6.81E+04 9.80E+04 
69 1 in 2 4.90E+07 4.90E+06 3.40E+01 6.81E+01 3.40E+02 8.51E+02 1.70E+03 3.40E+03 8.51E+03 1.70E+04 3.40E+04 4.90E+04 
34.5 1 in 4 2.45E+07 2.45E+06 1.70E+01 3.40E+01 1.70E+02 4.26E+02 8.51E+02 1.70E+03 4.26E+03 8.51E+03 1.70E+04 2.45E+04 
27.6 1 in 5 1.96E+07 1.96E+06 1.36E+01 2.72E+01 1.36E+02 3.40E+02 6.81E+02 1.36E+03 3.40E+03 6.81E+03 1.36E+04 1.96E+04 
13.8 1 in 10 9.80E+06 9.80E+05 6.81E+00 1.36E+01 6.81E+01 1.70E+02 3.40E+02 6.81E+02 1.70E+03 3.40E+03 6.81E+03 9.80E+03 
6.9 1 in 20 4.90E+06 4.90E+05 3.40E+00 6.81E+00 3.40E+01 8.51E+01 1.70E+02 3.40E+02 8.51E+02 1.70E+03 3.40E+03 4.90E+03 
2.76 1 in 50 1.96E+06 1.96E+05 1.36E+00 2.72E+00 1.36E+01 3.40E+01 6.81E+01 1.36E+02 3.40E+02 6.81E+02 1.36E+03 1.96E+03 
1.38 1 in 100 9.80E+05 9.80E+04 6.81E-01 1.36E+00 6.81E+00 1.70E+01 3.40E+01 6.81E+01 1.70E+02 3.40E+02 6.81E+02 9.80E+02 
0.552 1 in 250 3.92E+05 3.92E+04 2.72E-01 5.45E-01 2.72E+00 6.81E+00 1.36E+01 2.72E+01 6.81E+01 1.36E+02 2.72E+02 3.92E+02 
0.276 1 in 500 1.96E+05 1.96E+04 1.36E-01 2.72E-01 1.36E+00 3.40E+00 6.81E+00 1.36E+01 3.40E+01 6.81E+01 1.36E+02 1.96E+02 
0.138 1 in 1000 9.80E+04 9.80E+03 6.81E-02 1.36E-01 6.81E-01 1.70E+00 3.40E+00 6.81E+00 1.70E+01 3.40E+01 6.81E+01 9.80E+01 
0.0276 1 in 5000 1.96E+04 1.96E+03 1.36E-02 2.72E-02 1.36E-01 3.40E-01 6.81E-01 1.36E+00 3.40E+00 6.81E+00 1.36E+01 1.96E+01 
0.0138 1 in 10000 9.80E+03 9.80E+02 6.81E-03 1.36E-02 6.81E-02 1.70E-01 3.40E-01 6.81E-01 1.70E+00 3.40E+00 6.81E+00 9.80E+00 
0.00276 1 in 50000 1.96E+03 1.96E+02 1.36E-03 2.72E-03 1.36E-02 3.40E-02 6.81E-02 1.36E-01 3.40E-01 6.81E-01 1.36E+00 1.96E+00 
0.00138 1 in 100000 9.80E+02 9.80E+01 6.81E-04 1.36E-03 6.81E-03 1.70E-02 3.40E-02 6.81E-02 1.70E-01 3.40E-01 6.81E-01 9.80E-01 
0.000276 1 in 500000 1.96E+02 1.96E+01 1.36E-04 2.72E-04 1.36E-03 3.40E-03 6.81E-03 1.36E-02 3.40E-02 6.81E-02 1.36E-01 1.96E-01 





Table A.5: 60Co inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 1.03E+09 1.03E+08 9.25E+02 1.85E+03 9.25E+03 2.31E+04 4.63E+04 9.25E+04 2.31E+05 4.63E+05 9.25E+05 1.33E+06 
60.5 1 in 2 5.17E+08 5.17E+07 4.63E+02 9.25E+02 4.63E+03 1.16E+04 2.31E+04 4.63E+04 1.16E+05 2.31E+05 4.63E+05 6.66E+05 
30.25 1 in 4 2.58E+08 2.58E+07 2.31E+02 4.63E+02 2.31E+03 5.78E+03 1.16E+04 2.31E+04 5.78E+04 1.16E+05 2.31E+05 3.33E+05 
24.2 1 in 5 2.07E+08 2.07E+07 1.85E+02 3.70E+02 1.85E+03 4.63E+03 9.25E+03 1.85E+04 4.63E+04 9.25E+04 1.85E+05 2.67E+05 
12.1 1 in 10 1.03E+08 1.03E+07 9.25E+01 1.85E+02 9.25E+02 2.31E+03 4.63E+03 9.25E+03 2.31E+04 4.63E+04 9.25E+04 1.33E+05 
6.05 1 in 20 5.17E+07 5.17E+06 4.63E+01 9.25E+01 4.63E+02 1.16E+03 2.31E+03 4.63E+03 1.16E+04 2.31E+04 4.63E+04 6.66E+04 
2.42 1 in 50 2.07E+07 2.07E+06 1.85E+01 3.70E+01 1.85E+02 4.63E+02 9.25E+02 1.85E+03 4.63E+03 9.25E+03 1.85E+04 2.67E+04 
1.21 1 in 100 1.03E+07 1.03E+06 9.25E+00 1.85E+01 9.25E+01 2.31E+02 4.63E+02 9.25E+02 2.31E+03 4.63E+03 9.25E+03 1.33E+04 
0.484 1 in 250 4.13E+06 4.13E+05 3.70E+00 7.40E+00 3.70E+01 9.25E+01 1.85E+02 3.70E+02 9.25E+02 1.85E+03 3.70E+03 5.33E+03 
0.242 1 in 500 2.07E+06 2.07E+05 1.85E+00 3.70E+00 1.85E+01 4.63E+01 9.25E+01 1.85E+02 4.63E+02 9.25E+02 1.85E+03 2.67E+03 
0.121 1 in 1000 1.03E+06 1.03E+05 9.25E-01 1.85E+00 9.25E+00 2.31E+01 4.63E+01 9.25E+01 2.31E+02 4.63E+02 9.25E+02 1.33E+03 
0.0242 1 in 5000 2.07E+05 2.07E+04 1.85E-01 3.70E-01 1.85E+00 4.63E+00 9.25E+00 1.85E+01 4.63E+01 9.25E+01 1.85E+02 2.67E+02 
0.0121 1 in 10000 1.03E+05 1.03E+04 9.25E-02 1.85E-01 9.25E-01 2.31E+00 4.63E+00 9.25E+00 2.31E+01 4.63E+01 9.25E+01 1.33E+02 
0.00242 1 in 50000 2.07E+04 2.07E+03 1.85E-02 3.70E-02 1.85E-01 4.63E-01 9.25E-01 1.85E+00 4.63E+00 9.25E+00 1.85E+01 2.67E+01 
0.00121 1 in 100000 1.03E+04 1.03E+03 9.25E-03 1.85E-02 9.25E-02 2.31E-01 4.63E-01 9.25E-01 2.31E+00 4.63E+00 9.25E+00 1.33E+01 
0.000242 1 in 500000 2.07E+03 2.07E+02 1.85E-03 3.70E-03 1.85E-02 4.63E-02 9.25E-02 1.85E-01 4.63E-01 9.25E-01 1.85E+00 2.67E+00 





Table A.6: 60Co ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 2.35E+09 2.35E+08 2.11E+03 4.22E+03 2.11E+04 5.27E+04 1.05E+05 2.11E+05 5.27E+05 1.05E+06 2.11E+06 3.04E+06 
77.5 1 in 2 1.18E+09 1.18E+08 1.05E+03 2.11E+03 1.05E+04 2.63E+04 5.27E+04 1.05E+05 2.63E+05 5.27E+05 1.05E+06 1.52E+06 
38.75 1 in 4 5.88E+08 5.88E+07 5.27E+02 1.05E+03 5.27E+03 1.32E+04 2.63E+04 5.27E+04 1.32E+05 2.63E+05 5.27E+05 7.59E+05 
31 1 in 5 4.71E+08 4.71E+07 4.22E+02 8.43E+02 4.22E+03 1.05E+04 2.11E+04 4.22E+04 1.05E+05 2.11E+05 4.22E+05 6.07E+05 
15.5 1 in 10 2.35E+08 2.35E+07 2.11E+02 4.22E+02 2.11E+03 5.27E+03 1.05E+04 2.11E+04 5.27E+04 1.05E+05 2.11E+05 3.04E+05 
7.75 1 in 20 1.18E+08 1.18E+07 1.05E+02 2.11E+02 1.05E+03 2.63E+03 5.27E+03 1.05E+04 2.63E+04 5.27E+04 1.05E+05 1.52E+05 
3.1 1 in 50 4.71E+07 4.71E+06 4.22E+01 8.43E+01 4.22E+02 1.05E+03 2.11E+03 4.22E+03 1.05E+04 2.11E+04 4.22E+04 6.07E+04 
1.55 1 in 100 2.35E+07 2.35E+06 2.11E+01 4.22E+01 2.11E+02 5.27E+02 1.05E+03 2.11E+03 5.27E+03 1.05E+04 2.11E+04 3.04E+04 
0.62 1 in 250 9.41E+06 9.41E+05 8.43E+00 1.69E+01 8.43E+01 2.11E+02 4.22E+02 8.43E+02 2.11E+03 4.22E+03 8.43E+03 1.21E+04 
0.31 1 in 500 4.71E+06 4.71E+05 4.22E+00 8.43E+00 4.22E+01 1.05E+02 2.11E+02 4.22E+02 1.05E+03 2.11E+03 4.22E+03 6.07E+03 
0.155 1 in 1000 2.35E+06 2.35E+05 2.11E+00 4.22E+00 2.11E+01 5.27E+01 1.05E+02 2.11E+02 5.27E+02 1.05E+03 2.11E+03 3.04E+03 
0.031 1 in 5000 4.71E+05 4.71E+04 4.22E-01 8.43E-01 4.22E+00 1.05E+01 2.11E+01 4.22E+01 1.05E+02 2.11E+02 4.22E+02 6.07E+02 
0.0155 1 in 10000 2.35E+05 2.35E+04 2.11E-01 4.22E-01 2.11E+00 5.27E+00 1.05E+01 2.11E+01 5.27E+01 1.05E+02 2.11E+02 3.04E+02 
0.0031 1 in 50000 4.71E+04 4.71E+03 4.22E-02 8.43E-02 4.22E-01 1.05E+00 2.11E+00 4.22E+00 1.05E+01 2.11E+01 4.22E+01 6.07E+01 
0.00155 1 in 100000 2.35E+04 2.35E+03 2.11E-02 4.22E-02 2.11E-01 5.27E-01 1.05E+00 2.11E+00 5.27E+00 1.05E+01 2.11E+01 3.04E+01 
0.00031 1 in 500000 4.71E+03 4.71E+02 4.22E-03 8.43E-03 4.22E-02 1.05E-01 2.11E-01 4.22E-01 1.05E+00 2.11E+00 4.22E+00 6.07E+00 






Table A.7: 137Cs inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 3.12E+09 3.12E+09 1.38E+03 2.76E+03 1.38E+04 3.46E+04 6.91E+04 1.38E+05 3.46E+05 6.91E+05 1.38E+06 1.99E+06 
73.5 1 in 2 1.56E+09 1.56E+09 6.91E+02 1.38E+03 6.91E+03 1.73E+04 3.46E+04 6.91E+04 1.73E+05 3.46E+05 6.91E+05 9.95E+05 
36.75 1 in 4 7.79E+08 7.79E+08 3.46E+02 6.91E+02 3.46E+03 8.64E+03 1.73E+04 3.46E+04 8.64E+04 1.73E+05 3.46E+05 4.98E+05 
29.4 1 in 5 6.23E+08 6.23E+08 2.76E+02 5.53E+02 2.76E+03 6.91E+03 1.38E+04 2.76E+04 6.91E+04 1.38E+05 2.76E+05 3.98E+05 
14.7 1 in 10 3.12E+08 3.12E+08 1.38E+02 2.76E+02 1.38E+03 3.46E+03 6.91E+03 1.38E+04 3.46E+04 6.91E+04 1.38E+05 1.99E+05 
7.35 1 in 20 1.56E+08 1.56E+08 6.91E+01 1.38E+02 6.91E+02 1.73E+03 3.46E+03 6.91E+03 1.73E+04 3.46E+04 6.91E+04 9.95E+04 
2.94 1 in 50 6.23E+07 6.23E+07 2.76E+01 5.53E+01 2.76E+02 6.91E+02 1.38E+03 2.76E+03 6.91E+03 1.38E+04 2.76E+04 3.98E+04 
1.47 1 in 100 3.12E+07 3.12E+07 1.38E+01 2.76E+01 1.38E+02 3.46E+02 6.91E+02 1.38E+03 3.46E+03 6.91E+03 1.38E+04 1.99E+04 
0.588 1 in 250 1.25E+07 1.25E+07 5.53E+00 1.11E+01 5.53E+01 1.38E+02 2.76E+02 5.53E+02 1.38E+03 2.76E+03 5.53E+03 7.96E+03 
0.294 1 in 500 6.23E+06 6.23E+06 2.76E+00 5.53E+00 2.76E+01 6.91E+01 1.38E+02 2.76E+02 6.91E+02 1.38E+03 2.76E+03 3.98E+03 
0.147 1 in 1000 3.12E+06 3.12E+06 1.38E+00 2.76E+00 1.38E+01 3.46E+01 6.91E+01 1.38E+02 3.46E+02 6.91E+02 1.38E+03 1.99E+03 
0.0294 1 in 5000 6.23E+05 6.23E+05 2.76E-01 5.53E-01 2.76E+00 6.91E+00 1.38E+01 2.76E+01 6.91E+01 1.38E+02 2.76E+02 3.98E+02 
0.0147 1 in 10000 3.12E+05 3.12E+05 1.38E-01 2.76E-01 1.38E+00 3.46E+00 6.91E+00 1.38E+01 3.46E+01 6.91E+01 1.38E+02 1.99E+02 
0.00294 1 in 50000 6.23E+04 6.23E+04 2.76E-02 5.53E-02 2.76E-01 6.91E-01 1.38E+00 2.76E+00 6.91E+00 1.38E+01 2.76E+01 3.98E+01 
0.00147 1 in 100000 3.12E+04 3.12E+04 1.38E-02 2.76E-02 1.38E-01 3.46E-01 6.91E-01 1.38E+00 3.46E+00 6.91E+00 1.38E+01 1.99E+01 
0.000294 1 in 500000 6.23E+03 6.23E+03 2.76E-03 5.53E-03 2.76E-02 6.91E-02 1.38E-01 2.76E-01 6.91E-01 1.38E+00 2.76E+00 3.98E+00 






Table A.8: 137Cs ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 1.22E+09 1.22E+09 1.33E+04 2.67E+04 1.33E+05 3.34E+05 6.67E+05 1.33E+06 3.34E+06 6.67E+06 1.33E+07 1.92E+07 
72.5 1 in 2 6.08E+08 6.08E+08 6.67E+03 1.33E+04 6.67E+04 1.67E+05 3.34E+05 6.67E+05 1.67E+06 3.34E+06 6.67E+06 9.61E+06 
36.25 1 in 4 3.04E+08 3.04E+08 3.34E+03 6.67E+03 3.34E+04 8.34E+04 1.67E+05 3.34E+05 8.34E+05 1.67E+06 3.34E+06 4.81E+06 
29 1 in 5 2.43E+08 2.43E+08 2.67E+03 5.34E+03 2.67E+04 6.67E+04 1.33E+05 2.67E+05 6.67E+05 1.33E+06 2.67E+06 3.84E+06 
14.5 1 in 10 1.22E+08 1.22E+08 1.33E+03 2.67E+03 1.33E+04 3.34E+04 6.67E+04 1.33E+05 3.34E+05 6.67E+05 1.33E+06 1.92E+06 
7.25 1 in 20 6.08E+07 6.08E+07 6.67E+02 1.33E+03 6.67E+03 1.67E+04 3.34E+04 6.67E+04 1.67E+05 3.34E+05 6.67E+05 9.61E+05 
2.9 1 in 50 2.43E+07 2.43E+07 2.67E+02 5.34E+02 2.67E+03 6.67E+03 1.33E+04 2.67E+04 6.67E+04 1.33E+05 2.67E+05 3.84E+05 
1.45 1 in 100 1.22E+07 1.22E+07 1.33E+02 2.67E+02 1.33E+03 3.34E+03 6.67E+03 1.33E+04 3.34E+04 6.67E+04 1.33E+05 1.92E+05 
0.58 1 in 250 4.87E+06 4.87E+06 5.34E+01 1.07E+02 5.34E+02 1.33E+03 2.67E+03 5.34E+03 1.33E+04 2.67E+04 5.34E+04 7.69E+04 
0.29 1 in 500 2.43E+06 2.43E+06 2.67E+01 5.34E+01 2.67E+02 6.67E+02 1.33E+03 2.67E+03 6.67E+03 1.33E+04 2.67E+04 3.84E+04 
0.145 1 in 1000 1.22E+06 1.22E+06 1.33E+01 2.67E+01 1.33E+02 3.34E+02 6.67E+02 1.33E+03 3.34E+03 6.67E+03 1.33E+04 1.92E+04 
0.029 1 in 5000 2.43E+05 2.43E+05 2.67E+00 5.34E+00 2.67E+01 6.67E+01 1.33E+02 2.67E+02 6.67E+02 1.33E+03 2.67E+03 3.84E+03 
0.0145 1 in 10000 1.22E+05 1.22E+05 1.33E+00 2.67E+00 1.33E+01 3.34E+01 6.67E+01 1.33E+02 3.34E+02 6.67E+02 1.33E+03 1.92E+03 
0.0029 1 in 50000 2.43E+04 2.43E+04 2.67E-01 5.34E-01 2.67E+00 6.67E+00 1.33E+01 2.67E+01 6.67E+01 1.33E+02 2.67E+02 3.84E+02 
0.00145 1 in 100000 1.22E+04 1.22E+04 1.33E-01 2.67E-01 1.33E+00 3.34E+00 6.67E+00 1.33E+01 3.34E+01 6.67E+01 1.33E+02 1.92E+02 
0.00029 1 in 500000 2.43E+03 2.43E+03 2.67E-02 5.34E-02 2.67E-01 6.67E-01 1.33E+00 2.67E+00 6.67E+00 1.33E+01 2.67E+01 3.84E+01 






Table A.9: 233U inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 
TIMS (pink), ICP-MS (blue), alpha spectrometry (yellow).  For this isotopes the limits for ICP-MS and alpha 





























100 1 in 1 3.19E+06 6.39E+04 8.12E-01 1.62E+00 8.12E+00 2.03E+01 4.06E+01 8.12E+01 2.03E+02 4.06E+02 8.12E+02 1.17E+03 
53 1 in 2 1.60E+06 3.19E+04 4.06E-01 8.12E-01 4.06E+00 1.02E+01 2.03E+01 4.06E+01 1.02E+02 2.03E+02 4.06E+02 5.85E+02 
26.5 1 in 4 7.99E+05 1.60E+04 2.03E-01 4.06E-01 2.03E+00 5.08E+00 1.02E+01 2.03E+01 5.08E+01 1.02E+02 2.03E+02 2.92E+02 
21.2 1 in 5 6.39E+05 1.28E+04 1.62E-01 3.25E-01 1.62E+00 4.06E+00 8.12E+00 1.62E+01 4.06E+01 8.12E+01 1.62E+02 2.34E+02 
10.6 1 in 10 3.19E+05 6.39E+03 8.12E-02 1.62E-01 8.12E-01 2.03E+00 4.06E+00 8.12E+00 2.03E+01 4.06E+01 8.12E+01 1.17E+02 
5.3 1 in 20 1.60E+05 3.19E+03 4.06E-02 8.12E-02 4.06E-01 1.02E+00 2.03E+00 4.06E+00 1.02E+01 2.03E+01 4.06E+01 5.85E+01 
2.12 1 in 50 6.39E+04 1.28E+03 1.62E-02 3.25E-02 1.62E-01 4.06E-01 8.12E-01 1.62E+00 4.06E+00 8.12E+00 1.62E+01 2.34E+01 
1.06 1 in 100 3.19E+04 6.39E+02 8.12E-03 1.62E-02 8.12E-02 2.03E-01 4.06E-01 8.12E-01 2.03E+00 4.06E+00 8.12E+00 1.17E+01 
0.424 1 in 250 1.28E+04 2.56E+02 3.25E-03 6.50E-03 3.25E-02 8.12E-02 1.62E-01 3.25E-01 8.12E-01 1.62E+00 3.25E+00 4.68E+00 
0.212 1 in 500 6.39E+03 1.28E+02 1.62E-03 3.25E-03 1.62E-02 4.06E-02 8.12E-02 1.62E-01 4.06E-01 8.12E-01 1.62E+00 2.34E+00 
0.106 1 in 1000 3.19E+03 6.39E+01 8.12E-04 1.62E-03 8.12E-03 2.03E-02 4.06E-02 8.12E-02 2.03E-01 4.06E-01 8.12E-01 1.17E+00 
0.0212 1 in 5000 6.39E+02 1.28E+01 1.62E-04 3.25E-04 1.62E-03 4.06E-03 8.12E-03 1.62E-02 4.06E-02 8.12E-02 1.62E-01 2.34E-01 
0.0106 1 in 10000 3.19E+02 6.39E+00 8.12E-05 1.62E-04 8.12E-04 2.03E-03 4.06E-03 8.12E-03 2.03E-02 4.06E-02 8.12E-02 1.17E-01 
0.00212 1 in 50000 6.39E+01 1.28E+00 1.62E-05 3.25E-05 1.62E-04 4.06E-04 8.12E-04 1.62E-03 4.06E-03 8.12E-03 1.62E-02 2.34E-02 
0.00106 1 in 100000 3.19E+01 6.39E-01 8.12E-06 1.62E-05 8.12E-05 2.03E-04 4.06E-04 8.12E-04 2.03E-03 4.06E-03 8.12E-03 1.17E-02 
0.000212 1 in 500000 6.39E+00 1.28E-01 1.62E-06 3.25E-06 1.62E-05 4.06E-05 8.12E-05 1.62E-04 4.06E-04 8.12E-04 1.62E-03 2.34E-03 





Table A.10: 233U ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 5.15E+08 1.03E+07 9.02E+01 1.80E+02 9.02E+02 2.26E+03 4.51E+03 9.02E+03 2.26E+04 4.51E+04 9.02E+04 1.30E+05 
77 1 in 2 2.58E+08 5.15E+06 4.51E+01 9.02E+01 4.51E+02 1.13E+03 2.26E+03 4.51E+03 1.13E+04 2.26E+04 4.51E+04 6.49E+04 
38.5 1 in 4 1.29E+08 2.58E+06 2.26E+01 4.51E+01 2.26E+02 5.64E+02 1.13E+03 2.26E+03 5.64E+03 1.13E+04 2.26E+04 3.25E+04 
30.8 1 in 5 1.03E+08 2.06E+06 1.80E+01 3.61E+01 1.80E+02 4.51E+02 9.02E+02 1.80E+03 4.51E+03 9.02E+03 1.80E+04 2.60E+04 
15.4 1 in 10 5.15E+07 1.03E+06 9.02E+00 1.80E+01 9.02E+01 2.26E+02 4.51E+02 9.02E+02 2.26E+03 4.51E+03 9.02E+03 1.30E+04 
7.7 1 in 20 2.58E+07 5.15E+05 4.51E+00 9.02E+00 4.51E+01 1.13E+02 2.26E+02 4.51E+02 1.13E+03 2.26E+03 4.51E+03 6.49E+03 
3.08 1 in 50 1.03E+07 2.06E+05 1.80E+00 3.61E+00 1.80E+01 4.51E+01 9.02E+01 1.80E+02 4.51E+02 9.02E+02 1.80E+03 2.60E+03 
1.54 1 in 100 5.15E+06 1.03E+05 9.02E-01 1.80E+00 9.02E+00 2.26E+01 4.51E+01 9.02E+01 2.26E+02 4.51E+02 9.02E+02 1.30E+03 
0.616 1 in 250 2.06E+06 4.12E+04 3.61E-01 7.22E-01 3.61E+00 9.02E+00 1.80E+01 3.61E+01 9.02E+01 1.80E+02 3.61E+02 5.20E+02 
0.308 1 in 500 1.03E+06 2.06E+04 1.80E-01 3.61E-01 1.80E+00 4.51E+00 9.02E+00 1.80E+01 4.51E+01 9.02E+01 1.80E+02 2.60E+02 
0.154 1 in 1000 5.15E+05 1.03E+04 9.02E-02 1.80E-01 9.02E-01 2.26E+00 4.51E+00 9.02E+00 2.26E+01 4.51E+01 9.02E+01 1.30E+02 
0.0308 1 in 5000 1.03E+05 2.06E+03 1.80E-02 3.61E-02 1.80E-01 4.51E-01 9.02E-01 1.80E+00 4.51E+00 9.02E+00 1.80E+01 2.60E+01 
0.0154 1 in 10000 5.15E+04 1.03E+03 9.02E-03 1.80E-02 9.02E-02 2.26E-01 4.51E-01 9.02E-01 2.26E+00 4.51E+00 9.02E+00 1.30E+01 
0.00308 1 in 50000 1.03E+04 2.06E+02 1.80E-03 3.61E-03 1.80E-02 4.51E-02 9.02E-02 1.80E-01 4.51E-01 9.02E-01 1.80E+00 2.60E+00 
0.00154 1 in 100000 5.15E+03 1.03E+02 9.02E-04 1.80E-03 9.02E-03 2.26E-02 4.51E-02 9.02E-02 2.26E-01 4.51E-01 9.02E-01 1.30E+00 
0.000308 1 in 500000 1.03E+03 2.06E+01 1.80E-04 3.61E-04 1.80E-03 4.51E-03 9.02E-03 1.80E-02 4.51E-02 9.02E-02 1.80E-01 2.60E-01 






Table A.11: 235U inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 3.66E+06 7.33E+04 9.31E-01 1.86E+00 9.31E+00 2.33E+01 4.66E+01 9.31E+01 2.33E+02 4.66E+02 9.31E+02 1.34E+03 
53 1 in 2 1.83E+06 3.66E+04 4.66E-01 9.31E-01 4.66E+00 1.16E+01 2.33E+01 4.66E+01 1.16E+02 2.33E+02 4.66E+02 6.70E+02 
26.5 1 in 4 9.16E+05 1.83E+04 2.33E-01 4.66E-01 2.33E+00 5.82E+00 1.16E+01 2.33E+01 5.82E+01 1.16E+02 2.33E+02 3.35E+02 
21.2 1 in 5 7.33E+05 1.47E+04 1.86E-01 3.72E-01 1.86E+00 4.66E+00 9.31E+00 1.86E+01 4.66E+01 9.31E+01 1.86E+02 2.68E+02 
10.6 1 in 10 3.66E+05 7.33E+03 9.31E-02 1.86E-01 9.31E-01 2.33E+00 4.66E+00 9.31E+00 2.33E+01 4.66E+01 9.31E+01 1.34E+02 
5.3 1 in 20 1.83E+05 3.66E+03 4.66E-02 9.31E-02 4.66E-01 1.16E+00 2.33E+00 4.66E+00 1.16E+01 2.33E+01 4.66E+01 6.70E+01 
2.12 1 in 50 7.33E+04 1.47E+03 1.86E-02 3.72E-02 1.86E-01 4.66E-01 9.31E-01 1.86E+00 4.66E+00 9.31E+00 1.86E+01 2.68E+01 
1.06 1 in 100 3.66E+04 7.33E+02 9.31E-03 1.86E-02 9.31E-02 2.33E-01 4.66E-01 9.31E-01 2.33E+00 4.66E+00 9.31E+00 1.34E+01 
0.424 1 in 250 1.47E+04 2.93E+02 3.72E-03 7.45E-03 3.72E-02 9.31E-02 1.86E-01 3.72E-01 9.31E-01 1.86E+00 3.72E+00 5.36E+00 
0.212 1 in 500 7.33E+03 1.47E+02 1.86E-03 3.72E-03 1.86E-02 4.66E-02 9.31E-02 1.86E-01 4.66E-01 9.31E-01 1.86E+00 2.68E+00 
0.106 1 in 1000 3.66E+03 7.33E+01 9.31E-04 1.86E-03 9.31E-03 2.33E-02 4.66E-02 9.31E-02 2.33E-01 4.66E-01 9.31E-01 1.34E+00 
0.0212 1 in 5000 7.33E+02 1.47E+01 1.86E-04 3.72E-04 1.86E-03 4.66E-03 9.31E-03 1.86E-02 4.66E-02 9.31E-02 1.86E-01 2.68E-01 
0.0106 1 in 10000 3.66E+02 7.33E+00 9.31E-05 1.86E-04 9.31E-04 2.33E-03 4.66E-03 9.31E-03 2.33E-02 4.66E-02 9.31E-02 1.34E-01 
0.00212 1 in 50000 7.33E+01 1.47E+00 1.86E-05 3.72E-05 1.86E-04 4.66E-04 9.31E-04 1.86E-03 4.66E-03 9.31E-03 1.86E-02 2.68E-02 
0.00106 1 in 100000 3.66E+01 7.33E-01 9.31E-06 1.86E-05 9.31E-05 2.33E-04 4.66E-04 9.31E-04 2.33E-03 4.66E-03 9.31E-03 1.34E-02 
0.000212 1 in 500000 7.33E+00 1.47E-01 1.86E-06 3.72E-06 1.86E-05 4.66E-05 9.31E-05 1.86E-04 4.66E-04 9.31E-04 1.86E-03 2.68E-03 






Table A.12: 235U ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 5.24E+08 1.05E+07 9.16E+01 1.83E+02 9.16E+02 2.29E+03 4.58E+03 9.16E+03 2.29E+04 4.58E+04 9.16E+04 1.32E+05 
77 1 in 2 2.62E+08 5.24E+06 4.58E+01 9.16E+01 4.58E+02 1.15E+03 2.29E+03 4.58E+03 1.15E+04 2.29E+04 4.58E+04 6.60E+04 
38.5 1 in 4 1.31E+08 2.62E+06 2.29E+01 4.58E+01 2.29E+02 5.73E+02 1.15E+03 2.29E+03 5.73E+03 1.15E+04 2.29E+04 3.30E+04 
30.8 1 in 5 1.05E+08 2.09E+06 1.83E+01 3.66E+01 1.83E+02 4.58E+02 9.16E+02 1.83E+03 4.58E+03 9.16E+03 1.83E+04 2.64E+04 
15.4 1 in 10 5.24E+07 1.05E+06 9.16E+00 1.83E+01 9.16E+01 2.29E+02 4.58E+02 9.16E+02 2.29E+03 4.58E+03 9.16E+03 1.32E+04 
7.7 1 in 20 2.62E+07 5.24E+05 4.58E+00 9.16E+00 4.58E+01 1.15E+02 2.29E+02 4.58E+02 1.15E+03 2.29E+03 4.58E+03 6.60E+03 
3.08 1 in 50 1.05E+07 2.09E+05 1.83E+00 3.66E+00 1.83E+01 4.58E+01 9.16E+01 1.83E+02 4.58E+02 9.16E+02 1.83E+03 2.64E+03 
1.54 1 in 100 5.24E+06 1.05E+05 9.16E-01 1.83E+00 9.16E+00 2.29E+01 4.58E+01 9.16E+01 2.29E+02 4.58E+02 9.16E+02 1.32E+03 
0.616 1 in 250 2.09E+06 4.19E+04 3.66E-01 7.33E-01 3.66E+00 9.16E+00 1.83E+01 3.66E+01 9.16E+01 1.83E+02 3.66E+02 5.28E+02 
0.308 1 in 500 1.05E+06 2.09E+04 1.83E-01 3.66E-01 1.83E+00 4.58E+00 9.16E+00 1.83E+01 4.58E+01 9.16E+01 1.83E+02 2.64E+02 
0.154 1 in 1000 5.24E+05 1.05E+04 9.16E-02 1.83E-01 9.16E-01 2.29E+00 4.58E+00 9.16E+00 2.29E+01 4.58E+01 9.16E+01 1.32E+02 
0.0308 1 in 5000 1.05E+05 2.09E+03 1.83E-02 3.66E-02 1.83E-01 4.58E-01 9.16E-01 1.83E+00 4.58E+00 9.16E+00 1.83E+01 2.64E+01 
0.0154 1 in 10000 5.24E+04 1.05E+03 9.16E-03 1.83E-02 9.16E-02 2.29E-01 4.58E-01 9.16E-01 2.29E+00 4.58E+00 9.16E+00 1.32E+01 
0.00308 1 in 50000 1.05E+04 2.09E+02 1.83E-03 3.66E-03 1.83E-02 4.58E-02 9.16E-02 1.83E-01 4.58E-01 9.16E-01 1.83E+00 2.64E+00 
0.00154 1 in 100000 5.24E+03 1.05E+02 9.16E-04 1.83E-03 9.16E-03 2.29E-02 4.58E-02 9.16E-02 2.29E-01 4.58E-01 9.16E-01 1.32E+00 
0.000308 1 in 500000 1.05E+03 2.09E+01 1.83E-04 3.66E-04 1.83E-03 4.58E-03 9.16E-03 1.83E-02 4.58E-02 9.16E-02 1.83E-01 2.64E-01 






Table A.13: 238U inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 3.97E+06 7.94E+04 1.01E+00 2.02E+00 1.01E+01 2.52E+01 5.04E+01 1.01E+02 2.52E+02 5.04E+02 1.01E+03 1.45E+03 
53 1 in 2 1.98E+06 3.97E+04 5.04E-01 1.01E+00 5.04E+00 1.26E+01 2.52E+01 5.04E+01 1.26E+02 2.52E+02 5.04E+02 7.26E+02 
26.5 1 in 4 9.92E+05 1.98E+04 2.52E-01 5.04E-01 2.52E+00 6.30E+00 1.26E+01 2.52E+01 6.30E+01 1.26E+02 2.52E+02 3.63E+02 
21.2 1 in 5 7.94E+05 1.59E+04 2.02E-01 4.03E-01 2.02E+00 5.04E+00 1.01E+01 2.02E+01 5.04E+01 1.01E+02 2.02E+02 2.90E+02 
10.6 1 in 10 3.97E+05 7.94E+03 1.01E-01 2.02E-01 1.01E+00 2.52E+00 5.04E+00 1.01E+01 2.52E+01 5.04E+01 1.01E+02 1.45E+02 
5.3 1 in 20 1.98E+05 3.97E+03 5.04E-02 1.01E-01 5.04E-01 1.26E+00 2.52E+00 5.04E+00 1.26E+01 2.52E+01 5.04E+01 7.26E+01 
2.12 1 in 50 7.94E+04 1.59E+03 2.02E-02 4.03E-02 2.02E-01 5.04E-01 1.01E+00 2.02E+00 5.04E+00 1.01E+01 2.02E+01 2.90E+01 
1.06 1 in 100 3.97E+04 7.94E+02 1.01E-02 2.02E-02 1.01E-01 2.52E-01 5.04E-01 1.01E+00 2.52E+00 5.04E+00 1.01E+01 1.45E+01 
0.424 1 in 250 1.59E+04 3.17E+02 4.03E-03 8.07E-03 4.03E-02 1.01E-01 2.02E-01 4.03E-01 1.01E+00 2.02E+00 4.03E+00 5.81E+00 
0.212 1 in 500 7.94E+03 1.59E+02 2.02E-03 4.03E-03 2.02E-02 5.04E-02 1.01E-01 2.02E-01 5.04E-01 1.01E+00 2.02E+00 2.90E+00 
0.106 1 in 1000 3.97E+03 7.94E+01 1.01E-03 2.02E-03 1.01E-02 2.52E-02 5.04E-02 1.01E-01 2.52E-01 5.04E-01 1.01E+00 1.45E+00 
0.0212 1 in 5000 7.94E+02 1.59E+01 2.02E-04 4.03E-04 2.02E-03 5.04E-03 1.01E-02 2.02E-02 5.04E-02 1.01E-01 2.02E-01 2.90E-01 
0.0106 1 in 10000 3.97E+02 7.94E+00 1.01E-04 2.02E-04 1.01E-03 2.52E-03 5.04E-03 1.01E-02 2.52E-02 5.04E-02 1.01E-01 1.45E-01 
0.00212 1 in 50000 7.94E+01 1.59E+00 2.02E-05 4.03E-05 2.02E-04 5.04E-04 1.01E-03 2.02E-03 5.04E-03 1.01E-02 2.02E-02 2.90E-02 
0.00106 1 in 100000 3.97E+01 7.94E-01 1.01E-05 2.02E-05 1.01E-04 2.52E-04 5.04E-04 1.01E-03 2.52E-03 5.04E-03 1.01E-02 1.45E-02 
0.000212 1 in 500000 7.94E+00 1.59E-01 2.02E-06 4.03E-06 2.02E-05 5.04E-05 1.01E-04 2.02E-04 5.04E-04 1.01E-03 2.02E-03 2.90E-03 






Table A.14: 238U ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 5.78E+08 1.16E+07 1.01E+02 2.02E+02 1.01E+03 2.53E+03 5.06E+03 1.01E+04 2.53E+04 5.06E+04 1.01E+05 1.46E+05 
76.5 1 in 2 2.89E+08 5.78E+06 5.06E+01 1.01E+02 5.06E+02 1.26E+03 2.53E+03 5.06E+03 1.26E+04 2.53E+04 5.06E+04 7.28E+04 
38.25 1 in 4 1.45E+08 2.89E+06 2.53E+01 5.06E+01 2.53E+02 6.32E+02 1.26E+03 2.53E+03 6.32E+03 1.26E+04 2.53E+04 3.64E+04 
30.6 1 in 5 1.16E+08 2.31E+06 2.02E+01 4.05E+01 2.02E+02 5.06E+02 1.01E+03 2.02E+03 5.06E+03 1.01E+04 2.02E+04 2.91E+04 
15.3 1 in 10 5.78E+07 1.16E+06 1.01E+01 2.02E+01 1.01E+02 2.53E+02 5.06E+02 1.01E+03 2.53E+03 5.06E+03 1.01E+04 1.46E+04 
7.65 1 in 20 2.89E+07 5.78E+05 5.06E+00 1.01E+01 5.06E+01 1.26E+02 2.53E+02 5.06E+02 1.26E+03 2.53E+03 5.06E+03 7.28E+03 
3.06 1 in 50 1.16E+07 2.31E+05 2.02E+00 4.05E+00 2.02E+01 5.06E+01 1.01E+02 2.02E+02 5.06E+02 1.01E+03 2.02E+03 2.91E+03 
1.53 1 in 100 5.78E+06 1.16E+05 1.01E+00 2.02E+00 1.01E+01 2.53E+01 5.06E+01 1.01E+02 2.53E+02 5.06E+02 1.01E+03 1.46E+03 
0.612 1 in 250 2.31E+06 4.62E+04 4.05E-01 8.09E-01 4.05E+00 1.01E+01 2.02E+01 4.05E+01 1.01E+02 2.02E+02 4.05E+02 5.83E+02 
0.306 1 in 500 1.16E+06 2.31E+04 2.02E-01 4.05E-01 2.02E+00 5.06E+00 1.01E+01 2.02E+01 5.06E+01 1.01E+02 2.02E+02 2.91E+02 
0.153 1 in 1000 5.78E+05 1.16E+04 1.01E-01 2.02E-01 1.01E+00 2.53E+00 5.06E+00 1.01E+01 2.53E+01 5.06E+01 1.01E+02 1.46E+02 
0.0306 1 in 5000 1.16E+05 2.31E+03 2.02E-02 4.05E-02 2.02E-01 5.06E-01 1.01E+00 2.02E+00 5.06E+00 1.01E+01 2.02E+01 2.91E+01 
0.0153 1 in 10000 5.78E+04 1.16E+03 1.01E-02 2.02E-02 1.01E-01 2.53E-01 5.06E-01 1.01E+00 2.53E+00 5.06E+00 1.01E+01 1.46E+01 
0.00306 1 in 50000 1.16E+04 2.31E+02 2.02E-03 4.05E-03 2.02E-02 5.06E-02 1.01E-01 2.02E-01 5.06E-01 1.01E+00 2.02E+00 2.91E+00 
0.00153 1 in 100000 5.78E+03 1.16E+02 1.01E-03 2.02E-03 1.01E-02 2.53E-02 5.06E-02 1.01E-01 2.53E-01 5.06E-01 1.01E+00 1.46E+00 
0.000306 1 in 500000 1.16E+03 2.31E+01 2.02E-04 4.05E-04 2.02E-03 5.06E-03 1.01E-02 2.02E-02 5.06E-02 1.01E-01 2.02E-01 2.91E-01 






Table A.15: 237Np inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 2.09E+06 1.04E+03 3.89E-03 7.79E-03 3.89E-02 9.73E-02 1.95E-01 3.89E-01 9.73E-01 1.95E+00 3.89E+00 5.61E+00 
57.5 1 in 2 1.04E+06 5.22E+02 1.95E-03 3.89E-03 1.95E-02 4.87E-02 9.73E-02 1.95E-01 4.87E-01 9.73E-01 1.95E+00 2.80E+00 
28.75 1 in 4 5.22E+05 2.61E+02 9.73E-04 1.95E-03 9.73E-03 2.43E-02 4.87E-02 9.73E-02 2.43E-01 4.87E-01 9.73E-01 1.40E+00 
23 1 in 5 4.18E+05 2.09E+02 7.79E-04 1.56E-03 7.79E-03 1.95E-02 3.89E-02 7.79E-02 1.95E-01 3.89E-01 7.79E-01 1.12E+00 
11.5 1 in 10 2.09E+05 1.04E+02 3.89E-04 7.79E-04 3.89E-03 9.73E-03 1.95E-02 3.89E-02 9.73E-02 1.95E-01 3.89E-01 5.61E-01 
5.75 1 in 20 1.04E+05 5.22E+01 1.95E-04 3.89E-04 1.95E-03 4.87E-03 9.73E-03 1.95E-02 4.87E-02 9.73E-02 1.95E-01 2.80E-01 
2.3 1 in 50 4.18E+04 2.09E+01 7.79E-05 1.56E-04 7.79E-04 1.95E-03 3.89E-03 7.79E-03 1.95E-02 3.89E-02 7.79E-02 1.12E-01 
1.15 1 in 100 2.09E+04 1.04E+01 3.89E-05 7.79E-05 3.89E-04 9.73E-04 1.95E-03 3.89E-03 9.73E-03 1.95E-02 3.89E-02 5.61E-02 
0.46 1 in 250 8.35E+03 4.18E+00 1.56E-05 3.11E-05 1.56E-04 3.89E-04 7.79E-04 1.56E-03 3.89E-03 7.79E-03 1.56E-02 2.24E-02 
0.23 1 in 500 4.18E+03 2.09E+00 7.79E-06 1.56E-05 7.79E-05 1.95E-04 3.89E-04 7.79E-04 1.95E-03 3.89E-03 7.79E-03 1.12E-02 
0.115 1 in 1000 2.09E+03 1.04E+00 3.89E-06 7.79E-06 3.89E-05 9.73E-05 1.95E-04 3.89E-04 9.73E-04 1.95E-03 3.89E-03 5.61E-03 
0.023 1 in 5000 4.18E+02 2.09E-01 7.79E-07 1.56E-06 7.79E-06 1.95E-05 3.89E-05 7.79E-05 1.95E-04 3.89E-04 7.79E-04 1.12E-03 
0.0115 1 in 10000 2.09E+02 1.04E-01 3.89E-07 7.79E-07 3.89E-06 9.73E-06 1.95E-05 3.89E-05 9.73E-05 1.95E-04 3.89E-04 5.61E-04 
0.0023 1 in 50000 4.18E+01 2.09E-02 7.79E-08 1.56E-07 7.79E-07 1.95E-06 3.89E-06 7.79E-06 1.95E-05 3.89E-05 7.79E-05 1.12E-04 
0.00115 1 in 100000 2.09E+01 1.04E-02 3.89E-08 7.79E-08 3.89E-07 9.73E-07 1.95E-06 3.89E-06 9.73E-06 1.95E-05 3.89E-05 5.61E-05 
0.00023 1 in 500000 4.18E+00 2.09E-03 7.79E-09 1.56E-08 7.79E-08 1.95E-07 3.89E-07 7.79E-07 1.95E-06 3.89E-06 7.79E-06 1.12E-05 






Table A.16: 237Np ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 2.09E+06 1.04E+03 7.08E-05 1.42E-04 7.08E-04 1.77E-03 3.54E-03 7.08E-03 1.77E-02 3.54E-02 7.08E-02 1.02E-01 
76 1 in 2 1.04E+06 5.22E+02 3.54E-05 7.08E-05 3.54E-04 8.85E-04 1.77E-03 3.54E-03 8.85E-03 1.77E-02 3.54E-02 5.10E-02 
38 1 in 4 5.22E+05 2.61E+02 1.77E-05 3.54E-05 1.77E-04 4.43E-04 8.85E-04 1.77E-03 4.43E-03 8.85E-03 1.77E-02 2.55E-02 
30.4 1 in 5 4.18E+05 2.09E+02 1.42E-05 2.83E-05 1.42E-04 3.54E-04 7.08E-04 1.42E-03 3.54E-03 7.08E-03 1.42E-02 2.04E-02 
15.2 1 in 10 2.09E+05 1.04E+02 7.08E-06 1.42E-05 7.08E-05 1.77E-04 3.54E-04 7.08E-04 1.77E-03 3.54E-03 7.08E-03 1.02E-02 
7.6 1 in 20 1.04E+05 5.22E+01 3.54E-06 7.08E-06 3.54E-05 8.85E-05 1.77E-04 3.54E-04 8.85E-04 1.77E-03 3.54E-03 5.10E-03 
3.04 1 in 50 4.18E+04 2.09E+01 1.42E-06 2.83E-06 1.42E-05 3.54E-05 7.08E-05 1.42E-04 3.54E-04 7.08E-04 1.42E-03 2.04E-03 
1.52 1 in 100 2.09E+04 1.04E+01 7.08E-07 1.42E-06 7.08E-06 1.77E-05 3.54E-05 7.08E-05 1.77E-04 3.54E-04 7.08E-04 1.02E-03 
0.608 1 in 250 8.35E+03 4.18E+00 2.83E-07 5.67E-07 2.83E-06 7.08E-06 1.42E-05 2.83E-05 7.08E-05 1.42E-04 2.83E-04 4.08E-04 
0.304 1 in 500 4.18E+03 2.09E+00 1.42E-07 2.83E-07 1.42E-06 3.54E-06 7.08E-06 1.42E-05 3.54E-05 7.08E-05 1.42E-04 2.04E-04 
0.152 1 in 1000 2.09E+03 1.04E+00 7.08E-08 1.42E-07 7.08E-07 1.77E-06 3.54E-06 7.08E-06 1.77E-05 3.54E-05 7.08E-05 1.02E-04 
0.0304 1 in 5000 4.18E+02 2.09E-01 1.42E-08 2.83E-08 1.42E-07 3.54E-07 7.08E-07 1.42E-06 3.54E-06 7.08E-06 1.42E-05 2.04E-05 
0.0152 1 in 10000 2.09E+02 1.04E-01 7.08E-09 1.42E-08 7.08E-08 1.77E-07 3.54E-07 7.08E-07 1.77E-06 3.54E-06 7.08E-06 1.02E-05 
0.00304 1 in 50000 4.18E+01 2.09E-02 1.42E-09 2.83E-09 1.42E-08 3.54E-08 7.08E-08 1.42E-07 3.54E-07 7.08E-07 1.42E-06 2.04E-06 
0.00152 1 in 100000 2.09E+01 1.04E-02 7.08E-10 1.42E-09 7.08E-09 1.77E-08 3.54E-08 7.08E-08 1.77E-07 3.54E-07 7.08E-07 1.02E-06 
0.000304 1 in 500000 4.18E+00 2.09E-03 1.42E-10 2.83E-10 1.42E-09 3.54E-09 7.08E-09 1.42E-08 3.54E-08 7.08E-08 1.42E-07 2.04E-07 





Table A.17: 238Pu inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 1.10E+06 5.51E+02 7.62E-05 1.52E-04 7.62E-04 1.90E-03 3.81E-03 7.62E-03 1.90E-02 3.81E-02 7.62E-02 1.10E-01 
56.5 1 in 2 5.51E+05 2.76E+02 3.81E-05 7.62E-05 3.81E-04 9.52E-04 1.90E-03 3.81E-03 9.52E-03 1.90E-02 3.81E-02 5.49E-02 
28.25 1 in 4 2.76E+05 1.38E+02 1.90E-05 3.81E-05 1.90E-04 4.76E-04 9.52E-04 1.90E-03 4.76E-03 9.52E-03 1.90E-02 2.74E-02 
22.6 1 in 5 2.21E+05 1.10E+02 1.52E-05 3.05E-05 1.52E-04 3.81E-04 7.62E-04 1.52E-03 3.81E-03 7.62E-03 1.52E-02 2.19E-02 
11.3 1 in 10 1.10E+05 5.51E+01 7.62E-06 1.52E-05 7.62E-05 1.90E-04 3.81E-04 7.62E-04 1.90E-03 3.81E-03 7.62E-03 1.10E-02 
5.65 1 in 20 5.51E+04 2.76E+01 3.81E-06 7.62E-06 3.81E-05 9.52E-05 1.90E-04 3.81E-04 9.52E-04 1.90E-03 3.81E-03 5.49E-03 
2.26 1 in 50 2.21E+04 1.10E+01 1.52E-06 3.05E-06 1.52E-05 3.81E-05 7.62E-05 1.52E-04 3.81E-04 7.62E-04 1.52E-03 2.19E-03 
1.13 1 in 100 1.10E+04 5.51E+00 7.62E-07 1.52E-06 7.62E-06 1.90E-05 3.81E-05 7.62E-05 1.90E-04 3.81E-04 7.62E-04 1.10E-03 
0.452 1 in 250 4.41E+03 2.21E+00 3.05E-07 6.09E-07 3.05E-06 7.62E-06 1.52E-05 3.05E-05 7.62E-05 1.52E-04 3.05E-04 4.39E-04 
0.226 1 in 500 2.21E+03 1.10E+00 1.52E-07 3.05E-07 1.52E-06 3.81E-06 7.62E-06 1.52E-05 3.81E-05 7.62E-05 1.52E-04 2.19E-04 
0.113 1 in 1000 1.10E+03 5.51E-01 7.62E-08 1.52E-07 7.62E-07 1.90E-06 3.81E-06 7.62E-06 1.90E-05 3.81E-05 7.62E-05 1.10E-04 
0.0226 1 in 5000 2.21E+02 1.10E-01 1.52E-08 3.05E-08 1.52E-07 3.81E-07 7.62E-07 1.52E-06 3.81E-06 7.62E-06 1.52E-05 2.19E-05 
0.0113 1 in 10000 1.10E+02 5.51E-02 7.62E-09 1.52E-08 7.62E-08 1.90E-07 3.81E-07 7.62E-07 1.90E-06 3.81E-06 7.62E-06 1.10E-05 
0.00226 1 in 50000 2.21E+01 1.10E-02 1.52E-09 3.05E-09 1.52E-08 3.81E-08 7.62E-08 1.52E-07 3.81E-07 7.62E-07 1.52E-06 2.19E-06 
0.00113 1 in 100000 1.10E+01 5.51E-03 7.62E-10 1.52E-09 7.62E-09 1.90E-08 3.81E-08 7.62E-08 1.90E-07 3.81E-07 7.62E-07 1.10E-06 
0.000226 1 in 500000 2.21E+00 1.10E-03 1.52E-10 3.05E-10 1.52E-09 3.81E-09 7.62E-09 1.52E-08 3.81E-08 7.62E-08 1.52E-07 2.19E-07 






Table A.18: 238Pu ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 2.82E+08 1.41E+05 3.30E-04 6.59E-04 3.30E-03 8.24E-03 1.65E-02 3.30E-02 8.24E-02 1.65E-01 3.30E-01 4.75E-01 
64.5 1 in 2 1.41E+08 7.04E+04 1.65E-04 3.30E-04 1.65E-03 4.12E-03 8.24E-03 1.65E-02 4.12E-02 8.24E-02 1.65E-01 2.37E-01 
32.25 1 in 4 7.04E+07 3.52E+04 8.24E-05 1.65E-04 8.24E-04 2.06E-03 4.12E-03 8.24E-03 2.06E-02 4.12E-02 8.24E-02 1.19E-01 
25.8 1 in 5 5.63E+07 2.82E+04 6.59E-05 1.32E-04 6.59E-04 1.65E-03 3.30E-03 6.59E-03 1.65E-02 3.30E-02 6.59E-02 9.49E-02 
12.9 1 in 10 2.82E+07 1.41E+04 3.30E-05 6.59E-05 3.30E-04 8.24E-04 1.65E-03 3.30E-03 8.24E-03 1.65E-02 3.30E-02 4.75E-02 
6.45 1 in 20 1.41E+07 7.04E+03 1.65E-05 3.30E-05 1.65E-04 4.12E-04 8.24E-04 1.65E-03 4.12E-03 8.24E-03 1.65E-02 2.37E-02 
2.58 1 in 50 5.63E+06 2.82E+03 6.59E-06 1.32E-05 6.59E-05 1.65E-04 3.30E-04 6.59E-04 1.65E-03 3.30E-03 6.59E-03 9.49E-03 
1.29 1 in 100 2.82E+06 1.41E+03 3.30E-06 6.59E-06 3.30E-05 8.24E-05 1.65E-04 3.30E-04 8.24E-04 1.65E-03 3.30E-03 4.75E-03 
0.516 1 in 250 1.13E+06 5.63E+02 1.32E-06 2.64E-06 1.32E-05 3.30E-05 6.59E-05 1.32E-04 3.30E-04 6.59E-04 1.32E-03 1.90E-03 
0.258 1 in 500 5.63E+05 2.82E+02 6.59E-07 1.32E-06 6.59E-06 1.65E-05 3.30E-05 6.59E-05 1.65E-04 3.30E-04 6.59E-04 9.49E-04 
0.129 1 in 1000 2.82E+05 1.41E+02 3.30E-07 6.59E-07 3.30E-06 8.24E-06 1.65E-05 3.30E-05 8.24E-05 1.65E-04 3.30E-04 4.75E-04 
0.0258 1 in 5000 5.63E+04 2.82E+01 6.59E-08 1.32E-07 6.59E-07 1.65E-06 3.30E-06 6.59E-06 1.65E-05 3.30E-05 6.59E-05 9.49E-05 
0.0129 1 in 10000 2.82E+04 1.41E+01 3.30E-08 6.59E-08 3.30E-07 8.24E-07 1.65E-06 3.30E-06 8.24E-06 1.65E-05 3.30E-05 4.75E-05 
0.00258 1 in 50000 5.63E+03 2.82E+00 6.59E-09 1.32E-08 6.59E-08 1.65E-07 3.30E-07 6.59E-07 1.65E-06 3.30E-06 6.59E-06 9.49E-06 
0.00129 1 in 100000 2.82E+03 1.41E+00 3.30E-09 6.59E-09 3.30E-08 8.24E-08 1.65E-07 3.30E-07 8.24E-07 1.65E-06 3.30E-06 4.75E-06 
0.000258 1 in 500000 5.63E+02 2.82E-01 6.59E-10 1.32E-09 6.59E-09 1.65E-08 3.30E-08 6.59E-08 1.65E-07 3.30E-07 6.59E-07 9.49E-07 






Table A.19: 239Pu inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 1.11E+06 5.56E+02 7.69E-05 1.54E-04 7.69E-04 1.92E-03 3.84E-03 7.69E-03 1.92E-02 3.84E-02 7.69E-02 1.11E-01 
56.5 1 in 2 5.56E+05 2.78E+02 3.84E-05 7.69E-05 3.84E-04 9.61E-04 1.92E-03 3.84E-03 9.61E-03 1.92E-02 3.84E-02 5.53E-02 
28.25 1 in 4 2.78E+05 1.39E+02 1.92E-05 3.84E-05 1.92E-04 4.80E-04 9.61E-04 1.92E-03 4.80E-03 9.61E-03 1.92E-02 2.77E-02 
22.6 1 in 5 2.22E+05 1.11E+02 1.54E-05 3.07E-05 1.54E-04 3.84E-04 7.69E-04 1.54E-03 3.84E-03 7.69E-03 1.54E-02 2.21E-02 
11.3 1 in 10 1.11E+05 5.56E+01 7.69E-06 1.54E-05 7.69E-05 1.92E-04 3.84E-04 7.69E-04 1.92E-03 3.84E-03 7.69E-03 1.11E-02 
5.65 1 in 20 5.56E+04 2.78E+01 3.84E-06 7.69E-06 3.84E-05 9.61E-05 1.92E-04 3.84E-04 9.61E-04 1.92E-03 3.84E-03 5.53E-03 
2.26 1 in 50 2.22E+04 1.11E+01 1.54E-06 3.07E-06 1.54E-05 3.84E-05 7.69E-05 1.54E-04 3.84E-04 7.69E-04 1.54E-03 2.21E-03 
1.13 1 in 100 1.11E+04 5.56E+00 7.69E-07 1.54E-06 7.69E-06 1.92E-05 3.84E-05 7.69E-05 1.92E-04 3.84E-04 7.69E-04 1.11E-03 
0.452 1 in 250 4.45E+03 2.22E+00 3.07E-07 6.15E-07 3.07E-06 7.69E-06 1.54E-05 3.07E-05 7.69E-05 1.54E-04 3.07E-04 4.43E-04 
0.226 1 in 500 2.22E+03 1.11E+00 1.54E-07 3.07E-07 1.54E-06 3.84E-06 7.69E-06 1.54E-05 3.84E-05 7.69E-05 1.54E-04 2.21E-04 
0.113 1 in 1000 1.11E+03 5.56E-01 7.69E-08 1.54E-07 7.69E-07 1.92E-06 3.84E-06 7.69E-06 1.92E-05 3.84E-05 7.69E-05 1.11E-04 
0.0226 1 in 5000 2.22E+02 1.11E-01 1.54E-08 3.07E-08 1.54E-07 3.84E-07 7.69E-07 1.54E-06 3.84E-06 7.69E-06 1.54E-05 2.21E-05 
0.0113 1 in 10000 1.11E+02 5.56E-02 7.69E-09 1.54E-08 7.69E-08 1.92E-07 3.84E-07 7.69E-07 1.92E-06 3.84E-06 7.69E-06 1.11E-05 
0.00226 1 in 50000 2.22E+01 1.11E-02 1.54E-09 3.07E-09 1.54E-08 3.84E-08 7.69E-08 1.54E-07 3.84E-07 7.69E-07 1.54E-06 2.21E-06 
0.00113 1 in 100000 1.11E+01 5.56E-03 7.69E-10 1.54E-09 7.69E-09 1.92E-08 3.84E-08 7.69E-08 1.92E-07 3.84E-07 7.69E-07 1.11E-06 
0.000226 1 in 500000 2.22E+00 1.11E-03 1.54E-10 3.07E-10 1.54E-09 3.84E-09 7.69E-09 1.54E-08 3.84E-08 7.69E-08 1.54E-07 2.21E-07 





Table A.20: 239Pu ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 2.75E+08 1.37E+05 3.21E-04 6.43E-04 3.21E-03 8.04E-03 1.61E-02 3.21E-02 8.04E-02 1.61E-01 3.21E-01 4.63E-01 
64 1 in 2 1.37E+08 6.87E+04 1.61E-04 3.21E-04 1.61E-03 4.02E-03 8.04E-03 1.61E-02 4.02E-02 8.04E-02 1.61E-01 2.31E-01 
32 1 in 4 6.87E+07 3.43E+04 8.04E-05 1.61E-04 8.04E-04 2.01E-03 4.02E-03 8.04E-03 2.01E-02 4.02E-02 8.04E-02 1.16E-01 
25.6 1 in 5 5.49E+07 2.75E+04 6.43E-05 1.29E-04 6.43E-04 1.61E-03 3.21E-03 6.43E-03 1.61E-02 3.21E-02 6.43E-02 9.26E-02 
12.8 1 in 10 2.75E+07 1.37E+04 3.21E-05 6.43E-05 3.21E-04 8.04E-04 1.61E-03 3.21E-03 8.04E-03 1.61E-02 3.21E-02 4.63E-02 
6.4 1 in 20 1.37E+07 6.87E+03 1.61E-05 3.21E-05 1.61E-04 4.02E-04 8.04E-04 1.61E-03 4.02E-03 8.04E-03 1.61E-02 2.31E-02 
2.56 1 in 50 5.49E+06 2.75E+03 6.43E-06 1.29E-05 6.43E-05 1.61E-04 3.21E-04 6.43E-04 1.61E-03 3.21E-03 6.43E-03 9.26E-03 
1.28 1 in 100 2.75E+06 1.37E+03 3.21E-06 6.43E-06 3.21E-05 8.04E-05 1.61E-04 3.21E-04 8.04E-04 1.61E-03 3.21E-03 4.63E-03 
0.512 1 in 250 1.10E+06 5.49E+02 1.29E-06 2.57E-06 1.29E-05 3.21E-05 6.43E-05 1.29E-04 3.21E-04 6.43E-04 1.29E-03 1.85E-03 
0.256 1 in 500 5.49E+05 2.75E+02 6.43E-07 1.29E-06 6.43E-06 1.61E-05 3.21E-05 6.43E-05 1.61E-04 3.21E-04 6.43E-04 9.26E-04 
0.128 1 in 1000 2.75E+05 1.37E+02 3.21E-07 6.43E-07 3.21E-06 8.04E-06 1.61E-05 3.21E-05 8.04E-05 1.61E-04 3.21E-04 4.63E-04 
0.0256 1 in 5000 5.49E+04 2.75E+01 6.43E-08 1.29E-07 6.43E-07 1.61E-06 3.21E-06 6.43E-06 1.61E-05 3.21E-05 6.43E-05 9.26E-05 
0.0128 1 in 10000 2.75E+04 1.37E+01 3.21E-08 6.43E-08 3.21E-07 8.04E-07 1.61E-06 3.21E-06 8.04E-06 1.61E-05 3.21E-05 4.63E-05 
0.00256 1 in 50000 5.49E+03 2.75E+00 6.43E-09 1.29E-08 6.43E-08 1.61E-07 3.21E-07 6.43E-07 1.61E-06 3.21E-06 6.43E-06 9.26E-06 
0.00128 1 in 100000 2.75E+03 1.37E+00 3.21E-09 6.43E-09 3.21E-08 8.04E-08 1.61E-07 3.21E-07 8.04E-07 1.61E-06 3.21E-06 4.63E-06 
0.000256 1 in 500000 5.49E+02 2.75E-01 6.43E-10 1.29E-09 6.43E-09 1.61E-08 3.21E-08 6.43E-08 1.61E-07 3.21E-07 6.43E-07 9.26E-07 





Table A.21: 242Pu inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 1.18E+06 5.91E+02 8.17E-05 1.63E-04 8.17E-04 2.04E-03 4.08E-03 8.17E-03 2.04E-02 4.08E-02 8.17E-02 1.18E-01 
56.5 1 in 2 5.91E+05 2.96E+02 4.08E-05 8.17E-05 4.08E-04 1.02E-03 2.04E-03 4.08E-03 1.02E-02 2.04E-02 4.08E-02 5.88E-02 
28.25 1 in 4 2.96E+05 1.48E+02 2.04E-05 4.08E-05 2.04E-04 5.10E-04 1.02E-03 2.04E-03 5.10E-03 1.02E-02 2.04E-02 2.94E-02 
22.6 1 in 5 2.36E+05 1.18E+02 1.63E-05 3.27E-05 1.63E-04 4.08E-04 8.17E-04 1.63E-03 4.08E-03 8.17E-03 1.63E-02 2.35E-02 
11.3 1 in 10 1.18E+05 5.91E+01 8.17E-06 1.63E-05 8.17E-05 2.04E-04 4.08E-04 8.17E-04 2.04E-03 4.08E-03 8.17E-03 1.18E-02 
5.65 1 in 20 5.91E+04 2.96E+01 4.08E-06 8.17E-06 4.08E-05 1.02E-04 2.04E-04 4.08E-04 1.02E-03 2.04E-03 4.08E-03 5.88E-03 
2.26 1 in 50 2.36E+04 1.18E+01 1.63E-06 3.27E-06 1.63E-05 4.08E-05 8.17E-05 1.63E-04 4.08E-04 8.17E-04 1.63E-03 2.35E-03 
1.13 1 in 100 1.18E+04 5.91E+00 8.17E-07 1.63E-06 8.17E-06 2.04E-05 4.08E-05 8.17E-05 2.04E-04 4.08E-04 8.17E-04 1.18E-03 
0.452 1 in 250 4.73E+03 2.36E+00 3.27E-07 6.53E-07 3.27E-06 8.17E-06 1.63E-05 3.27E-05 8.17E-05 1.63E-04 3.27E-04 4.70E-04 
0.226 1 in 500 2.36E+03 1.18E+00 1.63E-07 3.27E-07 1.63E-06 4.08E-06 8.17E-06 1.63E-05 4.08E-05 8.17E-05 1.63E-04 2.35E-04 
0.113 1 in 1000 1.18E+03 5.91E-01 8.17E-08 1.63E-07 8.17E-07 2.04E-06 4.08E-06 8.17E-06 2.04E-05 4.08E-05 8.17E-05 1.18E-04 
0.0226 1 in 5000 2.36E+02 1.18E-01 1.63E-08 3.27E-08 1.63E-07 4.08E-07 8.17E-07 1.63E-06 4.08E-06 8.17E-06 1.63E-05 2.35E-05 
0.0113 1 in 10000 1.18E+02 5.91E-02 8.17E-09 1.63E-08 8.17E-08 2.04E-07 4.08E-07 8.17E-07 2.04E-06 4.08E-06 8.17E-06 1.18E-05 
0.00226 1 in 50000 2.36E+01 1.18E-02 1.63E-09 3.27E-09 1.63E-08 4.08E-08 8.17E-08 1.63E-07 4.08E-07 8.17E-07 1.63E-06 2.35E-06 
0.00113 1 in 100000 1.18E+01 5.91E-03 8.17E-10 1.63E-09 8.17E-09 2.04E-08 4.08E-08 8.17E-08 2.04E-07 4.08E-07 8.17E-07 1.18E-06 
0.000226 1 in 500000 2.36E+00 1.18E-03 1.63E-10 3.27E-10 1.63E-09 4.08E-09 8.17E-09 1.63E-08 4.08E-08 8.17E-08 1.63E-07 2.35E-07 





Table A.22: 242Pu ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 2.89E+08 1.45E+05 3.38E-04 6.76E-04 3.38E-03 8.45E-03 1.69E-02 3.38E-02 8.45E-02 1.69E-01 3.38E-01 4.87E-01 
64 1 in 2 1.45E+08 7.23E+04 1.69E-04 3.38E-04 1.69E-03 4.23E-03 8.45E-03 1.69E-02 4.23E-02 8.45E-02 1.69E-01 2.43E-01 
32 1 in 4 7.23E+07 3.61E+04 8.45E-05 1.69E-04 8.45E-04 2.11E-03 4.23E-03 8.45E-03 2.11E-02 4.23E-02 8.45E-02 1.22E-01 
25.6 1 in 5 5.78E+07 2.89E+04 6.76E-05 1.35E-04 6.76E-04 1.69E-03 3.38E-03 6.76E-03 1.69E-02 3.38E-02 6.76E-02 9.74E-02 
12.8 1 in 10 2.89E+07 1.45E+04 3.38E-05 6.76E-05 3.38E-04 8.45E-04 1.69E-03 3.38E-03 8.45E-03 1.69E-02 3.38E-02 4.87E-02 
6.4 1 in 20 1.45E+07 7.23E+03 1.69E-05 3.38E-05 1.69E-04 4.23E-04 8.45E-04 1.69E-03 4.23E-03 8.45E-03 1.69E-02 2.43E-02 
2.56 1 in 50 5.78E+06 2.89E+03 6.76E-06 1.35E-05 6.76E-05 1.69E-04 3.38E-04 6.76E-04 1.69E-03 3.38E-03 6.76E-03 9.74E-03 
1.28 1 in 100 2.89E+06 1.45E+03 3.38E-06 6.76E-06 3.38E-05 8.45E-05 1.69E-04 3.38E-04 8.45E-04 1.69E-03 3.38E-03 4.87E-03 
0.512 1 in 250 1.16E+06 5.78E+02 1.35E-06 2.71E-06 1.35E-05 3.38E-05 6.76E-05 1.35E-04 3.38E-04 6.76E-04 1.35E-03 1.95E-03 
0.256 1 in 500 5.78E+05 2.89E+02 6.76E-07 1.35E-06 6.76E-06 1.69E-05 3.38E-05 6.76E-05 1.69E-04 3.38E-04 6.76E-04 9.74E-04 
0.128 1 in 1000 2.89E+05 1.45E+02 3.38E-07 6.76E-07 3.38E-06 8.45E-06 1.69E-05 3.38E-05 8.45E-05 1.69E-04 3.38E-04 4.87E-04 
0.0256 1 in 5000 5.78E+04 2.89E+01 6.76E-08 1.35E-07 6.76E-07 1.69E-06 3.38E-06 6.76E-06 1.69E-05 3.38E-05 6.76E-05 9.74E-05 
0.0128 1 in 10000 2.89E+04 1.45E+01 3.38E-08 6.76E-08 3.38E-07 8.45E-07 1.69E-06 3.38E-06 8.45E-06 1.69E-05 3.38E-05 4.87E-05 
0.00256 1 in 50000 5.78E+03 2.89E+00 6.76E-09 1.35E-08 6.76E-08 1.69E-07 3.38E-07 6.76E-07 1.69E-06 3.38E-06 6.76E-06 9.74E-06 
0.00128 1 in 100000 2.89E+03 1.45E+00 3.38E-09 6.76E-09 3.38E-08 8.45E-08 1.69E-07 3.38E-07 8.45E-07 1.69E-06 3.38E-06 4.87E-06 
0.000256 1 in 500000 5.78E+02 2.89E-01 6.76E-10 1.35E-09 6.76E-09 1.69E-08 3.38E-08 6.76E-08 1.69E-07 3.38E-07 6.76E-07 9.74E-07 





Table A.23: 241Am inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 1.32E+06 6.58E+02 6.99E-04 1.40E-03 6.99E-03 1.75E-02 3.50E-02 6.99E-02 1.75E-01 3.50E-01 6.99E-01 1.01E+00 
57.5 1 in 2 6.58E+05 3.29E+02 3.50E-04 6.99E-04 3.50E-03 8.74E-03 1.75E-02 3.50E-02 8.74E-02 1.75E-01 3.50E-01 5.03E-01 
28.75 1 in 4 3.29E+05 1.64E+02 1.75E-04 3.50E-04 1.75E-03 4.37E-03 8.74E-03 1.75E-02 4.37E-02 8.74E-02 1.75E-01 2.52E-01 
23 1 in 5 2.63E+05 1.32E+02 1.40E-04 2.80E-04 1.40E-03 3.50E-03 6.99E-03 1.40E-02 3.50E-02 6.99E-02 1.40E-01 2.01E-01 
11.5 1 in 10 1.32E+05 6.58E+01 6.99E-05 1.40E-04 6.99E-04 1.75E-03 3.50E-03 6.99E-03 1.75E-02 3.50E-02 6.99E-02 1.01E-01 
5.75 1 in 20 6.58E+04 3.29E+01 3.50E-05 6.99E-05 3.50E-04 8.74E-04 1.75E-03 3.50E-03 8.74E-03 1.75E-02 3.50E-02 5.03E-02 
2.3 1 in 50 2.63E+04 1.32E+01 1.40E-05 2.80E-05 1.40E-04 3.50E-04 6.99E-04 1.40E-03 3.50E-03 6.99E-03 1.40E-02 2.01E-02 
1.15 1 in 100 1.32E+04 6.58E+00 6.99E-06 1.40E-05 6.99E-05 1.75E-04 3.50E-04 6.99E-04 1.75E-03 3.50E-03 6.99E-03 1.01E-02 
0.46 1 in 250 5.26E+03 2.63E+00 2.80E-06 5.59E-06 2.80E-05 6.99E-05 1.40E-04 2.80E-04 6.99E-04 1.40E-03 2.80E-03 4.03E-03 
0.23 1 in 500 2.63E+03 1.32E+00 1.40E-06 2.80E-06 1.40E-05 3.50E-05 6.99E-05 1.40E-04 3.50E-04 6.99E-04 1.40E-03 2.01E-03 
0.115 1 in 1000 1.32E+03 6.58E-01 6.99E-07 1.40E-06 6.99E-06 1.75E-05 3.50E-05 6.99E-05 1.75E-04 3.50E-04 6.99E-04 1.01E-03 
0.023 1 in 5000 2.63E+02 1.32E-01 1.40E-07 2.80E-07 1.40E-06 3.50E-06 6.99E-06 1.40E-05 3.50E-05 6.99E-05 1.40E-04 2.01E-04 
0.0115 1 in 10000 1.32E+02 6.58E-02 6.99E-08 1.40E-07 6.99E-07 1.75E-06 3.50E-06 6.99E-06 1.75E-05 3.50E-05 6.99E-05 1.01E-04 
0.0023 1 in 50000 2.63E+01 1.32E-02 1.40E-08 2.80E-08 1.40E-07 3.50E-07 6.99E-07 1.40E-06 3.50E-06 6.99E-06 1.40E-05 2.01E-05 
0.00115 1 in 100000 1.32E+01 6.58E-03 6.99E-09 1.40E-08 6.99E-08 1.75E-07 3.50E-07 6.99E-07 1.75E-06 3.50E-06 6.99E-06 1.01E-05 
0.00023 1 in 500000 2.63E+00 1.32E-03 1.40E-09 2.80E-09 1.40E-08 3.50E-08 6.99E-08 1.40E-07 3.50E-07 6.99E-07 1.40E-06 2.01E-06 






Table A.24: 241Am ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 3.56E+08 1.78E+05 3.66E-03 7.32E-03 3.66E-02 9.14E-02 1.83E-01 3.66E-01 9.14E-01 1.83E+00 3.66E+00 5.27E+00 
70 1 in 2 1.78E+08 8.90E+04 1.83E-03 3.66E-03 1.83E-02 4.57E-02 9.14E-02 1.83E-01 4.57E-01 9.14E-01 1.83E+00 2.63E+00 
35 1 in 4 8.90E+07 4.45E+04 9.14E-04 1.83E-03 9.14E-03 2.29E-02 4.57E-02 9.14E-02 2.29E-01 4.57E-01 9.14E-01 1.32E+00 
28 1 in 5 7.12E+07 3.56E+04 7.32E-04 1.46E-03 7.32E-03 1.83E-02 3.66E-02 7.32E-02 1.83E-01 3.66E-01 7.32E-01 1.05E+00 
14 1 in 10 3.56E+07 1.78E+04 3.66E-04 7.32E-04 3.66E-03 9.14E-03 1.83E-02 3.66E-02 9.14E-02 1.83E-01 3.66E-01 5.27E-01 
7 1 in 20 1.78E+07 8.90E+03 1.83E-04 3.66E-04 1.83E-03 4.57E-03 9.14E-03 1.83E-02 4.57E-02 9.14E-02 1.83E-01 2.63E-01 
2.8 1 in 50 7.12E+06 3.56E+03 7.32E-05 1.46E-04 7.32E-04 1.83E-03 3.66E-03 7.32E-03 1.83E-02 3.66E-02 7.32E-02 1.05E-01 
1.4 1 in 100 3.56E+06 1.78E+03 3.66E-05 7.32E-05 3.66E-04 9.14E-04 1.83E-03 3.66E-03 9.14E-03 1.83E-02 3.66E-02 5.27E-02 
0.56 1 in 250 1.42E+06 7.12E+02 1.46E-05 2.93E-05 1.46E-04 3.66E-04 7.32E-04 1.46E-03 3.66E-03 7.32E-03 1.46E-02 2.11E-02 
0.28 1 in 500 7.12E+05 3.56E+02 7.32E-06 1.46E-05 7.32E-05 1.83E-04 3.66E-04 7.32E-04 1.83E-03 3.66E-03 7.32E-03 1.05E-02 
0.14 1 in 1000 3.56E+05 1.78E+02 3.66E-06 7.32E-06 3.66E-05 9.14E-05 1.83E-04 3.66E-04 9.14E-04 1.83E-03 3.66E-03 5.27E-03 
0.028 1 in 5000 7.12E+04 3.56E+01 7.32E-07 1.46E-06 7.32E-06 1.83E-05 3.66E-05 7.32E-05 1.83E-04 3.66E-04 7.32E-04 1.05E-03 
0.014 1 in 10000 3.56E+04 1.78E+01 3.66E-07 7.32E-07 3.66E-06 9.14E-06 1.83E-05 3.66E-05 9.14E-05 1.83E-04 3.66E-04 5.27E-04 
0.0028 1 in 50000 7.12E+03 3.56E+00 7.32E-08 1.46E-07 7.32E-07 1.83E-06 3.66E-06 7.32E-06 1.83E-05 3.66E-05 7.32E-05 1.05E-04 
0.0014 1 in 100000 3.56E+03 1.78E+00 3.66E-08 7.32E-08 3.66E-07 9.14E-07 1.83E-06 3.66E-06 9.14E-06 1.83E-05 3.66E-05 5.27E-05 
0.00028 1 in 500000 7.12E+02 3.56E-01 7.32E-09 1.46E-08 7.32E-08 1.83E-07 3.66E-07 7.32E-07 1.83E-06 3.66E-06 7.32E-06 1.05E-05 





Table A.25: 243Am inhalation risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 1.37E+06 6.84E+02 7.27E-04 1.45E-03 7.27E-03 1.82E-02 3.63E-02 7.27E-02 1.82E-01 3.63E-01 7.27E-01 1.05E+00 
57.5 1 in 2 6.84E+05 3.42E+02 3.63E-04 7.27E-04 3.63E-03 9.08E-03 1.82E-02 3.63E-02 9.08E-02 1.82E-01 3.63E-01 5.23E-01 
28.75 1 in 4 3.42E+05 1.71E+02 1.82E-04 3.63E-04 1.82E-03 4.54E-03 9.08E-03 1.82E-02 4.54E-02 9.08E-02 1.82E-01 2.62E-01 
23 1 in 5 2.74E+05 1.37E+02 1.45E-04 2.91E-04 1.45E-03 3.63E-03 7.27E-03 1.45E-02 3.63E-02 7.27E-02 1.45E-01 2.09E-01 
11.5 1 in 10 1.37E+05 6.84E+01 7.27E-05 1.45E-04 7.27E-04 1.82E-03 3.63E-03 7.27E-03 1.82E-02 3.63E-02 7.27E-02 1.05E-01 
5.75 1 in 20 6.84E+04 3.42E+01 3.63E-05 7.27E-05 3.63E-04 9.08E-04 1.82E-03 3.63E-03 9.08E-03 1.82E-02 3.63E-02 5.23E-02 
2.3 1 in 50 2.74E+04 1.37E+01 1.45E-05 2.91E-05 1.45E-04 3.63E-04 7.27E-04 1.45E-03 3.63E-03 7.27E-03 1.45E-02 2.09E-02 
1.15 1 in 100 1.37E+04 6.84E+00 7.27E-06 1.45E-05 7.27E-05 1.82E-04 3.63E-04 7.27E-04 1.82E-03 3.63E-03 7.27E-03 1.05E-02 
0.46 1 in 250 5.47E+03 2.74E+00 2.91E-06 5.81E-06 2.91E-05 7.27E-05 1.45E-04 2.91E-04 7.27E-04 1.45E-03 2.91E-03 4.19E-03 
0.23 1 in 500 2.74E+03 1.37E+00 1.45E-06 2.91E-06 1.45E-05 3.63E-05 7.27E-05 1.45E-04 3.63E-04 7.27E-04 1.45E-03 2.09E-03 
0.115 1 in 1000 1.37E+03 6.84E-01 7.27E-07 1.45E-06 7.27E-06 1.82E-05 3.63E-05 7.27E-05 1.82E-04 3.63E-04 7.27E-04 1.05E-03 
0.023 1 in 5000 2.74E+02 1.37E-01 1.45E-07 2.91E-07 1.45E-06 3.63E-06 7.27E-06 1.45E-05 3.63E-05 7.27E-05 1.45E-04 2.09E-04 
0.0115 1 in 10000 1.37E+02 6.84E-02 7.27E-08 1.45E-07 7.27E-07 1.82E-06 3.63E-06 7.27E-06 1.82E-05 3.63E-05 7.27E-05 1.05E-04 
0.0023 1 in 50000 2.74E+01 1.37E-02 1.45E-08 2.91E-08 1.45E-07 3.63E-07 7.27E-07 1.45E-06 3.63E-06 7.27E-06 1.45E-05 2.09E-05 
0.00115 1 in 100000 1.37E+01 6.84E-03 7.27E-09 1.45E-08 7.27E-08 1.82E-07 3.63E-07 7.27E-07 1.82E-06 3.63E-06 7.27E-06 1.05E-05 
0.00023 1 in 500000 2.74E+00 1.37E-03 1.45E-09 2.91E-09 1.45E-08 3.63E-08 7.27E-08 1.45E-07 3.63E-07 7.27E-07 1.45E-06 2.09E-06 





Table A.26: 243Am ingestion risk assessment.  Colored lines indicated quantification limits for various analytical techniques. 





























100 1 in 1 3.58E+08 1.79E+05 3.68E-03 7.37E-03 3.68E-02 9.21E-02 1.84E-01 3.68E-01 9.21E-01 1.84E+00 3.68E+00 5.30E+00 
70 1 in 2 1.79E+08 8.96E+04 1.84E-03 3.68E-03 1.84E-02 4.60E-02 9.21E-02 1.84E-01 4.60E-01 9.21E-01 1.84E+00 2.65E+00 
35 1 in 4 8.96E+07 4.48E+04 9.21E-04 1.84E-03 9.21E-03 2.30E-02 4.60E-02 9.21E-02 2.30E-01 4.60E-01 9.21E-01 1.33E+00 
28 1 in 5 7.17E+07 3.58E+04 7.37E-04 1.47E-03 7.37E-03 1.84E-02 3.68E-02 7.37E-02 1.84E-01 3.68E-01 7.37E-01 1.06E+00 
14 1 in 10 3.58E+07 1.79E+04 3.68E-04 7.37E-04 3.68E-03 9.21E-03 1.84E-02 3.68E-02 9.21E-02 1.84E-01 3.68E-01 5.30E-01 
7 1 in 20 1.79E+07 8.96E+03 1.84E-04 3.68E-04 1.84E-03 4.60E-03 9.21E-03 1.84E-02 4.60E-02 9.21E-02 1.84E-01 2.65E-01 
2.8 1 in 50 7.17E+06 3.58E+03 7.37E-05 1.47E-04 7.37E-04 1.84E-03 3.68E-03 7.37E-03 1.84E-02 3.68E-02 7.37E-02 1.06E-01 
1.4 1 in 100 3.58E+06 1.79E+03 3.68E-05 7.37E-05 3.68E-04 9.21E-04 1.84E-03 3.68E-03 9.21E-03 1.84E-02 3.68E-02 5.30E-02 
0.56 1 in 250 1.43E+06 7.17E+02 1.47E-05 2.95E-05 1.47E-04 3.68E-04 7.37E-04 1.47E-03 3.68E-03 7.37E-03 1.47E-02 2.12E-02 
0.28 1 in 500 7.17E+05 3.58E+02 7.37E-06 1.47E-05 7.37E-05 1.84E-04 3.68E-04 7.37E-04 1.84E-03 3.68E-03 7.37E-03 1.06E-02 
0.14 1 in 1000 3.58E+05 1.79E+02 3.68E-06 7.37E-06 3.68E-05 9.21E-05 1.84E-04 3.68E-04 9.21E-04 1.84E-03 3.68E-03 5.30E-03 
0.028 1 in 5000 7.17E+04 3.58E+01 7.37E-07 1.47E-06 7.37E-06 1.84E-05 3.68E-05 7.37E-05 1.84E-04 3.68E-04 7.37E-04 1.06E-03 
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